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Collagen is an abundant structural protein in the extracellular matrix and plays a role 
in both structural integrity and support that guides tissue formation and homeostasis. 
Collagen or matrix disruption, leading to altered cell-matrix interactions, is 
implicated in disease pathophysiology. Collagen has in turn become an attractive 
biomaterial in regenerative medicine, proving valuable in various long-term, robust 
repair strategies. Osteoarthritis (OA) is a multifactorial disease leading to the 
degeneration of articular cartilage, affecting approximately 8.5 million in the UK 
population. Current repair procedures require surgical interventions, with varying 
degrees of success, easing pain and recovery time. Future repair strategies are now 
being focused around the formation of new tissue for implantation, incorporating 
collagen scaffolds, donor cell populations and functional differentiation.  
 
This thesis presents a thorough characterization of a novel jellyfish (R.pulmo) source 
of collagen, benchmarked against mammalian collagen like material compatible with 
human and bovine chondroprogenitor cell invasion, proliferation, and differentiation. 
Significantly, no increased immune response was observed compared to research and 
clinical grade mammalian collagen sources during in vitro examination. Excitingly, 
jellyfish collagen (JCol) also demonstrated hallmarks of chondro-mimicry, enabling 
bovine chondroprogenitor cell invasion, proliferation and differentiation. Using a 
sponge scaffold design JCol provides adequate structural cell-matrix support 
appropriate for enhanced chondrogenesis in the presence of TGFβ1. 
 
The robust body of evidence presented supports the development of JCol, a 
seemingly inert collagen source, for tissue engineering and/or regenerative medicine 
applications. Analogous to native articular cartilage, this supports further 
development of jellyfish collagen as a biomaterial for matrix assisted chondrocyte 
implantation (MACI) approaches in OA repair. Jellagen, industrial sponsor for the 
project, have adopted central observations from this thesis and are now progressing 
with wider commercial and development activities to support market and clinical 
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1.1 Multicellular organisms, tissues and extracellular matrix 
 
Within multicellular organisms, tissues are organised as communities of cells that 
work together to carry out specific functions, such as protection, movement and 
response to stimuli. The exact role of a tissue in an organism depends on what types 
of cell it contains. The multitude of tissue specific cell types and functions are 
maintained by differential transcriptional programs and rates, which are essential to 
tissue maintenance and repair (Ong and Corces, 2011). The spatial organisation of 
the cells that form tissues is also central to their function and survival. This 
organisation depends in part on polarity and external signals from neighbouring cells 
and or from the extracellular matrix (ECM) (Frantz et al., 2010).  
 
The ECM is critical to tissue structure, providing attachment sites for cells and 
relaying information regarding the spatial position of the cell. The ECM consists of a 
mixture of proteins and polysaccharides produced by nearby cells. Once synthesised, 
these molecules move to the appropriate side of the cell – such as the basal or apical 
face – where they are secreted (Overeem et al., 2015). Final ECM construction and 
organisation then occurs outside of the cell and is in general a mix of collagen, 
proteoglycan and polysaccharide that undergo turnover over time as a consequence 
of growth, development and homeostatic maintenance (Birk, 2011).  
 
1.1.1 Extracellular matrix  
 
As well as a supportive function, the ECM has been shown to be involved in cellular 
processes such as migration, differentiation and apoptosis (Naahidi et al., 2017). At 
the most basic level, the ECM is composed of water, proteins and polysaccharides 
(Frantz et al., 2010). The exact composition of the ECM is tissue specific and offers 
specialised cues to cells through mechanical properties and acting as a reservoir for 
growth factors (Kayabolen et al., 2017).  
 
The ECM can be divided into two categories: basement or interstitial with each 
having distinct properties. The interstitial matrix is responsible for the tensile 
strength exhibited by the tissue. It is hydrated and highly charged due to its content 
of fibrillar collagens, proteoglycans (PGs) and glycosaminoglycans (GAGs). 
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Alternatively, the basement membrane (BM) primarily contains collagen IV and is 
compact and less porous than its counterpart (Lu et al., 2012). 
 
The basement membrane is a specialised extracellular matrix, approximately 50 – 
100nm thick, and separates cells from connective tissue within the human body 
(LeBleu et al., 2007). The sheet-like structure of the basement membrane is 
composed of individual collagen type IV and laminin networks that are linked by 
extracellular proteins including nidogen and perlecan. The BM’s interaction with 
cells is dependent on its anchorage to the cell surface, which is mediated through 
adhesion receptors and sulphated glycolipids (Jayadev and Sherwood, 2017). A 
difference in the molecular composition of BMs allow for them to be tissue specific 
and defines plasticity between epithelial and endothelial cells in different organs. The 
interaction with cellular components of tissue gives the BM various functions 
including the compartmentalisation of tissues, cellular support and regulation of cell 
behaviour (Kalluri, 2003). 
 
The interstitial matrix, also known as the extracellular matrix, appears in the same 
location as the BM however it may also appear between connective tissue cells. The 
ECM can be seen as an amorphous gel that is composed from collagens, elastin and 
fibronectin (Kular et al., 2014). Although the ECM was once viewed as a simple 
structural framework within tissue, a more dynamic role has been elucidated. A 
number of functions can be assigned to the ECM including highly regulated 
homeostasis and behaving as a reservoir for molecules such as growth factors and 
cytokines (Wilson, 2014). As well as these functions, the ECM also serves as a 
cellular microenvironment, influencing cell behaviour such as migration and 
proliferation (Hubmacher and Apte, 2013). The combination of different roles 
highlights the importance of the extracellular matrix and the necessity of the matrix 
during developmental and repair processes within the human body (Wilson, 2014). 
 
1.2 Collagen  
 
 
Collagen is an insoluble, fibrous protein that can be found both in the extracellular 
matrix and connective tissues. Although it was originally believed that connective 
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tissue fibroblasts secreted collagen, it has now been shown that epithelial cells are 
able to produce various different isoforms of the protein that vary in their structure, 
allowing tissues to have different, functionally driven, tensile properties (Lodish et 




Figure 1.1: Type 1 collagen structure. α chains come together to form a triple 
helix. Repetitive Gly-X-Y regions allow for tight packing of the helix and major 
ligand binding regions (MLBR) allow for collagens to interact with other collagens 
and ECM proteins. The pro-collagen molecule has amino and carboxy regions 
cleaved to become a mature collagen molecule (Marini et al., 2017) 
 
Currently, the collagen superfamily is comprised of 28 members that present 
common structural features. Collagen molecules are formed by a combination of 
three homotrimeric or heterotrimeric alpha chains giving rise to a triple helix, seen in 
Figure 1.1 (Exposito et al., 2002). The definitive feature of collagen is the 
combination of three polypeptide chains in a left handed helix formation with a 
single amino acid residue stagger between each chain to form a right handed triple 
helical structure associated with tensile strength (Shoulders and Raines, 2009). The 
tightly packed helix is reliant upon the repetitive Gly-X-Y amino acid sequence 
within each individual polypeptide chain, with glycine taking the first position in 
each repeat and is depicted in α chain gene structures in Figure 1.2 (Parenteau-Bareil 
et al., 2010). This triple helical region can account for 95% of the total structure in 
collagen I to less than 10% in collagen XII (Ricard-Blum, 2011).  
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1.2.1 Collagen Biosynthesis 
 
Extensive research has been conducted centred on collagen biosynthesis, leading to a 
high level of understanding of fibrillar collagens and the single cells that have been 
shown to synthesise various types of collagen (Exposito et al., 2010). Precursor 
molecules, containing large amino (N) and carboxy (C) terminal pro-peptides are 
synthesised, with each pro-peptide N-terminus containing a signal sequence to allow 
for translocation into the lumen of the rough endoplasmic reticulum (Mouw et al., 
2014). A 15 amino acid region has been identified in the C-terminal pro-peptide that 
is thought to be involved in recognition of different chains showing that it plays a 
pivotal role in the assembly of the helix. Multiple sequence alignment of mammalian 
C-terminal peptides revealed that this region is composed of two hydrophilic 
portions of 12 and 3 amino acids separated by a highly conserved hydrophobic 
sequence (Exposito et al., 2010). 





Figure 1.2: Comparison of gene structure of human procollagens. Human procollagen α1 (IV), α2 (I), α1 (II) and α1 (III) genes. 
Solid lines represent intron sequences black boxes represent Gly-X-Y repeats and hatched boxes represent NC-1 domain coding exons. 
Sizes of intron and exons are indicated by the corresponding numbers above sequences (Soininen et al., 1986).
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Post-translational modification of the polypeptide chain is initiated during 
translocation. These modifications include prolyl-4-hydroxylation and prolyl-3-
hydroxylation at the Y and X positions respectively, and lysyl hydroxylation giving 
rise to hydroxylysine residues (Koide and Nagata, 2005). During this process, 
galactose and glucose residues are also attached to hydroxylysine residues whilst 
oligosaccharides are added to the C-terminal pro-peptide. Following translocation 
and modification, pro-peptide chains trimerize at the C-terminal domain forming 
intermolecular disulphide bonds and halting any further modification, with 
association only occurring if the correct chains are present for the distinct collagen 
type (Lodish et al., 2000a). 
 
Many proteins are involved in the triple helix formation of procollagen molecules 
including heat shock protein 47 (HSP47) and peptidyl-prolyl cis-trans isomerase 
(PPI). The stabilisation of procollagen at body temperature takes an average of more 
than 20 heat shock proteins (Ricard-Blum, 2011). The importance of these two 
proteins in helix formation has been indicated through in vitro experiments involving 
murine models, leading to fatal consequences (Gelse et al., 2003). Previous reports 
have shown that HSP47 knockout mice cause improper formation of type I and IV 
collagen, aggregating in the endoplasmic reticulum and leading to cell death 
(Kawasaki et al., 2014) 
 
Once secreted into the extracellular matrix both amino and carboxy pro-peptides are 
enzymatically cleaved producing mature collagen molecules that proceed to 
assemble into fibrils. N-terminal peptides are cleaved by a disintegrin and 
metalloproteinase with thrombospondin motif (ADAMTs) family members 2 and 3, 
whilst C-terminal peptides are removed by bone morphogenetic protein 1 (BMP1) 
(Ricard-Blum, 2011).  Following telopeptide cleavage, collagen chains come 
together to form fibrils. Their longitudinal orientation is staggered creating 
alternating areas of high and low density that is known as a D periodicity repeating at 
approximately 67nm and can be seen at the ultrastructural level (Yamauchi and 
Sricholpech, 2012).  
 
The stabilisation of collagen fibrils is enhanced with the formation of covalent 
crosslinks that occur due to the hydroxylation of lysines at the telopeptide region. 
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The proportion of hydroxylated lysine varies between tissues and is dependent on 
their function within tissues such as cartilage showing a larger percentage of 
hydroxylation compared to skin. Lysyl oxidases are copper dependent oxido-
deaminases that catalyse the formation of aldehydes between lysine and 
hydroxylysine residues whilst spontaneous reactions form intermediate crosslinks. 
During maturation of tissues these intermediate reducible crosslinks can be converted 
into non-reducible crosslinks changing the physical and mechanical properties of the 
tissues (Gelse et al., 2003). 
 
Assembly of supramolecular structures begins with the trimerization of three alpha 
chains to form a triple helical protomer with each helical portion flanked by non 
collagenous regions varying in sequence and length (Veit et al., 2006). Specific 
protomers organise themselves into suprastructures by forming end to end 
connections, lateral associations and supercoiling of helices (Khoshnoodi et al., 
2006). The exact mechanisms of how alpha chains recognize each other to form 
superstructures is not fully understood. In the case of collagen I and III it is thought 
that the non collagenous C-terminal domain are key in the selection binding and 
recognition of alpha chains to complete trimerization (Doege and Fessler, 1986). 
 
1.2.2 Collagen family structural and functional variety  
 
Collagen molecules occur in various suprastructures, such as fibrils and networks 
outlined in Table 1.1. These basic scaffold structures form attachments to other 
macromolecular complexes such as cell surface receptors and proteoglycans in order 
to fulfill a variety of functional roles in tissue development and homeostasis 
(Khoshnoodi et al., 2006). These distinct subfamilies are then outlined in more detail 
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I COL1A1-2 Bone, dermis, 
tendon, ligaments, 
cornea 
II COL2A1 Cartilage, vitreous 
body 
III COL3A1 Skin, vessel wall, 
reticular fibres 
V COL5A1-3 Lung, cornea, bone 
XI COL11A1-2 Cartilage, vitreous 
body 
XXIV COL24A1 Bone, brain, 
muscles, testis, 
ovaries 
XXVI COL26A1 Testis, ovaries 




IV COL4A1-6 Basement 
membranes 
Microfibrillar VI COL6A1-3 Dermis, cartilage, 
placenta, lungs 
Anchoring fibrils VII COL7A1 Skin, cervix, oral 
mucosa 
Network forming VIII COL8A1-2 Endothelial cells 









IX COL9A1-3 Cartilage, cornea 
XII COL12A1 Ligaments, 
tendons, 
perichondrium 
XIV COL14A1 Dermis, tendon, 
placenta, liver 
XIX COL19A1 Human 
rhabdomyosarcoma 
XX COL20A1 Sternal cartilage, 
corneal epithelium, 
embryonic skin 
XXI COL21A1 Blood vessel wall 





XIII COL13A1 Epidermis, lungs, 
liver 
XXV COL17A1 Dermal-epidermal 
junctions 
XXIII COL23A1 Lungs, tongue, 
kidney, cornea, 
brain 
XXV COL25A1 Brain 
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XV COL15A1 Smooth muscle, 
kidney, pancreas 
XVI COL16A1 Amnion, 
keratinocytes 
XVIII COL18A1 Lungs, liver 
 
Table 1.1: Collagen subfamily members. Collagen types divided into subfamilies 
with given gene and tissue distribution (Gelse et al., 2003). 
 
1.2.2.1 Fibril forming collagens 
 
The collagen family was previously considered to form fibrillar structures that 
contribute to the structural integrity of tissues and organs. They are found in the 
extracellular matrix and the interstitial tissue of parenchymal organs and behave as a 
scaffold structure lending their properties to tissues. Any disruption in the collagen 
metabolism and degradation also leads towards diseases, such as osteoarthritis and 
osteoporosis, further highlighting the importance of collagen as a structural protein 
(Gelse et al., 2003). 
 
Fibril forming collagens include type I, III and V, which are widely distributed 
throughout the body whilst other types, such as II and XI are predominantly found in 
cartilage and eye (Ricard-Blum and Ruggiero, 2005).  The 12 fibril forming  chains 
contain an uninterrupted collagenous domain (COL1) flanked by non collagenous N- 
and C-terminal pro-peptides that are cleaved in order to aid in fibril formation 
(Khoshnoodi et al., 2006). The C-terminal pro-peptide is also referred to as the NC1 
domain whilst the N pro-peptide is split into a short NC2 sequence that links the 
main triple helix to a minor version (COL2) and NC3, a globular N terminal (Ricard-
Blum and Ruggiero, 2005).  
 
The NC3 domain of  chains 1(I), 1(IIA), 1(III) and 2(V) all contain a cysteine 
rich repeat (CRR) domain characterised by the presence of 10 cysteine residues that 
are able to form disulphide bonds (Bornstein, 2002). CRR domains have been found 
present in homologous proteins of Xenopus chordin and Drosophila sog and bind to 
members of the TGF superfamily. The release of these growth factors plays a 
crucial role in dorsal-ventral patterning (Zhu et al., 1999). However, deletions of 
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CRR-containing domains in mice have shown normal development is unaffected 
(Bornstein, 2002). Although the exact mechanism of CRR domains have not been 
found it is believed that they are involved in roles such as molecular assembly and 
regulation of procollagen synthesis and fibrillogenesis (Ricard-Blum and Ruggiero, 
2005).  
 
Conversely, the NC3 domain of 1(V), 3(V), 1(XI), 2(XI), 1(XXIV) and 
1(XXVII) contain a 200 residue thrombospondin N-terminal like (TSPN) domain 
(Eyre et al., 2002). The function of TSPN domains in fibrillar collagens has not been 
elucidated however it is observed that the domain is released during N-terminal 
maturation of collagen type V and XI. Spontaneous mutation of human COL5A1 
restricting the release of the TSPN domain disrupted fibrillogenesis and caused 
classical symptoms of Ehlers-Danlos syndrome (Takahara et al., 2002).  
 
The vast majority of collagen fibrils are heterotypic, comprised of different types of 
collagen (Wu et al., 2010). Although the initial stages of fibrillogenesis have not 
been clearly defined, it is a process that relies upon leucine-rich proteoglycans and 
collagen V and XIV for regulation and these molecules are also thought to play roles 
in collagen crosslinking (Ricard-Blum, 2011).  
 
1.2.2.2 Fibril-associated collagen with interrupted triple helix (FACIT) 
collagens 
 
FACIT collagens are a specific collagen subtype, grouped together due to the regions 
of high homology combined with unique regions not found in other collagen 
classifications (Shaw and Olsen, 1991). Collagens classified as FACITs include 
types IX, XII, XIX, XX and XXII (Khoshnoodi et al., 2006). These collagens are 
classified by the presence of two or more short triple helical domains interrupted by 
several non collagenous domains (Ricard-Blum, 2011). The helical conformation is 
comprised of glycine side chains occupying the centre of the helix whilst Xaa and 
Yaa amino acids of the side chains point outwards. This organisation ensures that 
there are numerous amino acids at the surface of the protein that have the ability to 
interact with other molecules (Rest et al., 1991). Another characteristic feature of 
FACITs is a short C-terminal triple helical domain, comprised of 75 residues in 
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collagen XII to fewer than 30 residues in collagen IX that is contained by a cysteine 
containing motif and a non helical region (Birk, 2011).  
 
FACIT collagens display variances in the size and composition of their N-terminal 
domains. Collagens IX, XVI and XIX maintain a single TSPN module at the N-
terminal however in collagens XXI and XXII a von Willebrand factor A-like domain 
next to the TSPN domain. In certain species alternative splicing of collagens XIV, 
XII and XIX mRNA occurs in the N-terminal domains making FACIT collagens a 
complex molecule to study at protein level (Ricard-Blum et al., 2000). The specific 
function of FACIT collagens has yet to be elucidated however they are believed to 
stabilise the extracellular matrix. The expression of FACITs appears in 
developmentally regulated patterns suggesting that they have more diverse functions 
(Ricard-Blum and Ruggiero, 2005).  
 
Whilst fibrillar collagens aggregate, FACITs may interact with them in order to 
control fibril diameter and also aid in interaction with other ECM components (Rest 
and Garrone, 1991). Of the several collagens in the FACIT family, collagen IX is the 
most well studied FACIT collagen in structure and function. In the case of collagen 
IX and its association with fibrillar collagen, the non-C-terminal triple helix domains 
are incorporated into the collagen fibrils and stabilise the fibrillar organisation. 
Although this function has been elucidated in type IX collagen it is not seen as a 
phenomenon that occurs with all FACITs (Birk, 2011). 
 
1.2.2.3 Network forming collagens  
 
Individual types of collagen (type IV, VI, VIII and X) are able to aggregate in a 
linear and lateral fashion in order to form open networks that carry out a variety of 
functions such as anchorage and support for cells and serving as a molecular filter. 
Type IV collagen is often seen as the most important network forming collagen as it 
is the major constituent of the basement membrane (Knupp and Squire, 2005).  
 
Collagen VI is expressed throughout connective tissues and is formed by 3 alpha 
chains, 1, 2 and 3 that form beaded filaments (Ball et al., 2001). Each alpha 
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chain consists of a collagenous domain of approximately 335 residues that is capped 
by non-collagenous domains at the C- and N-terminals. Whilst the 1 and 2 chains 
are similar in size and possess three non-collagenous subdomains (N1, C1 and C2), 
the 3 chain is significantly longer with the N-terminal possessing 10 subdomains 
and the C-terminal possessing five (Khoshnoodi et al., 2006).  
 
Unlike fibrillar collagens, network-forming collagens, in particular type IV collagen, 
do not require cleavage of C- and N-terminal propeptides to form networks at the 
basement membrane. Collagen in the basement membrane is unique in its structure 
due to the self-assembly of individual protomers via aggregation and crosslinking 
forming a complex meshwork (Harvey and Thorner, 2005). 
 
1.2.2.4 Transmembrane collagens 
 
Transmembrane collagen function as cell surface receptors and matrix components 
and include collagen types XIII, XVII, XXIII and XXV as well as collagen related 
proteins such as macrophage receptor MARCO and ectodysplasin A (Franzke et al., 
2005). The alpha chains of this collagen type host a non collagenous N terminal 
domain that has three subdomains (intracellular, single transmembrane and 
extracellular linker) and a large extracellular domain (Khoshnoodi et al., 2006). 
Deletion studies conducted on type XIII and XVII N terminal regions show that they 
are necessary for the formation of the triple helix and that the process occurs in a N- 
to C-terminal manner, which is unlike all other collagen classifications (Areida et al., 
2001). 
 
1.2.2.5 Collagen receptors 
 
As well as offering a supportive role as part of the extracellular matrix, collagens 
also participate in cell-matrix interactions through receptor families that aid in 
various physiological processes including cell anchorage, polarity and differentiation 
(Ricard-Blum, 2011). Interaction of matrix components with collagen may occur in 
the helical COL domain or non-collagenous domains (Leitinger, 2011). Within the 
COL region specific amino acid motifs provide a site for interactions however the 
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COL region also plays host to cryptic binding sites that are able to form interactions 
following denaturation of the protein (Heino, 2007). Cryptic motifs have been shown 
to be important in the removal of denatured and degraded collagen (Engelholm et al., 
2009). Specific 6-12 amino acid motifs are found within the COL region for integrins 
and dimeric discoidin receptors (DDRs) whilst common motifs such as GPO, where 
O represents hydroxylysine, are recognised by GPVI and LAIR-1 (Leitinger, 2011).  
 
Integrins are a family of extracellular matrix receptors for cell adhesion that are 
formed through the non-covalent association of  and  subunits (Hynes, 2002). 
Four integrins behave as collagen receptors: 11 expressed by mesenchymal cells, 
21 primarily expressed in epithelial cells as well as platelets, 101 in 
chondrocytes and 111 in fibroblasts. GFOGER was the first motif identified as a 
high affinity binding site for 11 and 21 as well as 111 whilst a later study 
also identified GLOGER and GASGER as two additional binding motifs (Leitinger, 
2011).  
 
The discoidin domain receptors DDR1 and DDR2 belong to a subfamily of receptor 
tyrosine kinases where the ectodomain is split into two domains: N-terminal 
discoidin homology (DS) domain and a unique DDR globular domain. A single 
transmembrane domain connects the extracellular domain and the cytoplasmic 
domain (Leitinger, 2011). Both DDR1 and DDR2 are found throughout foetal and 
adult tissues with DDR1 found in epithelial cells and DDR2 found in mesenchymal 
(Alves et al., 1995). DDRs bind to a broad range of collagen types and have been 
shown to need an intact triple helix in order to bind (Leitinger, 2003).  
 
DDRs are regulators of cell adhesion, migration, proliferation and differentiation. 
They also influence matrix metalloproteinases to remodel the matrix (Leitinger, 
2011). Once DDR binding to collagen has occurred, phosphorylation of cytoplasmic 
tyrosine residues takes place and behaves as a docking site for adaptor molecules 
however it is uncertain how this process links to cellular processes (Ikeda et al., 
2002). As with integrins, DDRs bind to specific motif within the collagen molecule. 
DDR1 and DDR2 binding had been found to occur in the COL region at a GVMGFO 
motif that appears in collagens I-III (Xu et al., 2011). DDR1 and DDR2 extracellular 
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domains regulate collagen deposition within the extracellular matrix by inhibiting 
fibrillogenesis. When bound to collagen I, DDR2 affects mechanical properties of 
the fibre by reducing their length and Young’s modulus (Ricard-Blum, 2011). 
 
1.3 ECM structure, cell function and disease development  
 
Combinations of characteristics possessed by the ECM have an effect upon cellular 
functions, ranging from physical properties such as stiffness to the biochemical 
signature of tissue specific ECM exhibited by proteins, growth factors and signal 
receptors (Kim et al., 2011). The dynamic environment within a tissue is dependent 
upon the interactions of cells with the ECM as well as neighbouring cells.  These 
interactions allow for the regulation of cell function and homeostasis of the tissue, 
with a lack of interaction between cells and ECM leading to anoikis, a specific form 
of cell death (Marastoni et al., 2008). Adherent cells are protected from anoikis and 
the phenomenon is seen as a hallmark of cancer and is linked with tumour metastasis 
(Barthes et al., 2014).  
 
The primary function of the ECM is as a supportive structure and the physical 
properties of the extracellular matrix plays a role in cell fate, migration, proliferation 
and survival (Kim et al., 2011). The human body presents a wide range of tissues 
with various degrees of elasticity, from pliable brain tissue with an elastic modulus in 
kilopascal to hard, calcified bone exhibiting a modulus in megapascals. Cells within 
these tissues become accustomed to the environment in which they reside and are 
able to maintain their phenotype. However, studies have shown that the ECM 
environment is able to guide differentiation of mesenchymal stem cells down 
osteoblastic, skeletal muscular and neural lineages in an ECM biomechanical-
dependent manner (Park et al., 2011). 
 
Cleavage of the ECM is needed for regulating composition and structure as well as 
the release of specific growth factors and is undertaken by different families of 
proteases (Bonnans et al., 2014). Two major classes of proteases that are involved in 
matrix remodelling are matrix metalloproteinases (MMPs) and a disintegrin and 
metalloproteinases with a thrombospondin motif proteins (ADAMTS). MMPs are 
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secreted as zymogens and are activated either by proteolytic cleaveage by Ser 
preoteases or other MMPs or oxidation that modifies thiol groups, enabling the 
degradation of ECM proteins (Hynes and Naba, 2012). MMPs are capable of 
breaking down a multitude of ECM components including proteoglycans, fibronectin 
and laminin (MMP3 and MMP10). Collagen type III is typically targeted by MMP1 
whilst collagen I and II are targets of MMP8 and MMP13, respectively (Lu et al., 
2011). ADAMTS are proteinases that contain thrombospondin motifs are the 
carboxy terminal and are known to degrade collagen and proteoglycans found within 
the ECM (Bonnans et al., 2014).  
 
1.3.1 Increased ECM degradation 
 
Deregulation of ECM breakdown by MMPs and ADAMTs proteases, can affect 
matrix and cell interactions, leading to disease development and pathogenesis 
(Bonnans et al., 2014). Increased expression of MMP1, which is specific to the heart, 
results in a loss of collagen and subsequently contractility leading to cardiomyopathy 
(Kim et al., 2000). Whereas in osteoarthritis an increase of ADAMTS4 and 
ADAMTS5 are responsible for the degradation of the cartilage tissue (Bondeson et 
al., 2008).  The mechanisms that are responsible for upregulation of these 
degradative enzymes have yet to be discovered however it is thought that receptors 
involved in cell-matrix interaction may promote increased activation of MMPs and 
ADAMTs (Echtermeyer et al., 2009).  
 
1.3.2 Excessive ECM production 
 
Following chronic injury, the excessive production and deposition of ECM without 
appropriate breakdown can lead to fibrosis (Bonnans et al., 2014). The abnormal 
tissue development may result in fatalities due to organ failure and has also been 
shown to increase the risk of cancer when occurring in certain organs such as breast 
and liver (El-Serag, 2011).  Fibrosis is primarily mediated by fibroblasts and other 
stromal cells whereby the expression of approximately 60 ECM related genes are 
upregulated including those for collagen type I and III (Verrecchia et al., 2001). 
Fibrosis may also be stimulated immune cells that have been activated by 
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interleukin-33 (IL-33), in turn promoting the production of IL-13, which 
downregulates MMPs and stimulates collagen accumulation at the site of 
inflammation (Bailey et al., 2013).  
 
1.4 Regenerative medicine 
 
Currently, organ donation is unable to meet transplantation needs of patients 
suffering with chronic conditions (Mahla, 2016). Also, due to the expanding aged 
population being particularly susceptible to chronic degenerative diseases healthcare 
expenditure continues to increase (Nelson et al., 2008). Regenerative medicine is a 
distinct and major field in basic and translational research, linking to clinical need, in 
addressing the deformation or abnormal homeostasis of tissues in a wide variety of 
disease. Major advancements in medical treatment have been undertaken based on 
the principles of cellular and acellular/matrix associated technologies and tissue 
engineering, in order to replace or regenerate human tissues and organs while aiming 
to restore function (Mao and Mooney, 2015).  
 
Multiple strategies are being employed in order to achieve regeneration of tissues 
including stem cell biology, biomechanics and nanotechnology (Sampogna et al., 
2015). A successful tissue engineered construct is seen to combine three separate 
categories; biomaterials, cells and growth factors, shown in Figure 1.3, in order to 
mimic the numerous properties a single tissue may exhibit. Components of the triad 
can be used to manipulate the growth and development of tissues for the desired 
outcome (O'Brien, 2011). This triangular strategy is also known as the R3 paradigm 
where replacement of tissue, regeneration of damage tissue and rejuvenation of cells 
must occur (Nelson et al., 2008).  
 





Figure 1.3: Tissue engineering triad. Successful tissue engineering is dependent on 
the work between cells, signals and materials (O'Brien, 2011) 
 
1.5 Articular cartilage, osteoarthritis and regenerative medicine   
 
Adults possess three main types of cartilage: fibrocartilage, elastic cartilage and 
hyaline cartilage. Fibrocartilage, composed primarily of collagen type I in the form 
of fibres, is thought to be the strongest form found within the body and appears in 
intervertebral discs and between ligaments, tendons and bones. Elastic cartilage is 
present in sections of the trachea, outer ear and epiglottis. Randomly oriented elastin 
fibres provide the characteristic elasticity that aids in maintaining the shape and 
flexibility of organs (Camarero-Espinosa et al., 2016). 
 
Articular cartilage (AC) is hyaline cartilage found lining the osseous ends of 
diarthrodial joints, at approximately 2-4mm thick, and protects the underlying bones 
allowing for frictionless, pain-free movement (Musumeci et al., 2014). The tissue is 
avascular, aneural, alymphatic and has a white, glassy appearance and unlike 
fibrocartilage, there is no evidence to show that hyaline cartilage possesses collagen 
fibres at a macroscopic level (Temenoff and Mikos, 2000).  
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1.5.1 Articular cartilage structure  
 
The overall composition of articular cartilage can be seen as relatively simplistic as it 
contains a single, highly specialised cell type, the chondrocyte, which accounts for 
approximately 2% of the total volume of articular cartilage. These cells are encased 
within a dense and organised extracellular matrix that has three main components: 
water, collagen and proteoglycans (Fox et al., 2009). Indicated in Figure 1.4, 
articular cartilage has distinct zonal organisation comprising of a superficial, 
transitional, deep and calcified zone. The varying degrees of organisation found 
within articular cartilage are key to the mechanical, metabolic and transport 





Figure 1.4: Schematic representation of health articular cartilage along side 
histological staining of cartilage tissue. Chondrocytes maintain a flattened 
morphology at the superficial zone before becoming more rounded deeper into the 
tissue. Collagen fibrils change their orientation throughout the tissue to give its 
tensile properties (Fox et al., 2009) 
 
Zonal organisation transitions from the superficial zone, closest to the synovial fluid, 
to the calcified zone, adjacent to bone. This zonal structure varies the composition of 
the extracellular matrix and collagen orientation, increasing in stiffness through the 
tissue and allowing for cartilage to possess the tensile strength necessary for its role 
(Zhu et al., 2017). 
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The superficial or tangential zone of cartilage is the thinnest zone, closest to synovial 
fluid, that plays hosts to cells that appear ellipsoidal in morphology (Bhosale and 
Richardson, 2008). Chondrocytes within this zone secrete lubricin, an important 
lubricant that allows for the fluid, frictionless movement associated with cartilage. 
Lubricin or superficial zone protein, synthesised by synoviocytes and chondrocytes, 
is an O-glycosylated protein found on the articular surface and synovial fluid 
(Gleghorn and Bonassar, 2008). The structure of lubricin is such that the central 
domain holds a negative charge whilst the terminal portions of the protein are 
positively charged (Estrella et al., 2010). This charge distribution is believed to be 
the lubricating properties of the protein (Jay and Hong, 1992). The importance in 
lubricin is demonstrated in patients presenting with camptodactyly-arthropathy-coxa 
vara-pericarditis (CACP) syndrome where there is a lack of lubricin expression 
leading to fibrosis and failure of the joint (Jones et al., 2009).  
 
Three types of collagen are present in the superficial zone, type II, IX and XI, and 
are aligned parallel to the articular surface (Fox et al., 2009). The orientation of these 
collagen fibres allows for the articular surface to withstand the high tensile stresses 
(Klein et al., 2009). The transitional zone, also known as the middle zone, 
encompasses 40-60% of articular cartilage volume and is less organised in structure 
than the other zones (Pearle et al., 2005). Collagen fibrils within the deep zone are 
tightly packed together in a perpendicular manner and it is this arrangement in the 
region that leads to the deep zone being the provider of the greatest compressive 
resistance (Fox et al., 2009). The zone of calcification is separated from the other 
zones by the tidemark, also known as the chondro-osseous junction, and allows for a 
smooth transition in the mechanical properties exhibited by cartilage and bone as 
well as tethering the tissues together (Schultz et al., 2015). It is believed that damage 
in this zone leads to disease of both cartilage and bone with lesions causing an 
increase in vascularity and remodelling of the bone whilst a duplication of the 
tidemark is an indicator of osteoarthritis (Mansfield and Winlove, 2012).  
 
The articular cartilage matrix is predominantly made up of collagen type II, that 
provides the tensile strength that is characteristic of the tissue (Cohen et al., 1998). 
Other important contributors to the ECM include proteoglycans (PGs), in particular 
aggrecan a negatively charged proteoglycan that plays a major role in the ECM of 
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articular cartilage (McNary et al., 2012). Aggrecan is composed of a linear core 
protein that contains 3 globular domains: GD1, GD2 and GD3, that form aggregates, 
where multiple aggrecan molecules are attached, non-covalently, to a central 
hyaluronic acid filament, stabilised by the Link protein (Roughley and Mort, 2014). 
Glycosaminoglycans (GAG) chains are found between GD2 and GD3 and are most 
frequently found to be chondroitin and keratan sulphate (Chandran and Horkay, 
2012).  
 
One such GAG is chondroitin sulphate (CS), which exists as an unbranched 
sulphated GAG composed of repeating disaccharide units of N-acetylgalactosamine 
and glucuronic acid. CS is considered a highly charged polyanion due to the 4 and 6 
position of the N-acetylgalactosamine being sulphated (Henrotin et al., 2010). 
Negatively charge, CS is linked to osmotic swelling of cartilage due to its negative 
charge, while it has also been shown to play various protective roles within cartilage 
(James and Uhl, 2001). In vitro studies have proven that CS has the ability to reduce 
chondrocyte apoptosis as well as the production of MMPs, while it is needed to 
induce proteoglycan production (Martel-Pelletier et al., 2010). Another GAG, is 
keratan sulphate (KS), a linear polymer of N-acetylactosamine that is sulphated at 
carbon-6 of both sugar moieties (Meyer et al., 1953). KS expression has been 
observed in both the cornea and cartilage, with the latter tissue containing KSII 
specifically, which is O-linked via GalNAc to serine or threonine residues and binds 
exclusively to aggrecan in articular cartilage (Funderburgh, 2002). 
 
Hyaluronic acid (HA), also known as hyaluronan, is the simplest GAG as it is 
unbranched and unsulphated, consisting of between 2500 and 25000 repeating 
disaccharide units (Bastow et al., 2008). HA associates itself with HA binding 
proteins significantly contributing to the structural integrity of articular cartilage 
(Seyfried et al., 2004). HA is found bound to aggrecan in the cartilage matrix. 
Decrease HA size has ben attributed to diseased cartilage using histological staining 
(Bastow et al., 2008). Hyaluronic acid has been shown to interact with chondrocytes 
via the CD44 receptor, which plays a role in pericellular matrix assembly as well as 
intacellular signalling and matrix remodelling (Responte et al., 2012).  
 
 





Osteoarthritis (OA) is a degenerative disease that affects the entire synovial joint 
including bone and synovium. The most critical damage however occurs to the 
articular cartilage (Amoako and Pujalte, 2014). Diagnosis of OA can be observed 
radiographically to visualize joint space narrowing, through magnetic resonance 
imaging (MRI) or optical coherence tomography (OCT), or directly with an 
endoscope (Braun and Gold, 2012). Histological analysis of cartilage biopsies is a 
routine procedure that is undertaken in the grading of OA, with the OARSI system 
commonly used as the chosen guidelines, and is graded from 0 through to 6. Figure 
1.5 shows examples of articular cartilage at each grade (Waldstein et al., 2015). 
Grade 0 is healthy articular cartilage with no signs of OA. As grading increases the 
smooth superficial surface begins to break down, chondrocytes cluster and undergo 
apoptosis, formation of fissures and proteoglycan depletion is evident (Pritzker et al., 
2006). OA is a chronic condition that has the largest economic burden on medical 
and social services within the developed world due to healthcare costs and is 
expected to increase due to the rise in the aging population. Due to these reasons 
prevention and repair are critical (Bitton, 2009). 
 
 





Figure 1.5: Histological staining of articular cartilage demonstrating grades 0-5 
of OA. Histological staining with haematoxylin and eosin, Safranin O and 
counterstained with Fast Green shows depletion of proteoglycan and lesion 
formation (Waldstein et al., 2015). 
 
The cause of OA is abnormal mechanical loading that increases the vulnerability of 
the joint and occurs due to a variety of factors including aging, nutritional 
deficiencies and blunt trauma or injury (Hunter and Felson, 2006).  The change in 
loading leads to inflammation of the joint and deregulation of tissue homeostasis 
favouring the catabolic process (Goldring and Goldring, 2007). The mechanisms of 
matrix degradation are shown in Figure 1.6.  
 





Figure 1.6: Structural changes and signaling pathways involved in the 
development of OA (Glyn-Jones et al., 2015) 
 
OA is a progressive disease and occurs in stages (Blalock et al., 2015);  Firstly, 
changes or loss of the ECM occur, which are thought to be remodelled and repaired 
by resident chondrocytes and finally degradation occurs at a faster rate than 
synthesis/repair causing cartilage loss (Hendren and Larson, 2009). Other common 
features associated with OA are the spread of hypertrophic chondrocytes, osteophyte 
formation and narrowing of the joint (Ashkavand et al., 2013).  
 
1.5.2.1 Disease aetiology  
 
OA is now seen as a multifactorial disease, age however, remains the most common 
risk factor with the majority of patients over the age of 65 having radiographic 
differences in at least one joint (Jordan et al., 2007). Aging also affects the muscle 
and bone that in turn causes additional changes to joint loading. Studies conducted 
on articular chondrocytes show that aging promotes cell senescence and have 
reduced reparative capability due to alteration in receptor expression (Chen et al., 
2017).  
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Obesity has also been shown to be prominent in the aetiology of OA. Patients with 
obesity (BMI greater than 30kg/m2) are 6.8 times more likely to develop OA earlier 
in their life than those classified as normal weight (King et al., 2013). In addition to 
increased biomechanical loading on the knee joints there is increased secretion of 
cytokines IL1, IL6, IL8 and TNF linked to obesity, that lead to increased catabolic 
activity through MMP secretion (Kapoor et al., 2011). Inflammation is also observed 
in patients that present with OA following blunt trauma from sports injuries causing 
activation of the NF- B pathway, unbalancing anabolic and catabolic activity 
(Lieberthal et al., 2015).  
 
Degradative enzymes play an important role in the breakdown of cartilage by 
targeting components of the ECM, such as collagen and aggrecan for proteolysis. 
The molecular signature of OA cartilage, regardless of the cause, points towards the 
deregulation of pathways that give rise to excessive hypertrophy. During ossification 
chondrocytes become hypertrophic, remove ECM by expression of a disintegrin and 
metalloproteinase with thrombospondin motifs (ADAMTS) and MMPs; eventually 
undergoing apoptosis and subsequent replacement by osteoblasts. The Wnt/-catenin 
pathway is also known to drive endochondral ossification due to the upregulation of 
ADAMTS and MMPs (Takamatsu et al., 2014) causing the loss of proteoglycan in 
articular cartilage (Yuasa et al., 2008). ADAMTS4 and -5 are key enzymes involved 
in the degradation of aggrecan (Wang et al., 2011). ADAMTS5 is seen to be widely 
distributed in OA cartilage however both ADAMTS4 and ADAMTS5 may have 
variable activity depending on their localisation within the tissue (Dancevic and 
McCulloch, 2014). Another degradative enzyme involved in AC deterioration is 
MMP13, which targets collagen type II, IV and IX as well as proteoglycans (Wang et 
al., 2013). MMP13 has a higher catalytic affinity for collagen type II than any other 
collagen making it a potent enzyme for degradation of the cartilage matrix (Wang et 
al., 2011). Clinical studies have shown that patients with articular damage have 
higher levels of MMP13 whilst research with transgenic mice overexpressing 
MMP13 has also shown spontaneous OA-like articular cartilage (Wang et al., 2013). 
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1.5.2.2 Osteoarthritic repair 
 
Although non-surgical treatment may provide pain relief for the patient it is not seen 
as a preventative or restorative treatment option (Mushtaq et al., 2011). Partial and 
full thickness treatments require surgical intervention for long-term repair of the 
tissue, with the choice of surgery being dependent upon the depth of sustained 
lesions and surgical preference (García-Carvajal et al., 2013). Total arthroplasty, 
where the entire load bearing joint is replaced, is a popular option for elderly patients 
presenting with end stage OA but due to the limited lifespan of the prostheses it is 
unsuitable for younger patients (Bhosale and Richardson, 2008). Early intervention 
of damaged cartilage, such as an osteotomy, can be carried out to reduce further 
deterioration of cartilage however these are not seen as long-term solutions. An array 
of non-surgical options have been developed for the management and repair of OA 
cartilage from acellular techniques through to cell based technology with and without 
the use of scaffold materials (Makris et al., 2015).  
 
1.5.2.2.1 Non-surgical intervention 
 
Non-surgical OA treatments to reduce patient pain include both non-pharmacological 
and pharmacological treatments (Yusuf, 2016). The primary non-pharmacological 
treatment is exercise to achieve weight loss that can alleviate pressure on the joints 
however individualised exercise programs must be designed based upon the patient’s 
needs so not to further aggravate the condition (Yusuf, 2016). Non-steroidal anti-
inflammatory drugs (NSAIDS) are a popular pharmacological treatment for OA 
patients suffering with moderate-severe pain (Pelletier et al., 2016). These drugs 
alleviate pain by altering the damaged structure of OA, by reducing the amount of 
inflamed synovial fluid (Pelletier et al., 2016). NSAIDs block the production of 
prostaglandins by inhibiting the activity of cyclooxygenase (COX) enzymes and 
come in a variety of forms, ranging from topical gels and patches, to intravenous and 
oral preparations. Topical NSAIDs are typically the first line of treatment as they 
maintain their efficacy whilst reducing systemic exposure, this is however dependent 
upon patient history, due to concerns around cardiovascular and gastrointestinal 
complications (Crofford, 2013) (Pelletier et al., 2016). 
 
Chapter 1                                                                                                               Introduction 
 
 27 
1.5.2.2.2 Acellular approaches 
 
Arthroscopic treatment of cartilage defects is seen as a minimally invasive and cost 
effective procedure (Redman et al., 2005). A characteristic symptom of osteoarthritis 
is the chronic pain suffered by patients. Since the 1940’s a popular treatment option 
available to surgeons was lavage and debridement of the defects (Minas, 2011). 
During the procedure a saline solution is introduced to the joint to remove loose 
tissue (lavage) before smoothing the underlying bone of any damaged or dead tissue 
(debridement) (Ontario, 2005). 
 
A high tibial osteotomy is usually preformed with pain relief as the goal rather that 
cartilage repair. This surgical procedure realigns the joint so that biomechanical 
loading is not focused upon the damaged tissue (Hunziker, 2001). Although the aim 
of the surgery is not concentrated on repairing the tissue, patient follow up studies 
have shown that approximately 2 years after an osteotomy surgery cartilage lesions 
exhibit a fibrous, membranous tissue resembling fibrocartilage (Sabzevari et al., 
2016). 
 
1.5.2.2.3 Cellular approaches 
 
In 1997, Steadman suggested microfracture, a marrow stimulation technique, as a 
viable treatment of symptomatic focal defects in articular cartilage (Mancò et al., 
2016). During this treatment damaged cartilage is removed to reveal the subchondral 
bone plate and an arthroscopic awl is used to form 3-4mm holes, while avoiding 
lesion merging and/or collapsing (Schrock et al., 2017). The penetration of the 
underlying bone allows for lesion specific recruitment of mesenchymal stem cells 
(MSC) that then perform tissue reformation. The MSC clot that is formed is not 
mechanically stable however, placing emphasis on appropriate post-surgical 
rehabilitation with regards to creating an environment in which mesenchymal cells 
can migrate and differentiate within the lesion (Bark et al., 2014) (Erggelet and 
Vavken, 2016). 
 
While being viewed as a simple technique in terms of execution, with low 
complication rates, microfracture often fails to produce hyaline cartilage, instead  
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forming a tissue that is too rigid for the biphasic characteristic needed for shock 
absorption (Reilingh et al., 2017). Despite the fact that the tissue produced contains a 
lower collagen II content, microfracture continues to be an intervention chosen for 
patients of a younger age, with small (<2cm2) lesions. It has been noted that patients 
who have undergone this reparative surgery find improvements in regards to pain 
however the revision rates for surgery range between 2% and 31% and is likely due 
to the degradation of the fibrocartilage layer (York et al., 2017) (Kraeutler et al., 
2018).  
 
1.5.2.2.4 Autologous chondrocyte implantation 
 
Autologous chondrocyte implantation (ACI) was first developed in 1994 and has 
become a routine method in the treatment of full thickness cartilage defects 
(Brittberg et al., 1994).  This surgical option involves implantation of autologous 
chondrocytes into the defect and sealed under a periosteal patch (Dunkin and 
Lattermann, 2013). During this two-stage procedure, chondrocytes are harvested 
from a healthy area of cartilage before undergoing monolayer, cell culture 
proliferation. Following 3-4 weeks the cells are placed into the defect in hopes of 
replacing the damaged tissue (McCarthy et al., 2016).  
 
Currently, chondrocytes are the chosen cell source for ACI surgery. When cultured 
in monolayer however these articular chondrocytes have been shown to reduce their 
collagen II and proteoglycan expression, as a result of 2D culture shock and de-
differentiation (Dewan et al., 2014). This may be a contributor to the several 
disadvantages observed with ACI, despite the good clinical outcome observed in 60 
to 90% of follow up (between 1 to 11 years) ACI patients (Iwasa et al., 2009). The 
main issue is the hypertrophic nature of the regenerated tissue that often leads to the 
need for another operation (Gooding et al., 2006).  
 
1.5.2.2.5 Stem cells 
 
Multiple alternative cell sources have been sought for OA repair purposes, due to the 
disadvantages of using chondrocytes. Stem or pluripotent cells are a popular option, 
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in particular mesenchymal stem cells (MSCs) and induced pluripotent stem cells 
(iPSCs), due to the capability for self-renewal and ability to differentiate down 
different lineages (Lietman, 2016). MSCs are multipotent cells that have been proven 
to differentiate through chondrogenic, osteogenic and adipogenic lineages, outlined 
in Figure 1.7, and can be harvested from various sources including bone marrow and 
adipose tissue (Marion and Mao, 2006). Although they have lower differentiation 
potential than iPSCs they express low levels of major histocompatibility complex, 




Figure 1.7: Differentiation of MSCs through different lineages. MSCs are often 
chosen for regenerative medicine due to their plasticity.  Minimal criteria dictate that 
MSCs must be able to undergo chondrogenesis, osteogenesis and adipogenesis 
(Caplan and Bruder, 2001) 
 
MSCs are multi-lineage non-hematopoietic stem cells that are able to differentiate 
into cells with a mesodermal origin and can be identified through their expression of 
specific markers (Mahla, 2016). The minimal criteria for cells to be considered an 
MSC include the ability to adhere to plastic, differentate into osteoblasts, 
chondrocytes and adipocytes and express cell surface markers CD105, CD73 and 
CD90 whilst lacking the expression of haematopoietic markers CD45, CD34, and 
CD14 (Dominici et al., 2006). MSCs can be isolated from various tissues including 
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bone marrow, umbilical cord, adipose tissue and placenta. Aside from their ability to 
differentiate down osteogenic, chondrogenic and adipogenic lineages, MSCs have 
also been shown to integrate into the outer walls of arteries of organs and behave as 
pericytes to support blood vessel stability (Rohban and Pieber, 2017). All of these 
factors, multipotency, ease of isolation and capability for self-renewal, make MSCs a 
promising cell source for regenerative medicine purposes (Samsonraj et al., 2017). 
Allogenic MSCs may be isolated for ‘off the shelf’ availability but the ability to 
isolate autologous MSCs eliminates concerns of rejection and disease transmission 
(Marion and Mao, 2006). Although this cell source holds promise, clinical 
applications have brought to light the limitations of MSCs in regenerative medicine 
and tissue engineering. Direct injection and intravenous delivery of MSCs has led to 
inconsistent results within host tissue due to issues with long term survival 
(Samsonraj et al., 2017). MSCs have also been shown to exhibit inhibitory effects on 
T-cell proliferation and secrete cytokines that supress the immune response as well 
as encourage tumour growth in allogenic transplants (Rosenbaum et al., 2008).  
 
Mesenchymal stem cells have provided satisfactory clinical outcomes in regards to 
microfracture treatment. Despite this the tissue produced by the clot is often fibrous 
in nature and lack the durability for sustained movement required from the joint 




Stem cells are classified by functional attributes that include self-maintenance, 
proliferation and the ability to differentiate down different lineages (Potten and 
Loeffler, 1990). Progenitor cells are a populations of cells found within tissues that 
aid in homeostasis and retain a degree of plasticity and have the ability to 
differentiate into specific cell types (Mahla, 2016). Under specific biological, 
chemical and physical conditions tissue specific progenitor cells are able to 
differentiate and form cells that populate mature tissue and harvesting this potential 
holds promise within the tissue engineering and regenerative medicine fields (Heath, 
2000). Adult progenitor cells are cells that are capable of differentiation and self-
renewal and are usually found in a niche close to tissue containing mature cells 
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(Barry et al., 2001). Populations of multipotent mesenchymal progenitor cells have 
been found to be isolated from various tissues including cartilage, liver, fat and skin 
(Caplan, 2013). 
 
Chondroprogenitor cells can be harvested from the surface of articular cartilage via 
their affinity for fibronectin (Dowthwaite et al., 2004). This population of cells 
exhibits a high colony forming efficiency, expression of Notch-1 and possess the 
ability to undergo chondrogenesis in a 3D culture (Mazor et al., 2014). Recent 
studies using equine-derived chondroprogenitor cells have showcased an enhanced 
ability for cartilage repair when compared to bone marrow derived MSCs due to the 
lack of expression of RUNX2 and type X collagen, which are markers of epiphyseal 
chondrocytes (Somoza et al., 2014). 
 
1.6 Matrix-assisted approaches 
 
Matrix-assisted autologous chondrocyte implantation (MACI) is a popular next 
generation surgical technique that is similar to ACI with the addition of a matrix 
scaffold for guidance of tissue formation (Jacobi et al., 2011). Autologous 
chondrocytes are harvested and expanded to an appropriate number before being 
seeded into a 3-dimensional scaffold structure. After 4 weeks of culture within the 
scaffold the structure is implanted into the defect after being cut to size (Nixon et al., 
2015). The use of a 3D matrix is believed to minimise the chance of cell 
dedifferentiation and increase the chondrogenic potential of the implant 
(Niethammer et al., 2016).  
 
Various materials have been used for the fabrication of MACI scaffolds and are used 
within clinical settings including collagen and hyaluronan as well as synthetic 
materials like polyglycolic and polylactic acid, agarose and alginate based hydrogels 
and protein based matrices fabricated from collagen and gelatin (Armiento et al., 
2018). It is critical that the surrounding cartilage is healthy and any loose tissue is 
debrided before implantation. Unlike in ACI where the periosteal flap spans the 
entire defect, MACI requires the matrix to fit within the defect without any overlying 
flaps to allow for integration into the native tissue (Dunkin and Lattermann, 2013). 
Chapter 1                                                                                                               Introduction 
 
 32 
The use of a matrix is seen as an advantage as there is a higher chance of even cell 
distribution as well as a reduced risk of cell loss from the damaged area (Kreulen et 
al., 2017). 
 
MACI surgery can be seen as successful however there have been reports of graft 
failure due to lack of integration and the formation of fibrous tissue. In these cases it 
is vital to acknowledge that the development of cartilage is dependent on several 
factors such as exposure to growth factors and mechanical stimulation and the 
addition of these to MACI surgery may increase successful tissue repair outcome for 
patients (Collarile et al., 2017). MACI offers a technique that is attractive due to the 
reproducibility, safety and reduction in intraoperative time but requires further 
investigation in order to understand whether the long term benefits are superior to 
other surgical techniques that are available (Makris et al., 2015). 
 
One of the most popular materials to use is collagen due to the fact that the protein 
accounts for a large proportion of articular cartilage. Membranes such as Maix® and 
Chondro-Gide® are produced from a bilayer of porcine collagen I/III that can then 
be seeded with chondrocytes. The surface of these scaffolds provides mechanical 
strength whilst the inner surface stimulates cells to produce cartilage matrix (Fuss et 
al., 2000). Studies conducted on this conformation of scaffold have shown cell 
attachment and maintenance of chondrocytic phenotype as well as the limitation of 
cell migration from the defect (Ehlers et al., 1999). 
 
1.6.1 Scaffold properties and function 
 
Stem cells are often the cell source of choice for regenerative medicine due to their 
plasticity allowing them to repair the damaged tissue by repopulating the area with 
mature, differentiated cells (Ding et al., 2013). However, in order for tissues to be 
functional they require specific mechanical and structural properties that can be 
acquired through the introduction of a scaffold structure and material (Hosseinkhani 
et al., 2014). A large research field has developed around biomaterial biomimicry, 
where the choice material, examples of which are outline in Table 1.2, and basic 
structure of a scaffold is fabricated to imitate the structure and environment of the 
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native tissue that is designated for regeneration (Mahboudi et al., 2018). With this in 
mind, a number of properties must be taken into account when fabricating a scaffold, 
including architecture, mechanical integrity, biodegradability, biocompatibility and 
manufacturing technology (O'Brien, 2011). 
 
 




Collagen Bone, cartilage, heart, 
ligament 
Agarose Cartilage, heart, nerve 
PEG Adipose, bone, 
cartilage, nerve 
Ceramics Bone, cartilage 
 
Table 1.2: Natural and synthetic materials used in tissue engineering. A example 
of the range of natural and synthetic biomaterials has been used for different tissue 
engineering applications, often for the same tissue with differences in cellular 
response (Melton, 2008) 
 
Scaffolds fabricated for tissue engineering and regenerative medicine should have a 
highly porous and interconnected structure to allow for adequate cell migration and 
nutrient diffusion as well as the diffusion of waste products (Phelps and Garcia, 
2009). Pore size is also a crucial characteristic of scaffold design. Cells attach to the 
scaffold via ligands and peptide sequences, such as the GFOGER and RGD peptide 
sequences; on the material surface and ligand density is determined by surface area. 
Therefore average pore size must strike a balance whereby they are large enough to 
allow for cell migration but small enough to maintain adequate ligand density for 
efficient binding (Yannas et al., 1989). Scaffolds involved in chondrogenesis have 
been able to facilitate differentiation of chondrocytes with small pores (20-150μm) 
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whilst larger pore sizes (250-500μm) have been found to be better for proliferation 
and matrix deposition (Matsiko et al., 2015). 
 
Scaffolds produced from natural materials such as collagen, chitosan and cellulose 
are advantageous due to their occurrence in native ECM and allow for the attachment 
of cells via surface receptors (Saha et al., 2007). The surface properties of scaffolds 
play an important role in cell-matrix interaction and are responsible for proliferation 
and differentiation after attachment (Liu et al., 2014). An example of this is seen in 
chondrogenic differentiation of adipose derived stem cells which has been proven to 
be more effective on gelatin compared to alginate and agarose due to the similarity to 
native ECM environment (Awad et al., 2004). 
 
A range of critical pore sizes exists and is specific to the tissue to be repaired. An 
example of this is outlined in Table 1.3 (Murphy et al., 2010).  
 
Application Pore Size (μm) 
Bone regeneration 100-300 
Chondrogenesis 90-300 
Vascular smooth muscle growth 38-150 
Aggregation of cardiomyocytes 60 
 
Table 1.3: Examples of optimal pore sizes for specific applications in tissue 
engineering (Bružauskaité et al., 2016) 
 
Biological and chemical modifications to a scaffold may help to influence cell 
behaviour through the manipulation of specific signalling pathways (Dawson et al., 
2008) through the binding of different integrins (Liu et al., 2014). Synthetic materials 
used for tissue engineering can be chemically modified in order to help cellular 
differentiation however this may not be a cost effective method (Dawson et al., 
2008). 
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Proliferation of cells within a 3D environment occurs with a sufficient supply of 
oxygen and nutrients as well as the avoidance of the build up of waste materials 
(Hosseinkhani et al., 2014). The effect of dynamic culture, with the use of  
bioreactors, has proven effective in the proliferation and differentiation of stem 
cells as well as a more uniform distribution of nutrients (Ghasemi-Mobarakeh et al., 
2015). When static and dynamic culture were compared in chondrogenic culture of 
human MSCs within a hydrogel, static culture was better in differentiating cells. 
However, additional compression during dynamic culture improved chondrogenic 
differentiation (Guo et al., 2016). 
 
The topography of the ECM effects the cell in various ways with nano and micro 
patterned structures shown to stimulate cell alignment, migration, proliferation and 
gene expression (Ghasemi-Mobarakeh et al., 2015). These topographical features are 
often achieved through fabrication methods such as photolithography and chemical 
vapour deposition. Elecrospinning has been of particular interest as this method 
produces nanofibers that are similar in morphology to native ECM (Prabhakaran et 
al., 2012). In vitro chondrogenic differentiation of MSCs has been documented as 
more effective on chitosan microfibers compared to sponges (Ragetly et al., 2010).  
 
The mechanical properties of the scaffold should resemble the tissue it is to be 
implanted (Chan and Long, 2008). This has proven to be a difficult task for specific 
tissues, for example orthopaedic applications prove challenging as they must 
continue to have mechanical integrity from implantation through to the completion 
of matrix remodelling (Hutmacher, 2000). Although mechanical properties play an 
important role, tissue architecture has often been sacrificed in order to achieve a 
mechanically stable structure, which in turn has been detrimental for tissue growth 
and vascularisation. Therefore it is crucial that a balance is found between 
architecture and mechanics for a successful scaffold (O'Brien, 2011).  
 
Matrix stiffness is variable across tissues present in the human body from soft brain 
tissue (1kPa) to hard bone (30kPa) (Vincent and Engler, 2011). Stem cells possess 
the ability to differentiate into cells of different lineages and survive in environments 
that possess different mechanical properties. The material and overall structure of the 
scaffold play a role in the physical properties and may affect the differentiation 
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potential of cells (Ghasemi-Mobarakeh et al., 2015). As an example, bone tissue 
engineering studies have shown that MSCs have a higher rate of attachment, 
increased alkaline phosphatase activity and increased expression of osteopontin and 
collagen type I when cultured upon a stiff (25kPa) hydrogel compared to a soft 
(2kPa) hydrogel (Gandavarapu et al., 2014). Whereas studies considering 
cardiovascular regeneration showed an increased attachment in softer scaffolds 
(Wingate et al., 2012) and increased expression in endothelial markers when 
compared to harder substrates (Wingate et al., 2014). 
 
Scaffolds designed for tissue engineering purposes are not seen as permanent 
implants and should be resorbed with a balance between degradation and new tissue 
formation (Peters and Mooney, 1997). The bioresorbability of the material must 
occur over time via biological processes such as enzymatic degradation or hydrolysis 
(Parisi et al., 2018). Due to the nature of the scaffold being a temporary implant 
within the human body, care must be taken when choosing a material to ensure that 
the native material and its degraded products do not induce response such as 
inflammation or release toxins, carcinogens and mutagens (Williams, 2008). The 
most critical characteristic of a scaffold fabricated for tissue engineering purposes is 
that it should be biocompatible. Biocompatibility encompasses the ability for cells to 
adhere, function and migrate and proliferate whilst interacting with the construct and 





The formal definition of biocompatibility is stated as “the ability of a biomaterial to 
perform with an appropriate host response in the specific application” (Williams, 
2008). Materials chosen for regenerative medicine can be manipulated in order to 
achieve the functional properties required for its purpose, which include regeneration 
of the damaged tissue and cellular differentiation whilst inhibiting an immune 
response (Yang et al., 2008). Once a biomaterial has been implanted the body 
responds in a natural cascade that consists of interaction with blood and cells, 
provisional matrix formation and temporary inflammation. Under normal 
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circumstances the cascade will end at this point however if the material is not 
biocompatible the cascade will continue with the formation of granulation tissue and 
fibrotic tissue that may infiltrate the porous material and render it unfit for purpose 
(Naahidi et al., 2017).  
 
Aside from scaffold design, biocompatibility of the scaffold must be tested to ensure 
it does not cause any toxic effect to the body causing side effects. Three major 
responses that may occur are inflammation, fibrosis and immunogenicity (Anderson 
et al., 2010). The International Organization for Standardization has implemented 
standards that are required for the evaluation of medical devices (ISO: 10993) 
(Naahidi et al., 2017).  
 
Both clinical and research grade collagen is sourced from a wide variety of animals 
with mammalian collagen being the most common source due to the ease in 
obtainment and cost effective nature (Rodríguez et al., 2017). Whilst research grade 
products are produced using good laboratory practice, clinical grade collagen must 
adhere to set regulations such as those set out in good manufacturing practice (GMP) 
guidelines and includes quality assurance records, dedicated production suite and 
validated cleaning methods (Crawford et al., 2015). Porcine and bovine collagen is 
typically sourced from waste products after slaughter and can be obtained from 
calfskin, bones and tendons via acid extraction (Karim and Bhat, 2009).  
 
1.6.3 Alternative sources of collagen 
 
Collagen is a popular material and has been used in food, medical and 
pharmaceutical industries. Industrial applications of collagen have primarily been 
sourced through mammals, in particular bovine and porcine origins (Silva et al., 
2014). The concerns regarding the use of collagen from a bovine source has risen 
due to the outbreak of zoonotic diseases such as bovine spongiform encephalopathy 
(BSE) as well as the discovery that approximately 3% of the population are allergic 
to the material (Silvipriya et al., 2015). Another common mammalian source for 
collagen is porcine skin and bones, which are also obtained as waste material after 
slaughter (Karim and Bhat, 2009). Similar concerns of the transmission of zoonotic 
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disease is also applied to porcine material with the additional constraints of pigs 
being forbidden in some religions (Silvipriya et al., 2015). Research for an 
alternative source of collagen has increased over the past few years due to 
economical interest in industrial by-products found in the meat and fish industry as 
well as for sustainability issues (Gómez-Guillén et al., 2011).  
 
1.6.3.1 Recombinant collagen 
 
In vitro production of recombinant collagen I and III from human fibroblast cells was 
reported in the early 1980s (Uitto et al., 1980). The advances in genetic engineering 
have lead to the possibility of using a number of hosts, including bacteria, yeast and 
insect cells, for the production of recombinant collagen (Yu et al., 2014). A key 
enzyme, prolyl 4-hydroxylase, involved in the folding of collagen into a triple helix 
has no activity in bacteria and yeast and is only found at low levels in insect cells 
leading to collagen produced in these hosts as non-functional although this may be 
amended by the introduction of prolyl 4-hydroxylase into the recombinant system 
(Dong and Lv, 2016). Due to setbacks such as the lack of cofactor and enzymes 
needed for stabilisation, high cost and low yield, animal sourced collagen continues 
to remain the standard in research and clinical tests (Browne et al., 2013) 
 
1.6.3.2 Evolutionary conservation 
 
Collagens have been found in a variety of species and have been linked to metazoan 
evolution (Hynes, 2012). The ancestral origin of collagen has been investigated 
through phylogenetic and genomic analysis of the protein as well as studying intro-
exon organisation (Rodrigues-Pascual and Slatter, 2016). Intron-exon organisation 
analysis had led to specific hypotheses regarding the evolutionary lineage of 
collagen. The exons encoding for the triple helix in type I and III collagens are 54 
base pairs (bp) in length whilst multiples of 54 or 54 minus 9 bp encode other types. 
These observations have led to the suggestion that the original ancestral fibrillar 
collagen included an exon of 54 bp with a glycine codon and ending with a Y codon 
and encoding six Gly-X-Y repeats. Differences in gene length and triplet repeats are 
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believed to have arisen from multiple duplications of the primordial unit (Exposito et 
al., 2010). 
 
1.6.3.3 Sources of marine collagen 
 
Alternative sources of collagen have been investigated in a bid to circumvent the 
issues raised from traditional mammalian sourced collagen (Silva et al., 2014). 
Particular interest in marine collagens has arisen, as fish skin and bones are abundant 
in collagen and a by-product of the fish industry, usually seen as waste (Subhan et 
al., 2015). The qualities of waste marine collagen, specific to regenerative medicine, 
depend on a number of factors, including animal age, diet, and the habitat it resides 
within before capture (Silva et al., 2014).  
 
The denaturation temperature of collagen is highly dependent on the composition of 
amino acids, notably the proline and hydroxyproline content, with cold-water fish 
exhibiting lower denaturation temperatures than their mammalian counterparts 
(Subhan et al., 2015). The thermostability of marine collagen has been shown to be 
improved with the use of chemical compounds such as 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) and glutaraldehyde making it more 
suitable for implantation in clinical applications (Yamada et al., 2014). 
 
A large amount of fish, approximately 75%, is discarded during processing for the 
food industry (Silva et al., 2014). A considerable amount of waste from fisheries is 
discarded back into the sea and so an alternative method of dealing with waste 
products would be the use of products in collagen and gelatin extraction (Sotelo et 
al., 2015). Extraction of collagen from marine species is achieved by dilute acid due 
to fewer crosslinks being present when compared to mammalian sources (Yamaguchi 
et al., 1976). Despite this, fish collagen has been shown to have structurally similar 
α1 and α2 chains when compared to collagen type I obtained from calf (Yamada et 
al., 2014). Elastic salmon collagen has previously been prepared for vascular grafts 
producing little inflammatory reaction upon subcutaneous implantation in rats (Nagai 
et al., 2008) whilst Tilapia fish collagen sponges implanted into paravertebral 
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muscles in rabbits gave a similar inflammatory response to porcine collagen implants 
(Sugiura et al., 2009).  
 
Sea urchins have been examined as a source of collagen from the peristomial 
membrane that surrounds their mouth (Benedetto et al., 2014). Characterisation of 
the collagen showed it to be similar to mammalian type I in terms of the chain 
composition and D periodic banding pattern (Ribeiro et al., 2011). Unlike its 
mammalian counterpart, collagen from sea urchins is extracted in an insoluble  
fibrillar form, which is believed to be advantageous in mimicking the natural ECM 
without further modifications (Benedetto et al., 2014) 
 
1.6.3.3.1 Jellyfish collagen 
 
Jellyfish are free moving plankton with movement that coincides with the ocean 
current (Rastogi et al., 2017). These creatures are considered a model source for 
collagen isolation due to their gelatinous nature and the possession of a collagen rich 
mesogloea, shown in Figure 1.8. Collagen obtained from various species have been 
tested for their potential use in regenerative medicine, with promising results (Addad 
et al., 2011). The structure of jellyfish collagen has previously been reported to 
contain a high content of glutamine or glutamic acid and alanine whilst proline 
content was found to be lower when compared to collagen obtained from calfskin 
(Subhan et al., 2015). Extracts of jellyfish collagen obtained from Rhizostoma pulmo 
subjected to gel electrophoresis showed bands corresponding to alpha chains at a 
similar position to that of rat tail collagen (Addad et al., 2011). Isolated collagen 
from jellyfish is reported to resemble vertebrate collagen type II and support 
differentiation of cells, maintain cellular phenotype without dedifferentiation and 
cause little cytotoxicity when cells are cultured upon it (Hoyer et al., 2014).  
 





Figure 1.8: Schematic diagram showing anatomy of a jellyfish. Jellyfish collagen 
is often isolated from the collagen rich mesogloea or oral arms (Cronodon, 2016) 
 
Collagen isolated from jellyfish can be manipulated into constructs, typically 
sponges, for research into tissue engineering applications. Hoyer and colleagues 
produced sponges from Rhopilema esculentum, crosslinked with 1% EDC (Hoyer 
et al., 2014) whilst other studies have used Rhizostoma pulmo collagen 
crosslinked with different ratios of EDC/NHS (Addad et al., 2011). Jellyfish 
collagen (R. esculentum) has also been used in combination with salmon 
collagen to produce a biphasic scaffold with properties better suited for 
osteochondral implants (Bernhardt et al., 2018). 
 
Jellyfish derived collagen tested in vitro for biocompatibility has been shown to elicit 
no toxic effect towards primary human fibroblasts (Song et al., 2006). When 
compared directly to bovine collagen sources, increased cellular viability was 
observed for a wide variety of cells including fibroblastic, epithelial and osteoblastic 
cells (Subhan et al., 2015). Cytotoxicity tests on immune cell populations, antibody 
secretion and pro-inflammatory cytokines displayed that jellyfish collagen from 
Stomolophus nomurai meleagris gave a comparable response to the bovine 
counterpart (Song et al., 2006). Collagen isolated from Rhopilema esculentum has 
been evaluated for applications in cartilage regeneration producing porous scaffold 
structures that encourage chondrogenic differentiation of human mesenchymal stem 
cells with no cytotoxic effects (Hoyer et al., 2014). Another study using R. esulentum 
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collagen for nasal cartilage repair also reported that jellyfish collagen scaffolds 
showed no cytotoxic effect on rat and human nasal chondrocytes and produce an 
ECM that mimics that of native septal cartilage (Bermueller et al., 2013). The use of 
collagen obtained from R. pulmo has been tested for different applications such as for 
aptamer sensing applications for thrombin related neurodisease (Derkus et al., 2016). 
 
The extraction of marine collagen can be achieved in a similar fashion to mammalian 
collagen. Chemical treatment prior to the extraction allows crosslinks between 
collagen to be broken whilst basic treatment removes any non-collagenous materials 
without modifying the structure of collagen chains (Ehrlich et al., 2010). Acetic acid 
is typically used for the extraction of collagen from marine species although citric 
and lactic acid has also achieved isolation of collagen from marine tissues (Schmidt 
et al., 2015). 
 
1.7 Research aims 
 
Mammalian collagen is isolated from tissues and used in regenerative medicine and 
tissue engineering scaffolds. This collagen source has the required mechanical and 
biological properties required for specific tissue growth however ethical and 
immunological issues have lead to research for alternative sources. Research 
regarding marine collagen has shown that material isolated from a variety of species, 
particularly jellyfish, circumvents these problems. 
 
The assessment of alternative collagen sources must be undertaken to assess the 
maintenance of structural componsition through isolation procedures. Jellyfish 
collagen was examined for any sequence similarity, against mammalian collagen, for 
functional properties and as an indication of immunogenic potential. This structural 
characterization further informs the ability of the material to be moulded into 
structures and validated for biocompatibility and immunogenicity. 
 
Follow up data from cartilage repair surgery has shown that matrix assisted repair is 
superior to microfracture, a cell only technique. Matrix free (pellet) cultures has been 
standard in vitro technique used in research to investigate chondrogenesis. Cells 
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seeded in jellyfish collagen scaffolds and pellet cultures were differentiated and 
compared to analyse enhaced chondrogenic potential. 
 
These objectives were investigated using the following techniques; 
 Fourier transform infrared spectroscopy 
 Peptide sequencing and multi sequence alignment 
 Fluorescence activated cell sorting 
 Biochemical analysis of matrix formation 
 Histological analysis of matrix formation 




Collagen can be isolated from R. pulmo jellyfish and maintains the structural 
composition to allow fabrication of robust scaffolds. In depth, in vitro, examination 
of physical and biological properties of scaffolds and chondrogenic potential will be 
assessed for suitability of jellyfish collagen as a biomaterial for regenerative 














Materials and Methods  
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In line with the specific aims and objectives designed to test the stated hypothesis, 
this thesis is split into three results chapters. Identifying novel collagen sources for 
regenerative medicine requires exhaustive pre clinical development, encapsulating  
material science, biocompatibility and proof of concept research and development 




Figure 2.1: Approach to jellyfish collagen extraction and characterisation 
 
Each of these components has identified methodologies, which provide a standard of 
data required as a body of evidence to support the utility of each collagen source 
(Abraham et al., 2008). In this section the methods used to derive collagen from 
jellyfish (harvest), characterise that material for purity, structural integrity and 
malleability and also assess in vitro biocompatibility are outlined. The utility of pure 
jellyfish derived collagen is then assessed using an enhanced chondrogenesis model, 
with all biological assays outlined in detail.  
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2.1 Material characterisation (collagen) 
 
Jellyfish harvest, collagen isolation and characterisation  
 
2.1.1 Jellyfish harvest  
 
Rhizostoma pulmo jellyfish were caught in Camarthen Bay, Wales during May-
October using a stern trawling vessel with a 25mm net. Once caught, jellyfish were 
separated into bells and tentacles and stored on ice in insulated containers before 
being taken back to the facility in Cardiff and stored at -20°C. 
 
2.1.2 Optimised collagen isolation  
 
Established collagen isolation methods utilised in mammalian and marine collagen 
processes were utilised and optimised during this project to produce high yield 
jellyfish collagen (JCol). Based on acid solubilisation, a simple flow diagram of this 
process is outlined in Figure 2.2. Specific acid conditions such as molarity and 
incubation times/temperatures are outlined in detail in chapter 3.  
 





Figure 2.2: Collagen extraction condition testing. Sodium acetate was used to 
remove non-collagenous materials before testing different acid solubilisation 
methods. The addition of pepsin was tested to increase yield and salting out stage 
was also tested. All samples were lyophilised following extraction for further 
analysis.  
 
At each stage, collagen material was characterised for electrophoretic banding, 
characteristic amide peak banding (Fourier transform Infra red spectroscopy) and 
yield (dry weight to starting weight ratio) in line with basic characterisaiton 
requirements (Abraham et al., 2008). Outlined below are the methodologies used in 
each assay. The optimised isolation process was then selected based on a 
combination of these factors allied to speed and scalability. This protocol was then 
used for each batch isolation prior to downstream analysis for peptide sequencing of 
the α1 band and analysis of functional peptide composition.  
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2.1.2.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
Mini-PROTEAN®TGX® precast 4-20% gels (cat: 4561093, Bio-Rad) were used for 
sodium dodecyl polyacrylamide gel electrophoresis to separate proteins according to 
electrophoretic mobility. Protein samples were diluted 1 in 2 with 2x Laemmli buffer 
(cat: 1610737, Bio-Rad) and incubated at 95°C for 10 minutes to ensure protein 
samples were denatured, soluble and possessed a negative charge for SDS-PAGE. 
30μg of protein were loaded into each well, including a protein molecular weight 
marker (Dual Colour Protein Standards, cat: 1610374, Bio-Rad). A dual colour 
marker was used for ease in downstream analysis allowing for gel orientation and 
excision of chosen bands. The current was set to 120V until samples reached the 
bottom of the gel. After proteins were run by SDS-PAGE they were stained using 
Coomassie Blue. 
  
2.1.2.2 Coomassie Blue staining 
 
Following electrophoresis gels were stained with Coomassie Blue (94ml methanol, 
94 ml water, 38ml acetic acid and 1.25g Coomassie R250 (Sigma Aldrich, USA) for 
30 minutes. Gels were then destained using destaining buffer (100ml methanol, 
825ml water, 75ml acetic acid). Buffer was replaced frequently until background 
staining was no longer present and stained bands could be seen. 
 
2.1.3 Fourier transform infrared spectroscopy (FTIR) 
 
Collagen samples were lyophilized before the experiment. Lyophilsation was 
achieved using a Scanvac Coolsafe 55-9 freeze drier (Labogene, Denmark). A 
standard protocol was followed where samples were frozen at -20°C and placed in a 
vacuum chamber at -180°C until all liquid has sublimated. An equal quantity of 
collagen was added to the ATR-FTIR ZnSe/ diamond crystal stage. ATR FTIR 
spectra were performed using the ATR FITR Spectrum Two (Perkin Elmer) 
equipped with a deuterated triglycine sulphate (DTGS) detector. The system was 
illuminated by a Globar MIR source. ATR-FTIR spectra were acquired in absorption 
mode, using 64 co-added scans and a 4 cm−1 spectral resolution. The frequency range 
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used during each replicate experiments  were varying from 4000 cm−1 to 400 cm−1. 
Background spectra were achieved using the same parameters as the sample spectra 
in order to subtract the CO2 bands hence ensuring optimal spectra acquisitions and 
processing. 
 
Research grade rat tail collagen (cat: 08-115, Merck, UK) was used as a standard to 
determine amide peak positions in a mammalian collagen source, shown in figure 
2.3. 
 
Each spectrum was visualised and analysed using Spectrum 10 software (Perkin 
Elmer) and spectra data points were then extracted and plotted using excel software 
for convenience purposes. 
 
2.1.4 Protein sequencing 
 
Specific bands of interest were excised from the gel using a disposable sterile scalpel 
and placed in an eppendorf. Samples were then sent to Proteome Factory, Germany 
for peptide identification. The process consisted of cleavage via trypsin digestion 
followed by separation and detection with liquid chromatography – mass 
spectroscopy (LCMS). Mass spectroscopy spectra were then subjected to a database 
Figure 2.3: Research grade rat-tail collagen type I FTIR spectrum. FTIR spectra 
of rat-tail collagen depicting amide I, amide II and amide III peaks at 1635cm-1, 
1528cm-1 and 1245cm-1, respectively. 
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search against NCBI or Swissprot and data collated into an excel spreadsheet for 
further analysis.  
 
2.1.4.1 Informatics  
 
Peptide sequences were individually input into basic local alignment search tool 
(BLAST) and searched against a non-redundant protein sequences database to 
identify proteins with sequence similarity. Following BLAST alignment, specific 
human collagen sequence alignment to jellyfish peptides was conducted using 
Clustal Omega, a multi sequence alignment tool. Peptides and human collagen 
FASTA sequences were inputted into the system to give numbered graphical 
alignment output for ease in identifying nucleotide position.  Functional peptide 
analysis was then conducted using AbDesigner where human FASTA sequence was 
input and graphical output was used to inform functionality of areas with high 
sequence similarity to jellyfish peptides from multi sequence alignment.  
 
2.2 Material characterisation (scaffold) 
 
Sponge scaffold moulding, fabrication, Scanning electron microscopy, pore size 
analysis, thermal stability and resistance to collagenase digest  
 
2.2.1 Scaffold fabrication  
 
250μl of collagen was pipetted into a 96 well plate (Corning, UK) at a concentration 
of 4mg.ml-1 before being frozen at -20°C and lyophilised. The constructs were then 
cross-linked using 1-ethyl-(3-3-dimethylaminopropyl) carbodiimide hydrochloride 
(EDC) (cat no: E1769, Sigma Aldrich) in 80% ethanol at 1%, 0.5% and 0.25% w/v 
for 90 minutes. Scaffolds were rinsed in deionised water three times and left in 1% 
glycine overnight, at room temperature, to quench the reaction. The cross-linked 
constructs were then rinsed three times in deionised water before being lyophilised to 
dry and regain their cylindrical shape.  
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2.2.1.1 Scanning electron microscopy (SEM) 
 
Tissue and scaffold samples were washed three times at room temperature, in 50mM 
sodium cacodylate (Sigma, UK)-HCl buffer solution (pH 7.2-7.4) at 10 to 20 minute 
intervals to remove excess salt. The scaffolds were fixed overnight in 2% 
glutaraldehyde and then dehydrated in a series of graded ethanol (30% to 100%). 
Dehydrated samples were rinsed in 50% hexamethyldiasilazane solution (HMDS, 
Sigma, UK) in 100% ethanol for 10 minutes in a fume hood and then three times in 
100% HMDS and left overnight, at room temperature, to dry. The samples were then 
coated in a thin layer of chromium (~15nm) using sputter coating and were imaged 
using scanning electron microscopy (Hitachi 4800). A standard sputter coating cycle 
was followed according to manufacturers instruction (Quorum, UK).  
 
2.2.1.2 Pore size analysis 
 
Average scaffold pore size was calculated by measuring the widest point of pores 
within scaffold structures using proprietary SEM software (Hitachi). A total of 30 
pores were analysed per replicate and a total of 3 replicates were analysed from 
separate fabrication runs. 
 
2.2.2 Plastic compression 
 
Collagen scaffolds were fabricated as described in section 2.2.1 using a 24 well 
plate. Scaffolds were then hydrated with deionised water at room temperature, before 
a 24 well absorber (cat: 016-1R33, Lonza) was placed on top for 30 minutes to 
dehydrate and compress structures. Following compression scaffolds were placed in 
fresh deionised water and weighed. Wet weight prior to and following compression 
was used to analyse scaffold reswelling, quoted as milligrams.   
 
2.2.3 Differential scanning calorimetry 
 
Scaffolds were placed in platinum crucibles and heated in a Netzsch STA 449F1. 
Heating and cooling were performed in flowing argon gas with a temperature ramp 
Chapter 2                                                                                                Materials & Methods 
 
 52 
of 10C.min-1 from room temperature to 100°C. An empty platinum crucible was used 
for reference. This work was carried out alongside an experienced DSC technician 
and data provided for downstream analysis.  
 
2.2.4 Collagenase digest 
 
Scaffolds were placed in 5ml bijous tubes containing 3ml of standard culture  
(DMEM, Gibco, UK) media supplemented with 300U ml-1 collagenase and 
incubated at 37°C on a tube rotator (Miltenyi Biotec, UK). At specific time points (0, 
1, 2, 4, 6 and 12 hours), scaffolds were removed from media, blotted dry and 
weighed before returning to collagenase solution. All experients were carried out in 
triplicate.  
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2.3 JCol biocompatibility testing  
 
2D lawn culture, viability and proliferation, morphology (cell shape), 3D in vitro 
immunogenicity and cytokine release profiling.  
 
2.3.1 Tissue culture of human cell lines 
 
Human endometrial stromal cells (hESC), HEC50 and Ishikawa cells were cultured 
with DMEM: Nutrient Mixture F-12 supplemented with 10% foetal bovine serum 
(FBS), 1.5mM glutamine, 1mM sodium bicarbonate, 1mM sodium pyruvate, 1%  
penicillin streptomycin and maintained at 37°C and 5% CO2 until 80% confluency. 
At this point cells were washed with PBS before being subjected to trypsin treatment 
to allow for detachment from plastic. Trypsin was then neutralised before 
transferring to a 15ml falcon tube and centrifuging at 1200 rpm for 5 minutes to 
obtain a pellet. The resultant supernatant was removed and the cell pellet 
resuspended in culture media before subculturing into a new flask with fresh media.  
 
2.3.2 Sources of articular cartilage 
 
Animal models are seen as an effective tool for the development of therapeutic and 
surgical interventions intended for human application due to their mimicry of human 
tissue and disease progression. Smaller animals such as mice and rats are regularly 
used for research purposes however these animals often present with an open growth 
plate after skeletal maturity and are likely to confer enhanced reparative properties 
that are not comparable to human tissue (Chu et al., 2010). Larger animals have been 
shown to more closely mimic human cartilage than smaller animals (Reinholz et al., 
2004). Bovine metacarpophalanegeal (MCP) joints have been widely used as a 
model for human articular cartilage due to similarities in components and structure 
(Stockwell, 1978). The animal tissue used in this study was obtained from healthy 
animals entering the food chain. The tissue is classed as a food grade material that is 
discarded during food processing.  
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2.3.2.1 Bovine tissue isolation 
 
Fresh immature (approximately 7-14 days) bovine metacarpophalangeal (MCP) 
joints were obtained on the day of slaughter (Cig Calon Cymru Cyf, Llanelli, Wales). 
All joints were cleaned with soap and tap water before removing skin and inspecting 
for bruising and damaged joints were discarded. Healthy joints were sprayed with 
70% ethanol in order to minimise risk of contamination before being transferred to a 
sterile cabinet. Full thickness cartilage tissue was harvested from the medial and 
lateral condyles, as well as condylar ridge, using a 6mm biopsy punch. Harvested 
cartilage was placed in low glucose Dulbecco’s Modifies Eagle’s Medium (DMEM) 
(cat: 21885-108, ThermoFisher Scientific) before cell isolation was undertaken.  
 
2.3.2.2 Enzymatic digestion and cell isolation 
 
Whole tissue samples were subjected to sequential digestion using pronase and 
collagenase, respectively, to isolate cellular components of bovine MCP tissue. 
Tissue samples were placed in pronase diluted to 70 U ml-1 in DMEM for 2 hours at 
37°C and 5% CO2 on a tube rotator (Miltenyi Biotec, UK). Pronase solution was 
removed and tissue re-suspended in DMEM supplemented with 300 U ml-1 bacterial 
collagenase (cat: C9263, Sigma Aldrich) for 16 hours at 37°C and 5% CO2. 
Following sufficient tissue digestion, assessed by eye, the digest was passed through 
a 40μm cell strainer (cat: 15360801, Fisher Scientific) to separate debris and cells 
were collected into a 50ml falcon tube. Cells were counted using an automated cell 
counter (Bio-Rad, UK) and subjected to differential adhesion assay to select for 
chondroprogenitor (CP) cells.  
 
2.3.2.3 Differential fibronectin adhesion assay 
 
Stem cells can be classified by their ability to adhere to plastic surfaces (Dominici et 
al., 2006). CPs have previously been shown to be selected for via differential 
fibronectin adhesion assay (Dowthwaite et al., 2004). Six well plates (Grenier 
CELLSTAR®, cat: M8562, Sigma Aldrich) were coated with 10ug.ml-1 of 
fibronectin (cat: FN, Sigma, UK) in 0.1M phosphate buffered saline (PBS) at pH 7.4 
containing 1mM MgCl2 and 1mM CaCl2 at 4°C for 24 hours. Following incubation, 
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fibronectin was removed and wells washed with serum free DMEM. Full depth 
populations of cells were seeded at 1000 cells ml-1 and incubated for 30 minutes at 
37°C and 5% CO2. Media and non-adherent cells were then removed and replaced 
with DMEM supplemented with 1% penicillin and streptomycin, 0.5% ml-1 L-
glucose, 10mM HEPES, 1 mM sodium pyruvate, 2mM L-glutamine and 10% foetal 
bovine serum (FBS). Plates containing adherent cells were then incubated for 6 days 
prior to colony isolation. 
 
2.3.2.4 Clonal population isolation 
 
Following 6 days of culture, colonies comprising of 32 cells or more were isolated 
using sterile cloning rings (Sigma, UK) to discount transit-amplifying cells. Cloning 
rings were sealed to the plate by the application of Vaseline to the edge of the ring 
before being positioned upon suitable colonies. Once secured, 200μl of 0.05% 
trypsin (Gibco, UK) was added to detach cells from the surface of the plate. After 3 
minutes incubation, cell suspension was removed and transferred to a 6 well plate 
containing 3ml of DMEM containing FBS to inactivate trypsin activity.  
 
2.3.3 Cell culture medium  
 
DMEM was supplemented with 1% penicillin and streptomycin, 4.5g L-1 L-glucose, 
10mM HEPES, 1mM sodium pyruvate, 2mM l-glutamine and 10% foetal bovine 
serum (DMEM+) was used to culture CP cells.  
 
2.3.3.1 Monolayer expansion 
 
Cells were expanded in DMEM+ in an incubator at 37°C and 5% CO2, with media 
change taking place every 3 days. At 80% confluence, culture media was removed 
and cell monolayer washed with sterile PBS (Gibco, UK). Following PBS wash, 
cells were incubated in 0.05% trypsin-EDTA (Gibco, UK) for 5 minutes at 37°C and 
5% CO2. After gentle agitation, detached cells were transferred to a 15ml tube and 
centrifuged at 1200rpm for 5 minutes at room temperature. The supernatant was 
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discarded and cell pellet re-suspended by aspiration of 5ml of DMEM+ before cells 
were reseeded at a suitable density into a sterile tissue culture flask.  
 
2.3.4 Cellular differentiation 
 
Differentiation studies were undertaken to determine the phenotypic plasticity of 
cells.  
 
2.3.4.1 Chondrogenic differentiation 
 
Specific chondrogenic medium was used to induce chondrogenic differentiation of 
chondroprogenitors in 2D and 3D culture. Chondrogenic medium consisted of high 
glucose DMEM (Gibco, UK), supplemented with 10% heat inactivated FBS, 1% 
insulin transferring selenium (ITS) and 1% penicillin and streptomycin and 10ng ml -1 
TGFβ1. 
 
Sulphated GAGs were detected via alcian blue (Sigma, USA) staining (Williams et 
al., 2010). Monolayer cells were fixed with 10% NBFS for 20 minutes and washed in 
PBS 3 times. Cells were stained with 1% staining solution comprised of 1g alcian 
blue in 100ml of 0.1M hydrochloric acid (pH 2.5) for 30 minutes. Excess stain was 
removed and well washed with 0.1M HCl before immersing in PBS and imaging 
with a light microscope 
 
2.3.4.2 Osteogenic differentiation 
 
Osteogenesis of cells was induced with -MEM (Gibco, UK) culture media 
containing 2mM glutamine and supplemented with 10% heat inactivated FBS, 1% 
penicillin and streptomycin, 0.1μM dexamethasone, 0.2mM ascorbic acid-2-
phosphate and 10mM -glycerophosphate 
 
Alizarin red staining was used to show tissue calcification of monolayer cultures 
subjected to osteogenesis (Williams et al., 2010). Monolayer cultures were fixed in 
10% NBFS for 20 minutes and washed 3 times with PBS. After rinsing the cells were 
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stained with 2% Alizarin red (pH 4.22) solution for 30 seconds and excess stain 
removed. Samples were blotted dry and immersed in PBS before being viewed under 
a light microscope.  
 
2.3.4.3 Adipogenic differentiation 
 
Specific adipogenic media was used to induce adipogenesis and consisted of α-MEM 
media containing 2mM glutamine and supplemented with 10% heat inactivated FBS, 
1% penicillin and streptomycin, 1μM dexamethasone, 1.72μM of bovine insulin, 
0.2mM indomethacin and 0.5mM of isobutylmethlxanthine (IBMX). 
 
Oil red-O staining was used to indicate lipid deposits in monolayer culture (Williams 
et al., 2010). Monolayer cells subjected to adipogenesis were fixed in 10% NBFS for 
20 minutes and washed with PBS. Oil red-O was prepared from 0.5% Oil red-O in 
100% isopropanol by diluting 30ml of stock solution in 20ml distilled water. Cells 
were washed with 60% isoproponal prior to staining with Oil red-O for 15 minutes at 
room temperature. Excess stain was removed and wells immersed in PBS and 
viewed under a light microscope.  
 
2.3.5 Coating plates 
 
24 well plates (Corning, UK) were coated with 30μg/ml of collagen solution in 0.1M 
acetic acid and allowed to dry for overnight in sterile conditions before unoccupied 
areas were blocked with 1% BSA. Cells were seeded onto coated plates at a density 
of 5000 cells per well and cultured for a predetermined period of time.  
 
2.3.6 InCell image acquisition 
 
InCell Analyser 2000 (GE Healthcare) was used to analyse viable and dead cells 
Following culture period media was removed from monolayer cultures and washed 
gently with PBS. Phenol free media was supplemented with using 5μM 
carboxyfluorescein succinimidyl ester (CFSE) and 1μM EthD-2 to visualise live and 
dead cells respectively. 150μl of media containing fluorescent dye was added to each 
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well and incubated at 37°C for 20 minutes in the dark before removal of media and 
PBS wash. 4μM Hoescht in phenol free media was added to the wells and incubated 
at room temperature for 10 minutes before final wash and immersing wells in phenol 
free media.  
  
Image data was obtained using three emission spectra channels; DAPI nuclear 
staining (Channel 1 excitation/emission λ 358/461nm for 0.2 seconds), Texas Red 
protein staining (Channel 2 excitation/emission λ 589/615nm for 2.0 seconds) and 
FITC (Channel 3 excitation/emission λ 492/517nm for 3.0 seconds). Time exposure 
for each channel was consistent between experiments. Low magnification images 
were taken with the 10x with 20 fields of view taken for each well. The InCell 
analyser allows for random distribution of fields across the surface of the well, 
allowing for regions such as the edge of the well boundary to be excluded. Once 
analysis was completed, a data (XDCE) file is produced containing all accumulated 
imaged from the channels and fields of views chosen.  
2.3.6.1 InCell analysis 
 
XDCE data files were analysed using InCell Developer (GE Healthcare) to quantify 
number CFSE and EthD-2 stained cells allowing quantification of live and dead 
cells. Analysis software can segment objects by the intensity of the DAPI channel. 
The intensity of fluorescence produced by DAPI allows segmentation of the nucleus 
against background fluorescence. Fluorescence signal was determined pixel by pixel 
in absolute grey areas across each cell and individual cells were counted based upon 
the channel fluorescence was identified from. Data was accumulated and compressed 
before converting to an excel spreadsheet to show cell count.  
 
2.3.7 Cell morphology 
 
Cells were seeded at a density of 1x104 per well and cultured for a maximum of 5 
days. Images of cells were taken every 24 hours using a light microscope (Zeiss, 
UK). Morphological analysis of cells was undertaken using ImageJ software to 
obtain the shape index (SI). SI was calculated using the formula:  
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SI = 4π x Area/Perimeter2 
 
Cells that are deemed to have a circular shape have an SI of 1 whilst those that are 
more fibroblastic in morphology will have a value of 0 (Tiryaki et al., 2015).  
 
2.3.8 Whole blood patient recruitment 
 
Human peripheral blood was collected from healthy adult volunteers with informed 
written consent. Blood was collected into either 3.2% sodium citrate or lithium 
heparin anticoagulant 9ml Vacuette® tubes (Grenier Bio-One, Stonehouse, UK). 
Venesection was performed by trained phlebotomists in the Joint Clinical Research 
Facility, Institute of Life Science. This study was approved by the Wales Research 
Ethics Committee 6 (13/WA/0190).  
 
2.3.9 Fluorescent activated cell sorting 
 
Cells stained as described below were analysed within 2 hours using a 10 colour, 3 
lasers, Navios Flow Cytometer (Beckman Coulter, High Wycombe, UK). The 
instrument was turned on at least 1 hour prior to running to allow lasers to warm up 
and for quality control checks. To check instrument performance, FlowCheck and 
FlowSet beads (Beckman Coulter) were run. All samples were recorded without 
compensation, which was applied later in data analysis. Voltages were set on 
unstained samples.  
 
2.3.9.1 Leukocyte activation analysis 
 
Whole blood, taken from 3 individual, healthy donors, was stained with the 
following: CD15 and CD14; 100ng/μl CD3-APC-AF750 (clone UCHTI, IgG1, 
Backman Coulter); 25ng/μl CD62L-PE (clone DREG-56, IgG, eBioscience); 
100ng/μl CD11b-APC (clone CBRMI/5, IgG, eBioscience); 220ng/μl fMLP 
receptor-FITC (clone REA169, IgG, Miltenyi Biotec). Samples were vortexed, 
incubated and lysed using EasyLyse as it is formaldehyde free and will not affect 
dead cell staining. 1μl DRAQ7, final concentration 20uM (BioStatus, UK) was 
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added before running the samples. Whole blood stimulated with 10ng/ml LPS for 4 
hours at 37°C and 5% CO2 was used as a positive control and unstained samples 
were used for gating purposes. Blood exposed to 1% Triton-X 100 was used to 
determine DRAQ7 positive cell gates. AbC beads (Life Technologies, UK) were 
stained singly with each antibody and used for compensation. Within 2 hours of 
staining, samples were acquired on the Navios flow cytometer (three lasers (violet: 
405nm, blue: 488nm, red: 638nm) using linear forward scatter (FSC) versus side 
scatter (SSC) scale, flow rate set to high, and stop gate on 10,000 CD15+ events 
which would allow for the acquisition of approximately 10,000 total lymphocytes 
and 1,000 monocytes. Compensation and data analysis were performed using Kaluza 
1.3 (Beckman Coulter).  
 
2.3.9.2 Platelet activation analysis 
 
For platelet activation analysis, whole blood, from three individual, healthy donors 
was stained with 200μg/μl CD42b-FITC (clone HIPO, IgG1, eBioscience). Samples 
were vortexed, incubated and lysed using BD FACS lysing solution. Whole blood 
stimulated with 4 mM phorbol 12-myristate 13-acetate (PMA) for 20 minutes was 
used as a positive control; tubes were run on a logarithmic scale with 10,000 events 
as the stopping gate.  
 
2.3.10 Whole blood culture 
 
Whole blood culture (100ul blood/300ul RPMI, 2μM GlutaMax, 0.1mM 2-
mervaptoethanol) were left unstimulated or stimlulated with 10ng/ml E.coli OIII:B4 
lipopolysaccharide (Ultrapure LPS, Invivogen, France). After 24 hours at 37°C and 
5% CO2 cell free supernatants were harvested by centrifugation at 4°C, 515xg for 7 




Blood serum collected in section 2.3.8 was thawed for cytokine quantification using 
enzyme-linked immunosorbant assay (ELISA). IL-6 (cat: DY206, R&D Systems, 
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USA) and IL-10 (cat: DY217B, R&D Systems, USA) were detected using 
commercially available kits with protocol and antibodies provided.  
 
Capture antibodies were added to a 96 well ELISA plate (cat: 650001, Grenier Bio-
One, UK) following dilution to working concentration in PBS and sealed with a 
polyester film (cat: 391-1250, VWR, UK). The plate was incubated overnight at 4C 
on a rocker to allow adequate binding of antibodies to the plate. Each plate was 
washed with wash buffer (PBS with 0.05% Tween-20) 3 times. Any remaining wash 
buffer was removed by inversion and blotting against paper towels. Following this, 
the ELISA plate was blocked using blocking buffer (1% BSA in PBS) for 1 hour at 
room temperature to block unbound areas and prevent false positives. The plate was 
then washed as before and assay could be preformed.  
 
Known concentrations of IL-6 and IL-10 were used to generate a standard curve. The 
standards were provided with ELISA kits and contained 180ng/ml human IL-6 
standard and 150ng/ml of human IL-10 standard. IL-6 and IL-10 standards were 
produced by serial dilution using blocking buffer for each assay, to concentrations 
600, 300, 150, 75, 37.5, 18.75 and 9.38 pg/ml and 2000, 1000, 500, 250, 125, 62.5, 
31.25 pg/ml, respectively. Blocking buffer was prepared without standard to account 
for background and was subtracted from readings. Standards and samples were 
added to 96 well plates and incubated for 2 hour at room temperature to allow for IL-
6 and IL-10 to bind to capture antibodies. After incubation, excess samples were 
removed and plates washed with wash buffer, three times to remove unbound 
proteins.  
 
A biotinylated secondary detection antibody, which contained goat anti-human IL-6 
and goat anti-human IL-10. The plate was incubated with a secondary antibody for 2 
hours at room temperature to allow binding to target protein. The plate was washed 
with wash buffer, three times before streptavidin-horseradish peroxidase (HRP) was 
added to the plate and incubated for 20 minutes at room temperature in the dark. 
Plates were the washed as previously described.  
 
A substrate solution was added to the plate containing hydrogen peroxide and 
tetramethylbenzidine, which reacts with HRP and results in the development of a 
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blue colour that is directly proportional to target protein concentrations. Sulphuric 
acid (1M) was used to stop the reaction resulting in a colour change from blue to 
yellow. Optical density of each well was determined using the FLUOstar plate reader 
at an absorbance of 450nm.  
 
2.4 Biomaterial application 
 
3D chondrogenic culture, histology, biochemical assays, gene expression. 
2.4.1 Pellet formation 
 
Confluent cells were removed from the surface of the flask via trypsinisation 
(section 2.3.3.1). Cells were counted using an automated cell counter and 5x105 cells 
were added to a sterile eppendorf tube containing 500μl of expansion culture 
medium. The cell suspension was centrifuged at 2000rpm for 10 minutes at room 
temperature (5425, Eppendorf). The pellet was incubated for 24 hours at 37°C and 
5% CO2. Following 24 hours cell pellets were gently aspirated from the surface of 
the Eppendorf surface using a pipette in order to facilitate pellet rounding. 
Chondrogenic media was changed every 2 days until the end of the culture period.  
 
2.4.2 Scaffold seeding 
 
Scaffolds were equilibrated in culture media for 10 minutes prior to seeding and 
placed in 24 well plates coated with 2% agarose to stop cell attachment to the bottom 
of the plate. Confluent cells were removed from the surface of the flask and counted 
using an automated cell counter and 5x105 cells were resuspended in 80μl of media 
before seeding on the surface of the scaffold. Plates containing scaffolds were placed 
in an incubator at 37°C and 5% CO2 for 20 minutes to allow cell attachment to 
scaffolds before filling each well with 200μl of media. After 24 hours, culture media 
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2.4.3 Paraffin wax embedding  
 
Tissue and scaffold samples were washed in PBS before being fixed in neutral 
buffered formalin with saline (NBFS) at 4°C for 15 minutes. Samples were then 
washed and stored in PBS before being embedded at Singleton Hospital (ABMU, 
NHS). Wax embedding consisted of dehydrating samples through a series of graded 
ethanol (70%, 95% and twice at 100%) before being cleared in xylene for 20 minutes 
and infiltrated with paraffin wax for 1 hour at 56°C.  
 
2.4.3.1 Paraffin wax sectioning 
 
Wax embedded samples were sectioned at a thickness of 7μm using a microtome. 
Wax ribbons containing sections of sample were flattened by placing into a water 
bath at 45°C. Sections were removed by transferring onto poly-l-lysine histology 
slides and dried for 24 hours at 45°C. Prior to any staining, slides were 
deparaffinised by washing in xylene twice for two minutes. They were then 
rehydrated in a series of graded ethanol (100% twice, 95% and 70%) for two minutes 
and then immersed in tap water for two minutes.  
 
2.4.3.2 Haematoxylin and eosin 
 
Nuclear staining and tissue architecture were detected by haematoxylin and eosin 
(TSC biosciences, UK). Haematoxylin was diluted in water (1:2 ratio) and 1% eosin 
was prepared by dilution in water. Rehydrated slides were stained in haematoxylin 
for 1 minute and washed in water to remove excess stain. The stain was 
differentiated in 1% alcohol and washed in water before staining in eosin for 2 
minutes.  Slides were washed in water to remove excess stain and dehydrated in 
ethanol before clearing in xylene and mounted with DPX.  
 
2.4.3.3 Toluidine blue 
 
Sulphated GAG deposition was indicated via Toluidine blue staining (Williams et 
al., 2010). Rehydrated pellet sections were stained with 0.04% toluidine blue for 15 
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minutes and washed until water was clear. Stained sections were dried over night at 
45°C and mounted using DPX mounting medium before viewing under a light 
microscope.  
 
2.4.3.4 Picrosirius red 
 
Collagen fibrils were indicated histologically with picrosirius red staining. Sectioned 
sampled were hydrated through descending concentrations of ethanol before being 
stained with 0.1% (w/v) picrosirius red solution for 1 hour at room temperature 
before washing with water. Slides were then dehydrated in ethanol before being 
mounted in DPX mounting fluid and adding a coverslip before being examined under 




Paraffin wax embedded samples were dewaxed and rehydrated as described in 
section 2.4.3.1. Samples were treated in 3% hydrogen peroxide in methanol to 
reduce background staining and were then washed in PBST (PBS with 0.05% 
Tween-20) for 5 minutes. Following this, samples were treated for antigen retrieval 
and incubated at 65C in Tris-EDTA overnight before being washed in PBST and 
subjected to enzymatic treatment with 2U ml-1 hyaluronidase in PBST for 1 hour at 
37C. Samples were then washed in PBST for 5 minutes before blocking to prevent 
non-specific binding of antibodies with 2.5% normal horse block serum (RTU 
Vectastain Kit, Vector Laboratories, USA) for 30 minutes. Blocking serum was 
removed and primary antibodies diluted (dilutions stated below) in PBST was added 
to samples for 30 minutes at room temperature, with negative controls using PBST 
containing no primary antibodies. Following incubation with antibodies, samples 
were washed for 5 minutes in PBST and secondary antibodies were added for 10 
minutes at room temperature (RTU Biotinylated pan specific antibody Universal 
biotinylated Anti-Mouse/Rabbit/Goat IgG derived from horse) before washing for 5 
minutes in PBST. Streptavidin/peroxidase complex reagent (RTU Vectastain Kit, 
Vector Laboratories, USA) was applied to samples at room temperature for 5 
minutes before rinsing with PBST for a further 5 minutes and samples were 
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developed using NovaRED kit (Vector Laboratories, USA) for 5 minutes to allow for 
detection of streptavidin/peroxidase enzymatic activity.  
 
Samples were washed with deionised water and nuclei were counterstained with 
haematoxylin for 1 minute before dehydration in a series of graded alcohol. Sampled 
were then mounted with DPX and analysed via light microscope to examine the 
extracellular matrix.  
 
Project specific antibodies used; 
- Collagen type II (1:250, DHSB II-II6B3 raised in mouse) 
- Aggrecan (1:10, DHSB 12/21/1-C-6 raised in mouse) 
- Collagen I (1:2000, Sigma C2456, raised in mouse) 
 
2.4.4 Scaffold and pellet digestion 
 
Papain is a cysteine protease that is used for the digestion of samples for subsequent 
biochemical analysis (Estes and Guilak, 2011). Whole scaffold/pellet samples were 
digested in papain buffer (20mM NaAc pH 6.8, 1mM EDTA, 2mM DTT, 300μg ml-
1 papain) following completion of experimentation. Samples were incubated within 
an eppendorf containing papain buffer at 60°C in a water bath for 60 minutes or until 
no visible tissue remained. Digested samples were stored at -20°C until needed for 
biochemical analysis of DNA, GAG and hydroxyproline content. 
 
2.4.4.1 DNA quantification 
 
DNA quantification is assessed in order to normalise data obtained from GAG and 
hydroxyproline assays (Estes and Guilak, 2011). Quant-iT TM Picogreen dsDNA 
assay kit  (cat: P11496, ThermoFisher Scientific, UK) was used to quantify DNA 
content from scaffolds and pellets, in triplicate from three repeats, in accordance to 
the manufacturers protocol. Samples were quantified against a standard curve 
composed of a series of lambda DNA diluted in 1xTE buffer provided in the kit (0-
10ug/ml). Fluorescence was measured using a FLUOstar Omega plate reader at 
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520nm and cell number calculated with the assumption that every mammalian cell 
contains 7.7pg of DNA (Röder et al., 2015). 
 
2.4.4.2 DMMB assay 
 
A standard curve consisting of chondroitin sulphate (cat: C4348, Sigma-Aldrich, 
UK) diluted in water, ranging from 0-10μg ml-1 was produced. For each reaction, 
20μl of papain-digested sample was added to 200μl of DMMB reagent (16mg L -1 
dimethlmethylene blue, 3g polyvinyl alcohol, 3.04g glycine, 2.37g NaCl, 95ml 0.1M 
HCl) in a 96 well plate and shaken for 5 seconds. Glycosaminoglycan content  from 
scaffold and pellets was determined, in triplicate from three repeats, by 
spectrophotometric measurement of absorbance against the standard curve at 525nm 
using a plate reader (FLUOstar Omega, BMG) and normalised through division by 
the corresponding DNA content.  
 
2.4.4.3 Hydroxyproline assay 
 
Hydroxyproline assays were run to calculate collagen content samples. Papain 
digested samples were hydrolysed in 6M HCl for 24 hours at 110°C using a heating 
block and vacuumed dried overnight before reconstituting in deionized water. 
Following centrifugation to remove impurities, 30μl of each sample were added to a 
96 well plate and 70μl of diluent solution and 50μl oxidant were added to each 
sample before shaking for 5 minutes at room temperature. 125μl of colour reagents 
was added and samples shaken prior to 15 minutes incubation at 70°C. 
Hydroxyproline content was measured in terms of absorbance at 540nm using a plate 
reader and quantification determined against the standard curve of trans-4-hydroxy-
L-proline (0-100μg/ml).  
 
Composition of buffers is as follows 
- Stock buffer: 28.5g sodium acetate trihydrate, 18.75g tri sodium citrate 
dyhydrate, 2.75g citric acid, 200ml propan-2-ol 
- Diluent: 100ml propan-2-ol, 50ml H2O 
- Oxidant: 0.7g Chloramine T, 10ml H2O, 50ml stock buffer 
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- Colour reagent: 7.5g dimethylaminobenzaldehyde, 11.25ml perchloric acid 
(60%), 62.5ml propan-2-ol 
 
2.4.5 RNA extraction from native tissue 
 
Articular cartilage biopsy samples were placed in a shaking flask with a grinding ball 
and 250μl of trizol reagent. The flasks were then sealed and snap frozen in liquid 
nitrogen before homogenization of the sample via shaking at 2000rpm for 1 minute 
using a Mikro dismembrator-S (B. Braun Biotech International, Germany). The 
powdered material was collected and stored at -80°C until needed. RNA was 
extracted from the powdered material using RNeasy columns with a DNase1 on-
column digest as outlined in the Qiagen user manual. Isolated RNA was stored at -
80°C prior to quantification. 
 
2.4.6 RNA extraction from pellets and scaffolds 
 
RNA was extracted from samples on the day of experimental completion. Samples 
were placed in a 2ml eppendorf with 350ul RLT buffer (Qiagen, UK) and 
mechanically homogenized for 20 seconds using a TissueRuptor fitted with a sterile 
probe (Qiagen, UK). RNA was extracted using RNeasy columns with a DNase1 on-
column digest and stored at -80°C prior to quantification. 
 
2.4.6.1 RNA quantification 
 
Prior to quantification, RNA samples were thawed and mixed gently. RNA 
concentration was determined by spectrophotometric measurement of UV 
absorbance at 260nm and 280nm using a NanoDrop ND2000 instrument 
(ThermoFisher Scientific, UK) with molecular biology grade RNA free water 
(Ambion, UK) used as a reference. The shape and ratio of the absorbance curve was 
used to determine RNA quality and potential contamination. Purity was regarded as 
suitable if an A260/A280 value of approximately 2.0 was achieved.  
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2.4.6.2 cDNA conversion 
 
RNA was reverse transcribed to cDNA for the analysis of gene expression from 
samples. RNA samples were adjusted to a concentration of 100ng/μl with nuclease 
free water. 2μl of RNA at 100ng/μl was diluted with 38μl nuclease free water and 
used as a negative control for quantitative real-time PCR. A master mix was prepared 
using components from the high capacity cDNA reverse transcriptase kit (cat: 
3468814, Applied Biosystems) to reduce pipetting error. For each sample 2μl 10x 
RT buffer, 0.8μl 25x dNTP mix (100mM), 2μl 10x RT random primers, 1μl 
multiscribe™ reverse transcriptase, 1μl RNase inhibitor (cat: N8080119, Ambion) 
and 3.2μl nuclease free water was used. 10μl of master mix was added to 10μl of 
RNA sample for a 20μl total volume per reaction to obtain single stranded cDNA. 
The T100™ Thermal Cycler (cat: 186-1099, Bio-Rad) was programmed for the 
following steps 25°C for 10 minutes, 37°C for 120 minutes, 85°C for 5 minutes and 
then 4°C. Following completion of cDNA conversion, serial dilutions were made 
from cDNA stocks using nuclease free water for generation of a standard curve. 
cDNA at 1:10 was used as the working concentration for target gene expression 
analysis. cDNA was stored at -80°C until required. 
 
2.4.6.3 Quantitative polymerase chain reaction (qPCR) 
 
Quantitative polymerase chain reaction (qPCR) was undertaken using CFX96 Real 
Time PCR Detection system (Bio-Rad, UK). Primers were designed to amplify a 
single PCR product of approximately 75-150bp in length. An internal reference 
ribosomal protein S19 (RPS19) was used for normalisation as well as non-reverse 
transcribed RNA as a negative control. Each reaction was prepared to a total volume 
of 10μl; 2.5μl 4μM primer mix (forward and reverse), 2.5μl sample cDNA and 5μl 
SYBR Green. All PCR reactions were conducted in triplicate to reduce pipetting 
error. All PCR reactions were preformed in a clear unskirted 96 well plate (cat: 
MLL-9601, Bio-Rad) sealed with a microseal (cat: MSB-1001, Bio-Rad). Plates 
were heated for 30 seconds at 95°C then real time data was collected during 40 
cycles containing a 2 second step at 95°C and 5 seconds at the optimal annealing 
temperature for specific primers outlined in Table 2.1.  
 








RPS18 Forward CACTGGAGGCCTACACGCCG 65.26 119 
Reverse AGGCAATTTTCCGCCGCCCA 65.84 
COL2A1 Forward CTGGATGCCATGAAGGTTTT 56.27 93 
Reverse GCTCCACCAGTTCTTCTTGG 58.47 
COL1A1 Forward TAGGCCCAACCAGTCACCTGCGTAC 68.22 64 
Reverse GTTTCCACACGTCTCGGTCA 60.25 
COL10A
1 
Forward CCCATGCTTGGGTAGGTCTG 60.11 131 
Reverse CCATACCTGGTCGTTCTCGG 59.90 
ACAN Forward GCTACCCTGACCCTTCAT 55.51 76 
Reverse AAGCTTTCTGGGATGTCCAC 57.79 
SOX9 Forward TCAGCAAGACTCTGGGCAAG 59.96 151 
Reverse CCGTTCTTCACCGACTTCCT 59.68 
RUNX2 Forward GCGCATTCCTCATCCCAGTA 59.89 198 
Reverse TGGATGGACGGAGGAGTCAT 60.03 
 
Table 2.1: Primers used for qPCR 
 
2.5 Statistical analysis 
 
Statistical analysis was performed using SPSS software version 22. All data sets 
were first analysed for normality using the Shapiro-Wilk test. Statistical significance 
of parametric data was determined with an independent T-Test. If data was found to 
be significantly different from normal distribution, non-parametric testing using 
Mann Whitney –U testing was applied. All statistical significance threshold values in 
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Collagen has proven itself to be an efficacious biomaterial accepted due to its 
biocompatibility, with a wide variety of clinical requirements and applications 
(Ramshaw et al., 2009). Type I collagen belongs to the fibrillar collagens and is 
potentially the best investigated collagen subfamily. It is found abundantly expressed 
throughout the human body and is a critical component of the interstitial membrane 
(Henriksen and Karsdal, 2016). The most predominant market source of collagen I is 
porcine skin and bovine tendons and hide (Silva et al., 2014). New sustainable 
collagen sources are continually being sought as an alternative to traditional 
mammalian protein for biomaterial use in regenerative medicine applications (Addad 
et al., 2011).   
 
There are drawbacks from using mammalian collagen sources, with primary 
concerns resting around zoonotic disease transmission, allergic reactions to the 
material and religious restrictions (Browne et al., 2013). Understanding the structure 
and functional conservation of collagen sources, compared to human/mammalian 
sources, is a crucial indicator of suitability for purpose. These processes are essential 
in identifying any indication of potential downstream biocompatibility issues, early 
in the research and development phase (Lynn et al., 2004). Marine sources are of 
increasing interest, with waste from the fishing industry as well as sponges and/or 
jellyfish being used as alternatives to mammalian sources (Silva et al., 2014). 
Interestingly, jellyfish derived collagen has proven to be an appropriate source, 
capable of isolation and biocompatible cell expansion (Addad et al., 2011). 
 
3.1.1 Sequence informed structure function analysis  
 
Collagen is a triple helical molecule, shown to have evolutionary stability amongst 
mammalian species (Lynn et al., 2004). A complex structure, collagen comprises of 
non-helical C and N telopeptides that aid with fibrillar formation as well as 
crosslinking that allows for the stabilisation of the triple helix formation (Artym and 
Matsumoto, 2010). It is these non-helical regions that contain a greater degree of 
structural variability with approximately half of the amino acids exhibiting 
interspecies variation of collagen molecules. (Lynn et al., 2004). 




Native to Mediterranean, North Sea, Black Sea and Atlantic Ocean, numbers of the 
R. pulmo peak during the spring and summer (March to August) months with an 
increase in the water temperature (Muhammed and Sultana, 2008). Jellyfish possess 
a collagen content of approximately 60% of their body and are thought to have a 
high degree of conservation with various species showing similarities to vertebrate 
collagens type I, IV, V and a similar glycosylation patterns to type II (Hoyer et al., 
2014). Sequencing jellyfish collagen to confirm its homology with the human 
protein, as well as others commercially available, is the first step towards 
understanding biocompatibility.  
 
3.1.1.2 Collagen Extraction and Characterisation 
 
Collagen extraction is typically carried out through (a) chemical hydrolysis or (b) 
enzymatic hydrolysis, with the chemical process favoured within the food industry 
(Schmidt et al., 2015). Acid soluble extraction is usually the preferred process, as the 
traditional extraction procedure is laborious, taking between 7-10 days to complete 
(Pacak et al., 2011). A pre-wash stage is used to remove all non-collagenous 
substances, before collagen extraction via solubilisation in neutral saline solutions, 
acidic solutions or acidic solutions with the addition of enzymes such as pepsin and 
separation using filtration or centrifugation. The optimisation of particular steps in 
the extraction protocol, such as the use of inorganic or organic acid during 
solubilisation, can affect the final collagen yield and must be considered for every 
new collagen source (Schmidt et al., 2015).  
 
A suite of techniques is currently used to characterise extracted collagen; broadly 
categorised into structural, chemical and morphological analysis. Collagen purity, 
helical content as well as thermal properties are assessed through methods such as 
SDS PAGE and differential scanning calorimetry, respectively. The chemical 
features of collagen are analysed focusing on surface elemental analysis and 
hydrophobicity whilst morphological analysis includes the presentation of 
characteristic D banding, topographical analysis and fibre orientation, determined via 
SEM or AFM (Abraham et al., 2008). Other techniques, such as fourier transform 
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infrared spectroscopy (FTIR) have been used to analyse extracted collagen from 
different species. Collagen exhibits characteristic amide peaks, that can be used to 
confirm the presence of the triple helix (Silva et al., 2014).  
 
Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) is 
a fingerprint technique that can be used for molecular identification by measuring the 
vibrational modes of molecular bonds to obtain a spectrum (Baker et al., 2014). The 
sensitivity of detection has been demonstrated in various experiments. An example 
of ATR-FTIR fingerprint detection has been exhibited in experiments by Bobroff et 
al. where the shift in peaks was observed for poly-L-lysine (PLL) with fatty-acyl- 
chains of differing length giving each molecule a distinct spectrum (Bobroff et al., 
2016). Collagen has previously been assessed via this technique for confirmation 
with particular attention paid to amide I, II and III peaks found in the region of 
approximately 1650cm-1 as a result of the stretching vibration from peptide carbonyl 
(-C=O) groups, 1530cm-1 resulting from a vibrational bending from amine (N-H) 
groups and 1240cm-1 attributed to amide bending, respectively (Vidal and Mello, 
2011). 
 
3.1.2 Scaffold fabrication 
 
Tissue engineering scaffolds are a representation of the physical structure and space, 
supporting cell growth and allowing tissue development (Carletti et al., 2011). 
Collagen based tissue devices are flexible in their fabrication with characteristics 
such as strength and durability tailored by variation in the crosslinking materials and 
methods (Davidenko et al., 2015). Although the triple helix structure of the molecule 
aids stability, depending on hydroxyproline content, the structure can be further 
stabilised for different applications ranging from a lesser crosslinked structure for 
wound healing and heart valves to highly crosslinked and stable scaffolds for 
osteochondral tissue repair (Ramshaw et al., 2009). Scaffold composition, 
architecture and mechanical properties all play important roles in guiding correct cell 
formation for repair of damaged tissues (Davidenko et al., 2015). Another vital 
component when designing scaffolds for tissue engineering is the biodegradability of 
the material. A scaffold must degrade in an adequate time frame to allow for the cells 
Chapter 3                                                                     R. pulmo Collagen Characterisation 
 
 74 
to remodel the tissue. Collagen scaffold biodegradability can be verified in vitro by 
the use of collagenase, a family of enzymes that break peptide bonds within the 
protein (Bitar and Zakhem, 2014).  
 
Scaffolds designed for tissue engineering strike a balance between mechanical 
function and bio-factor delivery (Iwasa et al., 2009). A critical component of scaffold 
fabrication is its porous architecture dictating many factors including nutritional 
transport, cell migration and attachment (Hollister, 2005). SEM is used to assess the 
porous nature of scaffolds (Zhang et al., 2014b). Extracted collagen must be assessed 
for its fabrication suitability and potential for ideal scaffold composition and 
structure. Physical and biochemical scaffold properties can be modified to better 
mimic natural matrix properties (Davidenko et al., 2015). The degree of crosslinking 
should ideally mirror the mechanical properties of the tissue being replicated. One of 
the most successful chemical crosslinking agents for collagen sponges and hydrogels 




The chapter hypothesis states that R. pulmo derived marine collagen is a suitable 
material for human regenerative medicine. In order to contribute significant evidence 
base to test this hypothesis, extracted collagen alpha bands are processed for protein 
level sequencing and analysis conducted to assess homology against mammalian 
collagen sources. Potential downstream regenerative medicine applications are 
dependent on the ability to mould or fabricate a 3D scaffold structure compatible 
with cell invasion. This chapter assesses the suitability of R.pulmo extracted collagen 
for sponge scaffold fabrication. 
 
3.1.3.1 Aims and objectives 
 
A series of aims and objectives were designed in order to test the stated hypotheses; 
 
 Identify a fast, high yield collagen isolation methodology compatible with 
industry scale production  
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 Incorporate a suite of characterisation techniques to inform quality control at 
the multiple stages of collagen extraction, including gel electrophoresis, and 
FTIR analysis to identify amide peaks indicative of maintained collagen 
confirmation   
 Sequence the alpha1 band of the extracted R. pulmo collagen to align with 
published peptide sequences from mammalian sources to assess the degree of 
sequence conservation  
 Develop scaffold fabrication protocols and assess the suitability of the 
collagen source for moulding methodologies, forming stable, potentially 
biomimetic 3D scaffolds for downstream applications in regenerative 
medicine  
 Utilise a multidisciplinary suite of material characterisation techniques 
(porosity, thermal stability and biodegradability properties) to assess scaffold 
suitability and functional compatibility with downstream regenerative 
medicine applications   
 
3.2 Results  
 
Current industrial scale collagen extraction processes are defined by four major 
stages; (A) acid extraction for collagen solubilisation (B) pepsin digestion for 
telopeptide cleavage (C) salt precipitation for efficient collagen isolation and (D) 
separation, through filtering or centrifugation to yield pure collagen. Following this 
process, the isolated, pure research grade collagen is re-suspended in acetic acid prior 
to storage and shipment to customers (Schmidt et al., 2015).   
 
In order to develop a faster, scalable R. pulmo collagen extraction process, a critical 
review of the literature was conducted, identifying crucial extraction stages and cross 
referenced to Jellagen Pty Ltd’s current/proprietary extraction. From this, a defined, 













Figure 3.1: Optimised extraction process for testing. Critical stages in collagen 
extraction outlined (A-D) and mapped against known collagen extraction for 
Rhizostoma pulmo (E).  
 
For each stage (A to D) a number of variables were identified and tested for their 
effect on collagen yield, purity and confirmation, using FTIR analysis and gel 
electrophoresis, respectively. These outputs were used to select quality control end 
point measurements to inform a new, optimised extraction process compatible with 
industry scale up.  
 
R.pulmo jellyfish was fished from Camarthen Bay, immediately stored on ice and 
shipped back to Jellagen UK premises in Cardiff. Flash frozen R. pulmo material was 
stored at -20°C over a period of 6-12 months and used for collagen extraction as and 
when appropriate. Five individual extraction processes were conducted using the 
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same fished batch of R. pulmo and the extracted collagen analysed for yield (dry 
weight relevant to start material), purity and confirmation (FTIR).  
3.2.1 Sodium citrate collagen extraction 
 
Acid extraction methods for collagen stabilisation are variable in the literature, with 
differing acids used. Acetic acid, used traditionally, is proven to solubilise collagen. 
This stage however is slow, with efficient solubilisation requiring up to 3 days 
(Schmidt et al., 2015). Alternatively, sodium citrate is an alternative acid 
solubilisation step, which may be as efficient, when combined with agitation (Pacak 
et al., 2011).  
 
Sodium citrate (0.1M) was used here, with downstream digestion, in the presence 
and absence of pepsin, according to the rapid extraction outlined in Pacak et al 
(Pacak et al., 2011). Centrifugal separation was used to rapidly precipitate. Figure 
3.2 demonstrates the results for R. pulmo extracted collagen using this method, 









Figure 3.2: Sodium citrate R.pulmo collagen extraction in the presence and 
absence of pepsin. A bespoke extraction protocol was devised using sodium citrate 
stabilisation and downstream centrigugation (A).  Images of freeze dried material 
and FTIR spectra were obtained after extraction in the absence (B) and presence (C) 
of pepsin. 
 
Figure 3.2 (A) shows a simplified flow diagram of the devised sodium citrate 
extraction. An initial sodium acetate wash and centrifugation was followed by pellet 
re-suspension in 0.1M sodium citrate (17% wt/vol). During this point of the protocol, 
the addition of pepsin is optional. Followed by a final centrifugation step lead to the 
yield of collagen within the supernatant. The final yield of material (dry weight) 
from a starting weight of 5g jellyfish tissue was 0.278g ± 0.02 (5.55%) and 0.342g ± 
0.02 (6.83%) for extraction without and with pepsin digestion, respectively.  
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The image, in Figure 3.2 (B), shows a brittle white powder, obtained following 
freeze-drying, that was difficult to re-suspend in acid leading to a viscous solution 
with precipitate. When processed for FTIR, Figure 3.2 (C), a difference in peaks 
across the collected spectrum was observed, when compared to a control rat-tail 
collagen preparation. The nearest major peaks from this extraction protocol, when 
compared to the control, were observed at 1720cm-1, 1599cm-1 and 1207cm-1. The 
peak at 1720cm-1 is typically associated with aldehydes or ketones (C=O) showing 
this extraction causes a loss in the characteristic amide I peak. The loss of the amide 
II peak is also seen in this extraction, observed at a higher wavelength, 1599cm-1. 
Although a shift occurs in the position of the amide III peak it remains within the 
range of wavelength used for classification, between 1300-1180cm-1. 
 
An identical extraction, with the addition of a pepsin digestion, was also tested in 
Figure 3.2 (D). A similar white, brittle powder was obtained after freeze-drying. The 
collagen was difficult to resuspend in acetic acid, producing a viscous solution with 
precipitates. FTIR analysis, shown in Figure 3.2 (E), displayed altered spectrum 
with a change in peaks when compared to a rat-tail collagen standard, with the most 
similar peaks observed at 1689cm-1, 1593cm-1 and 1221cm-1. The addition of pepsin 
in the extraction allows for the amide I peak to be regained at 1689cm -1 as well as 
maintenance of the amide III peak at 1221cm-1. The addition of pepsin with a sodium 
citrate extraction leads a peak at 1593cm-1, which falls outside the amide II 
classification region of 1575-1500cm-1. 
 
The lack of particular amide peaks along with the brittle nature of the final material 
led to the conclusion that sodium citrate was not an appropriate acid for 
solubilisation and extraction of collagen from R. pulmo. 
 
3.2.2 Acetic acid extraction 
 
Organic acids, such as acetic acid, are routinely used for collagen extraction. Acetic 
acid is capable of solubilising non-crosslinked collagen as well as the inter-strand 
crosslinks also found in collagen (Schmidt et al., 2015). To test the appropriate use 
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of acetic acid, 0.25M was used with downstream digestion in the absence and 




Figure 3.3: Acetic acid R.pulmo extraction in the presence and absence of 
pepsin. Extraction protocol was devised using acetic acid (A) and images of freeze 
dried material and FTIR spectra were obtained after extraction in the absence (B) and 
presence (C) of pepsin. 
 
A flow diagram of the extraction protocol is outlined in Figure 3.3 (A) where, 
following a sodium acetate wash and centrifugation, the pellet was resuspended in 
0.25M acetic acid to solubilise collagen (10% wt/vol), in the presence and absence of 
pepsin. The resultant solution was then analysed for collagen content.  
 
Figure 3.3 (B) shows material obtained from acetic acid extraction without the use 
of pepsin digestion. A yield of 0.038g ± 0.001 (1.9%) was achieved from 2g of raw 
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jellyfish tissue. A brittle, white material was obtained after freeze-drying, that 
became a sticky precipitate when attempting to resuspend in acetic acid. FTIR 
analysis, Figure 3.3 (C), of this material revealed peaks closest to rat-tail control 
samples at 1655cm-1, 1597cm-1 and 1182cm-1. The spectrum from this extraction 
revealed that the amide I and amide III peaks remained within the expected 
wavelength range whilst the amide II peak was positioned at an increased 
wavelength falling outside the expected amide II range.  
 
Using an identical extraction with the addition of a pepsin digestion stage, material 
was obtain and analysed, shown in Figure 3.3 (C). Using this extraction method a 
yield of 0.144g ± 0.02 (7.2%) was obtained from 2g of raw jellyfish tissue. The 
material obtain from acetic acid extraction with the aid of pepsin yielded a less brittle 
material than extracted in the absence of pepsin however resuspension lead to a 
solution with large precipitates. Figure 3.3 (D) shows FTIR analysis of acetic acid 
extraction with pepsin digestion showed peaks similar to control rat-tail collagen at 
1652cm-1, 1560cm-1 and 1261cm-1. In a similar manner to the extraction lacking 
pepsin digestion, the amide I peak is maintained however the addition of pepsin 











Figure 3.4: Acetic acid R.pulmo extraction with salt precipitation. Extraction 
protocol was devised using acetic acid with salt precipitation (A) and images of 
freeze dried material (B) and FTIR spectra were obtained after extraction (C). 
 
A pre-wash stage with an alkaline buffer in addition to salt precipitation, following 
acid solubilisation, is thought to improve purity and yield by removing non-
collagenous material from native tissue samples (Pacak et al., 2011). In Figure 3.4 
(A), the protocol of pre-wash and downstream salt precipitation is shown. Depicted 
in Figure 3.4 (B) is the freeze-dried material that had a soft texture and could be 
easily resuspended into acetic acid with no visible precipitates. The final yield of 
material obtained after this extraction was 0.375g ± 0.01 (0.7%) from 50g (40% 
wt/vol) of raw jellyfish tissue. When compared to rat-tail collagen FTIR spectrum, 
Figure 3.4 (C), the material gave similar peaks at 1685cm-1, 1554cm-1and 1243cm-1 
which although shows a shift in peak positions, are still within the amide regions I, II 
and III, respectively.          
 
Table 3.1 outlines the summary of the modified rapid extractions protocols and their 
effect on collagen yield. Clearly indicated here, alongside the physical properties of 
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the materials is that acetic acid followed by salt precipitation is the ideal rapid 




Table 3.1: Summary of collagen extraction yield and characterisation. 
 
Sodium citrate extraction in the absence and presence of pepsin digestion gave a 
product that was brittle and sticky and FTIR analysis revealed the shift in peak 
positions leading to the loss of amide I and II, respectively. Acetic acid extraction in 
the absence of pepsin yielded a brittle material that was difficult to resuspend and 
FTIR spectrum obtained showed a shift in the amide II peak, falling out of the 
characteristic range. When acetic acid was used in the presence of pepsin, FTIR 
analysis revealed that amide I, II and III peaks were present within the expected 
wavelength values but resuspension of the material lead to large precipitates 
remaining in the solution. The removal of the pepsin digestion in favour of a salt 
precipitation led to a soft material that was resuspended with ease in acetic acid and 
displayed amide I, II and III peaks on the FTIR spectrum.  
 
3.2.3 Scalable collagen extraction  
 
An established, protracted (12 day) collagen extraction protocol exists within 
Jellagen Pty Ltd and is also used by Contract Research Organisations (CROs) in the 
field. In order to assess the effect of this process on collagen confirmation and purity, 
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specific variable testing and FTIR quality control measurements were conducted. 
This was done with the aim of integrating the rapid extraction process stages (section 
3.2.2). While this process was convoluted, once again a series of extractions were 
performed where distinct variables were adjusted, merging the scalable and rapid 
protocols for a new, optimised industry scale process. This process is now embedded 
in Jellagen production facility, and is outlined in Figure 3.5.  






Figure 3.5: Optimised scalable extraction for conserved collagen confirmation. An early R. pulmo extraction protocol adopted by 
Jellagen taking a total of 12 days used 0.5M acid to solubilise collagen (left) whereas an in house extraction protocol used a pre-wash 
step using sodium acetate and salt precipitation to obtain collagen (right). A final protocol was adopted by combining both in house and 
Jellagen’s early protocol to include a pre-was stage and add further extraction stages using differing molarities of acetic acid (centre).  
Chapter 3                                                                     R. pulmo Collagen Characterisation 
 
 86 
Two batches were analysed from the Jellagen scalable process, outlined in Figure 
3.6, aiming to incorporate the rapid scale extraction stages. This process was then 
modified according the devised in house protocol in Figure 3.5, the results of which 
are shown in Figure 3.7.  
 
 
Figure 3.6: Jellagen batch collagen extraction analysis. FTIR (A and C) and gel 
electrophoresis (B and D) were used to analyse collagen extraction from 2 separate 
batch runs.  
 
Figure 3.6 (A) shows the FTIR spectra and gel electrophoresis results from the first 
batch of collagen extracted via the existing Jellagen protocol. When compared to rat-
tail collagen the FTIR spectra depict the major peaks closest to those found in 
collagen at 1647cm-1, 1477cm-1 and 1181cm-1. Gel electrophoresis of rat-tail and 
bovine collagen show α1 and α2 bands (highlighted in red) at approximately 115 and 
135kDa, respectively. Collagen obtained from batch one extraction was also 
subjected to gel electrophoresis and no visible bands were revealed upon staining, 
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shown in Figure 3.6 (B). The analysis of the second batch of collagen produced by 
Jellagen was also conducted. FTIR spectrum of jellyfish collagen, shown in Figure 
3.6 (C) is compared against commercially available rat-tail collagen with peaks 
visible at 1645cm-1, 1590cm-1 and 1112cm-1. Figure 3.6 (D) shows gel 
electrophoresis of rat-tail collagen α1 and α2 band at approximately 115 and 
135kDa, highlighted, however jellyfish collagen obtained from batch two showed no 
visible bands at this molecular weight following staining at two different loading 
concentrations but displays bands at lower molecular weights.  
 
3.2.4 Collagen protein analysis  
 
Protein sequence is capable of indicating the degree of conservation between 
R.pulmo collagen and human variants, in terms of functional peptides and cell 
binding peptides, providing essential structure/function information, which can 
determine the suitability of the collagen as a base material for scaffold fabrication. 
These alongside mechanical and morphological parameters will provide the essential 
base to assess potential applications in regenerative medicine, later in this thesis.  
Proteins are coded for by the DNA sequence, which is unknown for the collagen 
locus in R.pulmo species, however the obtainment of R.pulmo collagen peptide 
sequences allows for the analysis and subsequent identification of functionally 
important amino acid chains (Choi et al., 2010).  
 
Alpha chains are of particular interest when investigating collagen. Collagen fibrils 
are formed through three α chains in heterotrimeric or homotrimeric combinations 
(Gelse et al., 2003). The polypeptide structures of α chains is primarily composed of 
Gly-X-Y repeats and are joined together through interstrand hydrogen bonds that aid 
in the stability of the protein structure (Bhowmick and Fields, 2013). 
 
3.2.4.1 Peptide sequence quality control  
 
Peptide sequencing was used to identify the amino acid composition of the α1 band 
following tryptic digestion (Grundy et al., 2009). In this ‘bottom up’ approach the 
peptides obtained through cleavage are analysed through mass spectrometry however 
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this technique undergoes various quality control measures to ensure the achievement 
of reproducible data (Bittrremieux et al., 2017). These include a minimum length of 
12 amino acids and ideally 2 positive changes from tryptic digestion for mass 
spectrometry without ionisation issues (Steen and Mann, 2004), the identification of 
contaminants such as skin and hair (Keller et al., 2008) and peak shape during the 
liquid chromatography phase to avoid oversampling (Rudnick et al., 2010).  
 
Total R.pulmo collagen was denatured and separated using gel electrophoresis prior 
to extraction of the alpha1 band for sequencing. Shown in Figure 3.7 is the 




Figure 3.0.7: Alpha1 collagen band extraction for sequencing. Rat-tail and bovine 
collagen type I run against jellyfish collagen to locate alpha 1 band. Alpha 1 band for 
rat-tail and bovine collagen is found at ~135kDa (green arrow) and jellyfish collagen 
alpha 1 is found at ~175kDa (red arrow).  
 
R.pulmo derived α1 band sequencing yielded 436 rows of peptides detected. Each 
data file consisting of detected peptide sequences listed against quality control 
parameters including tag length that enables identification of peptides, average level 
of confidence (ALC), length of detected peptide, mass to charge (m/z) ratio, charge 
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(z) value, retention time (RT), area of the peak, mass of the sample, value in parts per 
million (ppm), accession value for contaminated peptides, post translational 
modifications (oxidation and hydroxylation), local confidence values and mass 
spectrometry mode. The resultant peptides were analysed for their quality, using the 
accepted quality control range of 90% or above average confidence level, according 
to Renard et al. (Grundy et al., 2009).  
 
In total, 436 peptides were reported, 123 with an ALC of 90+; 99 with an ALC of 
80+; 80 with an ALC of 70+; 63 with an ALC of 60+ and 70 with an ALC of 50+. 
From these 23.9% were contaminated and discarded. Of the remaining 331 
sequences, only those with an ACL above 90 were considered for analysis. Table 3.2 
lists the 32 peptide sequences detected based on the ALC, an arbitrary cut off 






Peptide Sequence ALC 
(%) 
Length PTM 
SGLEGEVGPR 99 10 N/A 
GPPGQVGPAGLEGK 98 14 Oxidation/Hydroxylatio
n 
GNLGPDGLAGR 97 11 N/A 
GTAGLLGATGK 97 11 N/A 
GPLGNQGLPGPR 97 12 Oxidation/Hydroxylatio
n 
GLAGPAGLLGR 96 11 N/A 
GENGLTGASGLQGR 96 14 Deamidation 
TGSSGLPGMLGR 96 12 Oxidation/Hydroxylatio
n 
QGPFGGVGLPGLAGSAQR 96 18 Oxidation/Hydroxylatio
n 
GDTGPQGPMGPLGER 96 15 N/A 
QAPGVTGVAGETGAMGPR 96 18 Oxidation/Hydroxylatio
n 
GLTGQVGQGAGPVGK 95 15 N/A 
GMLGNQGDDGLQGK 95 14 Deamidation 
GPLDGANGLDGNDGKDGR 94 18 Oxidation/Hydroxylatio
n/Deamidation 
AGAPGVTGVAGETGAMGPR 94 19 N/A 
VATGEVGQGAGPVGK 94 15 N/A 
GPVGPNGPTGPQR 94 13 N/A 
GPNQTGQPGAQGPTGPAANR 94 20 N/A 
VLVLLTDGEQTK 93 12 N/A 
GPLNGADGLDGNDGKDGR 93 18 Oxidation/Hydroxylatio
n 
NGPPGPEGPGGALGSPGASYYR 93 22 Oxidation/Hydroxylatio
n 
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GPPPGPEGPGGALGSPGASGDPGR 93 24 Oxidation/Hydroxylatio
n 
GLTGQVGQEGPVGK 93 14 N/A 
GPVGPDGPTGPQR 93 13 N/A 
DGQDGEQGDEGSVGPQGDKGPR 92 22 Oxidation/Hydroxylatio
n/Deamidation 
QNGDVGALGNAGR 91 13 Deamidation 
GPERGPPGPDGESGPR 91 16 N/A 
GPVGPDGPTGPAGR 91 14 N/A 
EGNGLTGASGLQGR 90 14 Deamidation 
GPVGPNGPTGQPR 90 13 Deamidation 
DANGLTGASGLQGR 90 14 Deamidation 
DGTGPQGPMGPLGER 90 15 Oxidation 
 
Table 3.2: Output from mass spectometry following trypsin digestion of 




In order to assess the functional content of the peptides reported all 90+ ACL 
peptides identified were alignment searched against any known peptide sequence 
stored within the basic local alignment search tool (BLAST) database (Madden, 
2013). BLAST searches through the database to find matches to a query sequence 
and gives an output highlighting names and lengths of the results from the target 
database as well as scored and expect (E) value (Pertsemlidis and Fondon, 2001) 
Individual peptides, as shown in Table 3.2, were inputted and BLAST output 
recorded according to the related protein, species from which the related protein 
belongs and an E value. E values are given as a statistical indicator to how significant 
a match is. The E value indicates how well the sequence matches to the database and 
how likely the similarity occurred by chance. The closer the E value is to 1, the more 
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likely the match is to be genuine rather than by chance due to multiple match 
searches (Donkor et al., 2014). 
 
Of the unique, high quality peptide sequences identified, 32 with an ALC of 90% and 
above were BLAST aligned to show the top three most similar sequences, with 100% 
aligned to non-mammalian sources, further sub divided to marine (18.75%) and 
bacterial (58.33%) species as summarised in Table 3.3.  
 
Sequence Related Protein Species E 
value 
SGLEGEVGPR Collagen a2(VIII) chain like Sincocyclocheilus 
grahami 
68 
 Hypothetical protein Myxococcus 
stipitatus 
69 
 Phage tail region protein  Myxococcus 
stipitatus 
69 
GPPGQVGPAGLEGK Cuticle collagen dpy-5 Trichinella papuae 1.1 
 Fibril forming collagen alpha 
chain like  
Spodoptera litura 1.6 
 Collagen alpha1(V) chain 
isoform X2 
Esox lucius 2.3 
GNLGPDGLAGR Class I SAM dependent 
methytransferase 
Olsenella 42 





 MATE family efflux transporter Oleispira 
antarctica 
84 
GTAGLLGATGK Hypothetical protein Aquabacterium 
parvum 
118 
 Polyketide synthase Streptomyces 167 
 Type I polyketide synthase Streptomyces 
catelarensis 
167 
GPLGNQGLPGPR Collagen alpha1(XXVIII) chain Nothoprocta 
perdicaria 
1.5 
 Collagen alpha1(XXVIII) chain Tinamus guttatus 1.5 
 Collagen alpha1(IX) chain 
precursor 
Danio rerio 2.2 
GLAGPAGLLGR Hypothetical protein Acidobacteria 
bacterium 
7.4 
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GENGLTGASGLQGR Collagen triple helix repeat 




 Collagen alpha1(XXVII) chain Parus major 4.5 
 Collagen alpha1(I) chain like Cyanistes 
caeruleus 
4.5 
TGSSGLPGMLGR Glycosyltransferaase Actinoplanes 36 





 Acetylcholinesterase collagenic 
tail peptide like 
Monopterus albus 36 
QGPFGGVGLPGLAGSAQR Hypothetical protein Verruconis 
gallopava 
4.5 
 Signal recognition particle 
protein 
Jannaschia rubra 13 
 Alpha mannosidase Xanthomonas 
prunicola 
18 





 Hypothetical protein Glaesserella 
parasuis 
0.084 
 Hypothetical protein Glaesserella 
parasuis 
0.084 
QAPGVTGVAGETGAMGPR Collagen like protein Paenibacillus 
catalpae 
0.8 





 Collagen like protein Paenibacillus 
pectinilyticus 
1.1 
GLTGQVGQGAGPVGK Nitrate reductase Marine 
microorganism 
31 
 Hypothetical protein Amycolatopsis 
orientalis 
44 
 Hypothetical protein Paenibacillus 62 
GMLGNQGDDGLQGK Collagen alpha1(XXVII) chain Melopsittacus 
undulatus 
6.4 
 Collagen alpha1(XXVII) chain 
like 
Nestor notabilis 6.4 
 Hypothetical protein Salpingoeca 
rosetta 
9.1 
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GPLDGANGLDGNDGKDGR Autotransporter/adhesin Mannheimia 
varigena 
0.013 
 Autotransporter/adhesin Mannheimia 
varigena 
0.013 





Collagen like protein Lysunubacillus 
fusiformis 
0.042 
 Collagen like protein Paenibacillus 
catalpae 
0.12 





VATGEVGQGAGPVGK Hypothetical protein Streptomyces 
noursei 
7.7 
 Molecular chaperone DnaJ Tetrasphaera 
duodecadis 
31 
 Molecular chaperone DnaJ Tetrasphaera 31 





 Collagen alpha1(I) chain like Mizuhopecten 
yessoensis 
0.23 
 Hypothetical protein Runella 0.33 
GPNQTGQPGAQGPTGPAA
NR 
Hypothetical protein Rhizobiales 
bacterium 
0.012 










VLVLLTDGEQTK Hypothetical protein Alphaproteobacter
ia bacterium 
4.4 
 BatB protein Sphingopyxis 6.3 





GPLNGADGLDGNDGKDGR Hypothetical protein Rodentibacter 
myodis 
0.036 
 Putative uncharacterised 
protein 
Alistipes 0.1 





Hypothetical protein Bacillus populi 0.002 
 Collagen alpha1(III) chain Tinamus guttatus 0.012 
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SMC protein Elmeria necatrix 0.006 
 Cutile collagen 34 Loa loa 0.011 
 Hypthetical protein Scleropages 
formosus 
0.012 
GLTGQVGQEGPVGK Hypothetical protein Chara braunii 13 
 TonB-dependent receptor Woodsholea 
maritima 
37 
 Collagen alpha1(I) chain Tetranychus 
urticae 
52 
GPVGPDGPTGPQR Putative tail protein Erwinia phage 0.23 
 Collagen like protein Bacillus 
thuringiensis 
0.47 





Phage tail fiber protein Phage NCTB 0.008 
 Collagen alpha1(I) chain like Orbicella faveolata 0.009 
 Collagen alpha1(V) chain like Schistosoma 
haematobium 
0.024 
QNGDVGALGNAGR ABC transporter ATP binding 
protein 
Nocardioides 7.6 





 ABC transporter ATP binding 
protein 
Nocardioides 7.6 
GPERGPPGPDGESGPR Inner ear specific collagen like Cyprinodon 
variegatus 
0.036 
 Collagen alpha1(XXIV) chain Paramormyrops 
kingsleyae 
0.051 





GPVGPDGPTGPAGR Collagen alpha1(XVIII) chain 
like 
Clupea harengus 0.035 
 Collagen like protein Mesorhizobium 
ciceri 
0.035 
 Collagen like protein Mesorhizobium 
ciceri 
0.035 
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 Hypothetical protein Rhodosalinus 52 
 LysM peptidoglycan binding 
domain containing protein 
Sphingomonas 74 
GPVGPNGPTGQPR Hypothetical protein Bacillus korlensis 0.48 





 Collagen alpha1(IV) chain Latimeria 
chalumnae 
1.9 





 LysM peptidoglycan domain 
containing protein 
Sphingomonas 37 
 Hypothetical protein Sphingomonas 37 
DGTGPQGPMGPLGER Collagen alpha1(I) chain like 
isoform X1 
Lucilia cuprina 0.34 
 Collagen alpha1(I) chain like 
isoform X2 
Lucilia cuprina 0.34 






Table 3.3: BLAST results for individual R.pulmo peptides. Peptides sequences 
run through BLAST database and results showing top 3 related protein, species and 
E value for corresponding peptides.  
 
Collagen and collagen related proteins are frequently found amongst related proteins 
during the database search. Taking E values into account, peptides such as 
GTAGLLGATGK show that the peptide has similarity to polyketide synthase in 
Streptomyces, however the E value is 151 implying that this is likely to be by chance 
when compared to the peptide AGAPGVTGVAGETGAMGPR, matched to 
collagen-like protein partial from Lysinibacillus dusiformis which has an E value of 
0.038.  
 
3.2.4.3 Collagen alignment  
 
Sequence alignment compares sequences by searching for a similar arrangement of 
patterns between sequences. The three common sequence alignments are pairwise, 
multiple and structural sequence alignment. The overall aim in aligning sequences is 
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to understand whether they exhibit similarities as a result of structural, functional or 
evolutionary relationships (Renard et al., 2010). Data extracted from sequence 
alignment can identify sequence identity, where the positions of nucleotides and/or 
amino acids are exactly the same, sequence similarity, where the matches are taken 
into consideration and any substitutions are scored so that conservative sequences are 
give a higher score than non-conservative sequences, and sequence homology where 
the similarity between nucleotide or amino acid position is strictly due to an 
evolutionary event (Madden, 2013). The alignment of jellyfish collagen peptides to 
human COL1A1 and COL3A1, chosen due to the use of these collagen types in 
regenerative medicine, was obtained using Clustal Omega and shown in Figure 3.8 
and Figure 3.9, respectively.  
 





Figure 3.8: Sequence alignment of human COL1A1 sequence to R.pulmo 
peptides. 32 peptides with an ACL% of 90 and above were compared against human 
COL1A1 using Clustal Omega to give an alignment. 
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Figure 3.8 (A) shows alignment of peptides against the known human COL1A1 
sequence at position 961 to 1020, whilst Figure 3.8 (B) shows positions 1021 to 
1080 using Clustal Omega. At nucleotide positions 998 to 1015 a partial alignment is 
made to 7 R. pulmo peptide sequences. At the positions 1070 to 1080, 10 R. pulmo 
peptides are partially aligned to the human COL1A1 sequence making this area of 




Figure 3.9: Sequence alignment of human COL3A1 sequence to R.pulmo 
peptides. 32 peptides with an ACL% of 90 and above were compared against human 
COL3A1 using Clustal Omega to give an alignment. 
 
Figure 3.9 shows the alignment of 32 R. pulmo peptides, with an ALC of 90% and 
above, against human COL3A1. Of the 32 peptides, 16 peptide sequences were 
partially aligned at nucleotide positions 926 to 960. This region of the COL3A1 gene 
showed the highest proportion of sequence alignment.  
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Sequence alignments, both global and local, are used to search databases and obtain 
similarities against a target sequence. Sequences that provide similarities have 
traditionally been used in order to infer protein function (Clark and Radivojac, 2011). 
The identification of specific sites within a protein allows for the understanding of 
biological processes (Lapidoth et al., 2015).AbDesigner is a web application used for 
the design of peptide directed antibodies. The software displays protein features 
as a graphical output denoting regions of interest such as binding sites, post-
translational modification and local secondary structures using the relevant 
Swiss-Prot protein record (Pertsemlidis and Fondon, 2001). 
 
Human COL1A1 and COL3A1 were input through the AbDesigner software and 
nucleotide positions with high similarity to R.pulmo peptides were checked for 










Figure 3.10: AbDesigner output for human COL1A1. Positions 998 to 1015 (A) 
and 1070 to 1080 (B) highlighted to show functional features of the protein. 
 
Figure 3.10 (A) shows the Abdesigner output for human COL1A1 with position 998 
to 1015 highlighted. The graphical output depicts that this portion of the sequence is 
part of the mature collagen α1 chain, a part of the triple helical region and is also 
seen in pfam01391 peptide sequence that is crucial for triple helix formation. Figure 
3.10 (B) highlights the position 1070 to 1080 and once again shows that the sequence 
is found in the mature chain and triple helical region of the protein.  
 





Figure 3.11: AbDesigner output for human COL3A1. Positions 926 to 960 are 
highlighted to show areas of functional relevance and interest. 
 
Figure 3.11 is the graphical output of human COL3A1 with nucleotide positions 926 
to 960 are highlighted in a box. The region corresponds to the area with the highest 
number of R.pulmo peptides showing partial similarity. In a similar fashion to the 
COL1A1 gene, the highlighted region shows the mature α1 chain of collagen and 
belongs to the triple helix region. COL3A1 also exhibits a splice variant in this 
region where this particular sequence does not occur in isoform 2 of the gene.  
 
The functional search of both human genes found a particular region of interest in 
COL1A1 for pfam01391. Pfam01391 is also known as the collagen triple helix 
repeat and contains 20 copies of Gly-X-Y repeat that forms a triple helix. Although 
this repeat is a critical structural feature to aid in tensile strength of connective tissue 
the triple helical structure can also be found in other collagens including bacterial 
collagen-like triple helix repeat proteins (Donkor et al., 2014). A final database 
search was done to evaluate any similarities between the unique 32 R.pulmo peptides 
and pfam01391 sequence as a function portion of the human COL1A1 sequence.  





Figure 3.12: Sequence alignment of pfam01391 to R.pulmo peptides. 
 
Figure 3.12 shows Clustal Omega output for the pfam01391 sequence against 32 
high quality R.pulmo peptides. The pfam01391 sequence exhibits the typical Gly-X-
Y repeat expected to be found in the triple helix region of collagen molecules. The 
32 peptides analysed for alignment shows varying degrees of sequence similarity 
apart from peptide 19, which is not aligned to the pfam sequence at any position. All 
peptides exhibit areas of Gly-X-Y repeats however the substitution of 
hydroxyproline when compared to the pfam01391 sequence is to be expected due to 
the lower hydroxyproline content found in marine collagen.  
 
3.2.5 Collagen plasticity and moulding  
 
The majority of cells within human tissues reside within an ECM which are tissue 
specific in their composition (Mount, 2004). Due to the native state of tissue 
requiring a complex ECM, regenerative medicine employs the field of tissue 
engineering to mimic the environment and restore or improve tissue function that has 
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been lost to disease or trauma (Pertsemlidis and Fondon, 2001). The fabrication of 
scaffolds for regenerative medicine applications requires particular attention to 
scaffold architecture. A highly porous structure with interconnected pores is needed 
to allow diffusion of nutrients and waste products whilst a critical mean pore size is 
required for cell adhesion and migration, with this latter component being dependent 
on the tissue that is aiming to be restored (Pisitkun et al., 2012). 
 
In order to assess the plasticity of the collagen, the material was moulded using a 96 
well plate and crosslinked using the chemical crosslinking reagent EDC, which has 
previously been proven to form 3D constructs with collagen extracted from a 
different species of jellyfish (McElroy et al., 2011).  
 
A concentration of 4 mg/ml was chosen for scaffold fabrication in this instance. 
Previous research has used collagen scaffolds of varying concentrations (2-40 
mg/ml) however those with a low collagen content <4 mg/ml have been used to 
mimic tissue (Whatmore, 2001). A common source of collagen is that obtained from 
rat-tail that has been used in research, maintaining cell viability and proliferation 
(Chan and Long, 2008). Gelatin is thermally denatured collagen that has a 
disordered, random coil arrangement that has also been used to form scaffolds for 
answering biomaterials based questions (Dhandayuthapani et al., 2011). With this in 
mind, jellyfish collagen constructs were compared with rat-tail collagen and bovine 
gelatin scaffolds as a positive and negative control, respectively, for the ability to 
form a scaffold, average pore size within the constructs as well as stability and 
biodegradability.  
 
In the interest of time, scaffold materials will be abbreviated as shown in Table 3.4.  
  






Table 3.4: Abbreviations for materials used to fabricate scaffolds. 
 
With collagen isolation from R.pulmo jellyfish optimised and characterisation of 
resultant peptides indicating similarity in specific regions when aligned with 
COL1A1 and COL3A1, in particular to pfam01391, the peptide sequence which is 
involved in the triple helix formation. Following these results scaffold fabrication 
and characterisation was performed. A summary of work for this chapter can be seen 
below in Figure 3.13.  





Figure 3.13: Flow diagram of work concerning collagen isolation and scaffold 
fabrication. 
 
3.2.5.1 Moulding  
 
Scaffold fabrication can be achieved using various techniques, with freeze-drying 
considered to yield porous, foam-like constructs by sublimating the solution the 
polymer is frozen in (O'Brien, 2011).  
 
To fabricate scaffolds, 4mg/ml of RTCol, JCol or BGel were pipetted into a 96 well 
plate and freeze dried before crosslinking with the zero length crosslinker, EDC to 
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ensure stability against degradation. Following a final freeze-drying process, scaffold 
structures were analysed for pore size, thermal stability and stability against 




Figure 3.14: 3D collagen moulding and gross sturcture. Scaffolds fabricated from 
RTCol, JCol and BGel viewed from the side (A) and top down (B). Scale bars 
indicate 5mm.  
 
Figure 3.14 shows fabricated scaffolds from side view (A) and top down (B). 
RTCol, JCol and BGel were all successfully moulded and crosslinked to produce 
cylindrical, porous scaffolds. All constructs had a height of approximately 5mm and 
width of 3mm. Scaffolds produced from each material maintained a dry, porous 
structure that was easily broken however when saturated with liquid scaffolds 
became sponge like in behaviour and absorbed and expelled liquid upon 
compression.  
 
3.2.5.1.1 Scaffold characterisation  
 
High-resolution morphology imaging is an accepted method to assess interconnected 
structures (Hoyer et al., 2014). Scanning electron microscopy (SEM) is based on 
accelerated electrons moving down a column and focused on the sample via various 
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electromagnetic lenses. Once the electrons hit the sample, backscattered or secondary 
electrons are detected and the signal converted to produce an electron micrograph 
(Antoine et al., 2014). Each collagen mould structure was coated with 15nm 
chromium to ensure conductance and avoid surface charging (Parenteau-Bareil et al., 
2010). Figure 3.14 show images for RTCol, JCol and BGel, moulded structures at 
4mg/ml., respectively. All structures were imaged at low (30-100K) and high 
magnification (600-500K).  
 
Scaffold pore size has been shown to impact cell behaviours such as migration, 
proliferation and differentiation (Gorgieva and Kokol, 2011). Computer software, 
including SEM software, has previously been used to analyse images and elucidate 
pore size (Lu et al., 2013). Images obtained using Hitachi S-4800 SEM software 
were used to measure 30 pores to obtain average pore size from scaffolds fabricated 
from RCol, JCol and BGel, from three replicates, shown in Figure 3.15, 3.16 and 









Figure 3.15: SEM images of RTCol scaffolds and pore size at different 
crosslinking concentrations. Low magnification (A) and high magnification (B) 
SEM images were taken to assess architecture at 0.25, 0.5 and 1% EDC 
concentration. High magnification images were used to calculate average pore size 
(C). Data shown is the standard deviation from a minimum of three independent 
repeats, statistical significance shown according to paired Mann Whitney U test 
(*p<0.05; **p<0.01; ***p<0.001). Scale bars in low and high magnification 
represent 1mm and 200μm, respectively. 
 
Figure 3.15 (A) shows RCol scaffolds imaged at low magnification and Figure 3.15 
(B) at high magnification using SEM and demonstrate leafy, porous structures with 
interconnected pores after crosslinking with EDC at 0.25%, 0.5% and 1% w/v. 
Figure 3.15 (C) depicts the average pore size for scaffolds at each crosslinking 
concentration, obtained from high magnification images. Scaffolds crosslinked at 
0.25% EDC have an average pore size of 28.80μm, 0.5% show an average pore size 
of 32.69μm and 1% exhibit an average pore size of 28.85μm. No significant 
difference was observed in average pore size between different crosslinking 
concentrations. 






Figure 3.16: SEM images of JCol scaffolds and pore size at different 
crosslinking concentrations. Low magnification (A) and high magnification (B) 
SEM images were taken to assess architecture at 0.25, 0.5 and 1% EDC 
concentration. High magnification images were used to calculate average pore size 
(C). Data shown is the standard deviation from a minimum of three independent 
repeats, statistical significance shown according to paired Mann Whitney U test 
(*p<0.05; **p<0.01; ***p<0.001). Scale bars in low and high magnification 
represent 1mm and 200μm, respectively. 
 
JCol scaffolds crosslinked with 0.25%, 0.5% and 1% EDC were imaged with SEM at 
low magnification, Figure 3.16 (A) and high magnification, Figure 3.16 (B), and are 
show to produced leafy, interconnected porous constructs. Figure 3.16 (C) shows the 
average pore size of scaffolds at different crosslinking concentrations with average 
values of 62.70μm, 61.43μm and 54.76μm for 0.25%, 0.5% and 1% EDC 
concentration, respectively. A significant difference in average pore size was 
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observed between 0.25% and 1% EDC concentration (p=0.019) and between 0.5% 




Figure 3.17: SEM images of BGel scaffolds and pore size at different 
crosslinking concentrations. Low magnification (A) and high magnification (B) 
SEM images were taken to assess architecture at 0.25, 0.5 and 1% EDC 
concentration. High magnification images were used to calculate average pore size 
(C). Data shown is the standard deviation from a minimum of three independent 
repeats, statistical significance shown according to paired Mann Whitney U test 
(*p<0.05; **p<0.01; ***p<0.001). Scale bars in low and high magnification 
represent 1mm and 200μm, respectively. 
 
Scaffolds fabricated from BGel were imaged with SEM at both low and high 
magnification, shown in Figure 3.17 (A) and Figure 3.17 (B), respectively. These 
images depict that BGel scaffolds crosslinked at 0.25%, 0.5% and 1% EDC 
concentration give rise to a porous architecture with interconnected pores. High 
magnification images were used to obtain average pore size at each crosslinking 
concentration, shown in Figure 3.17 (C). Average pore sizes of were observed at 
26.09μm for 0.25% EDC, 96.77μm for 0.5% EDC and 83.66μm for 1% EDC with 
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BGel. A significant difference in average pore size was seen between 0.5% and 1% 
(p<0.001) and between 0.25% and 1% EDC concentration (p<0.001).  
 
3.2.5.2 Plastic compression  
 
Scaffolds produced in the traditional way are hyper hydrated and have properties that 
do not match native tissue due to the lack of fibril density (Ashworth et al., 2014). 
Unconfined plastic compression expels liquid from the moulded structure in order to 
increase fibrillar density (Vernon-Parry, 2000). The application of external 
mechanical force not only produces a mechanically stronger construct but also 
reduces the effects of contraction and degradation (Kashi et al., 2014). In order to 
test the suitability of plastic compression applied to JCol, 2ml of collagen was 
pipetted into a 24 well plates and scaffold produced using the method outlined in 
section 3.2.5.1. Following fabrication, scaffolds were compressed for 30 minutes 




Figure 3.18: SEM images of compressed JCol scaffolds at different crosslinking 
concentrations. Low (x50) and high (x300) magnification images of compressed 
JCol scaffolds crosslinked at 0.25, 0.5 and 1% EDC. Scale bars in low and high 
magnification represent 1mm and 100μm, respectively. 
 
Figure 3.18 shows SEM images of JCol scaffolds following compression and 
crosslinking at 0.25, 0.5 and 1% EDC. Scaffolds under all crosslinking conditions 
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show that constructs maintain a leafy structure with interconnected pores, exhibiting 
that compression does not change morphological features of scaffolds after being 





Figure 3.19: Weight of JCol scaffolds before and after compression and 
reswelling. JCol scaffolds crosslinked with 1, 0.5 and 0.25% EDC were weighed 
before and after compression and were placed in PBS before weighing to check for 
reswelling. All data shown is the standard deviation from a minimum of three 
independent repeats, statistical significance shown according to T test (*p<0.05; 
**p<0.01; ***p<0.001).  
 
Figure 3.19 depicts weights of JCol scaffolds at 1, 0.5 and 0.25% EDC crosslinker 
concentration during compression. Scaffolds crosslinked at 1% EDC had an initial 
wet weight of 132.89mg, which decreased to 15.89mg following compression. When 
compressed scaffolds were placed in PBS they rehydrated to have a final wet weight 
of 117.89mg. Both compressed and rehydrated scaffolds showed a significant 
decrease (p<0.001 for both) in weight compared to the initial samples. The exact 
same trend was seen for scaffolds crosslinked with 0.5% EDC. Original scaffold 
weight was 141.33mg, decreasing to 15.33mg after compression and increasing 
again after incubation in liquid to 121.44mg. Weight for compressed and rehydrated 
scaffolds were significantly decreased (p<0.001) when compared to the initial weight 
of fabricated constructs at 0.5% EDC concentration. Scaffolds produced with 0.25% 
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EDC had an initial wet weight of 67.44mg before compression where weight 
decreased to 5.67mg. When allowed to rehydrate in PBS scaffold wet weight 
increased to 57.0mg. In a similar fashion to scaffolds crosslinked at 1 and 0.5%, 
scaffolds compressed and rehydrated exhibited a significant (p<0.001) decrease in 
weight compared to the original scaffold weight.  
 
3.2.5.3 Collagen scaffold stability  
 
Native collagen possess an array of inter and intramolecular crosslinks that aid in the 
structural stability found within tissues. Extraction of collagen from tissues reduces 
the number of crosslinks and changes the physical properties of the material 
(Bružauskaité et al., 2016). In order to enhance the physical characteristics and 
resistance against proteolytic degradation of collagen scaffolds, crosslinking can be 
undertaken in various forms. A popular choice of chemical crosslinking is using the 
agent EDC that may be coupled with NHS, to form crosslinks that are lower in 
density that other crosslinking agents but have favourable biological properties (Loh 
and Choong, 2013). In order to form stable scaffolds from RTCol, JCol and BGel, 
materials were crosslinked with EDC at 0.25%, 0.5% and 1% w/v and assessed to 
ensure that an optimal crosslinking concentration would be applied for further 
experiments.  
 
3.2.5.3.1 Thermal stability  
 
Scaffolds produced for regenerative medicine have various characteristics that may 
be manipulated in order for them to be fit for purpose; this includes resistance against 
thermal and enzymatic degradation (Cheema and Brown, 2013). Differential 
scanning calorimetry (DSC) is a technique that allows for the observation of 
thermodynamic properties of biological macromolecules by measuring the 
differential heat flow from the calorimeter as reference and sample cells are heated 
linearly over a period of time. DSC has previously been used to identify biopolymer 
melting, lipid-protein interactions and conformational changes of proteins 
(Serpooshan et al., 2010). This technique has also been used to assess the efficiency 
and extent of crosslinking in scaffolds (Braziulis et al., 2012). In order to assess the 
Chapter 3                                                                     R. pulmo Collagen Characterisation 
 
 115 
thermal stability of RTCol, JCol and BGel scaffolds crosslinked at 0.25, 0.5 and 1% 
EDC concentration, constructs were placed in platinum crucibles and heated from 
room temperature to 100°C and a graph obtained. An empty platinum pan was also 
measured as a reference.   






Figure 3.20: DSC of scaffolds crosslinked at various EDC concentrations. DSC 
data for RTCol (A), JCol (B) and BGel (C) scaffolds crosslinked at 0.25%, 0.5% and 
1% EDC. 
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Figure 3.20 (A) shows DSC graphs of RTCol scaffolds crosslinked at 0.25, 0.5 and 
1% EDC. Scaffolds fabricated with 0.25% and 0.5% EDC show a peak at 37°C 
whilst those made with 1% EDC display a broader peak spanning a higher range of 
temperatures. Figure 3.21 (B) displays DSC graphs from JCol scaffolds. Constructs 
crosslinked with 0.25% and 0.5% EDC exhibit peaks at approximately 37°C in a 
similar fashion to RTCol scaffolds at the same concentration. JCol scaffolds 
crosslinked with 1% EDC show a broader peak showing much small change in 
thermal energy produced by these constructs. DSC of BGel scaffolds are shown in 
Figure 3.21 (C). These scaffolds display a change in trend from JCol and RTCol 
scaffolds with 1% EDC BGel scaffolds showing the greatest change in the thermal 
energy however the peak of the graph still occurs at 37°C. BGel scaffolds at 0.5% 
and 0.25% display broader peaks with a smaller change in thermal energy that span 
over 37°C. 
 
3.2.5.3.2 Collagen enzymatic degradation 
 
Scaffolds designed for regenerative medicine applications must fulfil the requirement 
of being biodegradable to enable adequate remodelling of the damaged tissue 
(Davidenko et al., 2015). As a consequence of the break down of the scaffold 
material, cells are able to produce their own extracellular matrix for tissue repair. It is 
important that the by-products of degradation be non-toxic in order to maintain a 
good level of cell viability (Ahmad et al., 2015). In vivo, collagenases such as MMPs 
are responsible for the degradation of collagen and work by binding to the collagen, 
unwinding the triple helix and finally cleaving each strand. As bacterial collagenases 
work under the same principles, they can be used to investigate degradation in vitro 
(Davidenko et al., 2015). Scaffolds fabricated from RTCol, JCol and BGel 
crosslinked with 0.25%, 0.5% and 1% EDC were incubated with serum free DMEM 
containing 300U/ml of collagenase and scaffold weight was monitored over a period 
of time to assess degradation.   
 





Figure 3.21: Collagenase treatment of scaffolds crosslinked with EDC. Scaffolds 
crosslinked with 0.25% (A), 0.5% (B) and 1% (C) EDC were incubated with 
collagenase and weighed regularly to assess resistance to degradation.  
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Figure 3.21 (A) shows the weight of RTCol, JCol and BGel scaffolds crosslinked at 
0.25% EDC concentration following collagenase digest over a 12 hour period. 
RTCol scaffolds decrease in weight over time following incubation with collagenase. 
Average initial scaffold wet weight was recorded at 54.33mg and decreased until no 
remaining scaffold was visible at 4 hours. JCol scaffolds had a similar initial start 
weight of 53.89mg. At 4 hours JCol scaffolds crosslinked with 0.25% EDC were still 
visible and had an average weight 22.22mg however no scaffold was visible by 12 
hours. Gelatin scaffolds fabricated with 0.25% had a lower initial weight when 
compared to the other materials at 48.0mg and decreased in weight following 
collagenase digestion with an average weight of 17.11mg at 4 hours and no scaffold 
available to weight by 12 hours. The same experiment was conducted using scaffolds 
fabricated with 0.5% EDC, shown in Figure 3.21 (B). RTCol scaffolds at this 
crosslinking concentration began with an average weight of 48.78mg, which 
decreased to 6.11mg by 6 hours following incubation with collagenase. JCol 
scaffolds had a slightly higher average starting weight of 56.44mg that decreased to 
18mg after 6 hours whilst BGel scaffolds had an initial average weight of 43.78mg, 
decreasing after 6 hours to 14.33mg. At 12 hours no scaffold was visible to be 
weight for any material crosslinked at 0.5% EDC concentration. Figure 3.21 (C) 
shows average scaffold weight following 12 hours collagenase digestion of scaffolds 
crosslinked with 1% EDC. RTCol scaffold weight began at 63.78mg and fell to 
5.67mg after 6 hours. JCol scaffolds had an initial weight of 58.22mg, which 
decreased after 6 hours to 7.33mg whilst BGel scaffolds had a lower start weight of 
36.89mg that decreased to 11.78mg at 6 hours of incubation. At 12 hours no 















Suitable, alternative sources of collagen that are compatible with large scale 
extraction are needed to meet the ever-growing demand due to the copious use of 
collagen in the medical, food and cosmetic industries (Meena et al., 1999). Marine 
species have been identified as an abundant source of collagen with extraction 
demonstrated from, scales, skin, bones and cartilage (Silva et al., 2014). Seasonal 
blooms of jellyfish have been recognised as a potential source of collagen for 
regenerative medicine. While overfishing has disturbed parts of the world’s oceans, 
these abundant blooms can be harvested, with minimal cause for concern due to their 
involvement in beach closures, fish deaths and clogging of coastal power and 
desalination plants (Brotz et al., 2012).  
 
Focusing on identifying and developing a scalable extraction process for R. pulmo 
derived jellyfish collagen; the data presented here demonstrates clearly that acid 
extraction of jellyfish collagen can be incorporated into large, industry scale 
production. Jellyfish collagen solutions have been characterised for their similarity 
with mammalian collagen, using an array of accepted assays (Abraham et al., 2008). 
SDS PAGE, FTIR, differential scanning calorimetry and SEM analyse collagen 
purity, amide banding, thermal stability and morphological features such as banding 
and fibre orientation respectively (Abraham et al., 2008). The α1 band sequencing 
cross-references with 40 collagen/collagen related proteins when searching sequence 
similarity, while functional peptide sequencing indicates potential structural 
variations when compared directly to mammalian collagen. These are also observed 
when the collagen solution is freeze-dried to a sponge scaffold, potentially 
explaining differences in collagen scaffold interconnectivity, pore size, collagenase 
digestion and thermal stability (Terzi et al., 2018) 
 
Marine collagen suitability for applications in human regenerative medicine and 
tissue engineering is reliant on multiple characteristics determined by biological 
information such as evolutionary conservation and functional peptide homology 
(Pawelec et al., 2016). Whilst the evolutionary conservation between jellyfish and 
human collagens is beyond the scope of this project previous reports have 
demonstrated that jellyfish collagen exhibits a triple helix flanked by N and C 
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terminals in a similar fashion to mammalian collagen, see Figure 1.1 (Exposito et 
al., 2008). Sequence similarity was exhibited in the peptide sequences obtained from 
the alpha1 band, with top results reporting no alignment to mammalian and 18.75% 
marine sources. This observation is supported by electrophoretic migration of the α1 
band, at 175kDa in comparison to 135kDa observed in mammalian collagen types. 
Migration of triple helical proteins is not correlated to their molecular mass; Addad 
and Cheng have also shown difference in electrophoretic pattern. R pulmo jellyfish 
collagen gave α1 bands in a similar or slightly higher position when compared to rat-
tail collagen (Addad et al., 2011), whilst bands from R. esculentum jellyfish showed 
bands around 116kDa. The differences in electrophoretic pattern may be attributed to 
differences in structure that are thought to have arisen during evolution (Cheng et al., 
2017a).  
 
Jellyfish collagen from R. pulmo and R. esculentum has previously been extracted 
using the traditional procedure where tissue was allowed to dissolve in acetic acid for 
overnight (Bermueller et al., 2013). To increase the final collagen yield a pepsin 
digest step was added and salted out with the use of sodium chloride (Schmidt et al., 
2015). Finally, pure collagen was obtained through centrifugation and the pellet 
resuspended in acetic acid for downstream experimental analysis (Addad et al., 
2011). Pacak and colleagues understood the need for a rapid process to be developed 
for a cost effective way of meeting the ever-growing commercial demand for 
collagen. Using dermal samples, sources of collagen type I, from lamb, rabbit and 
human, a vigorous agitation protocol was developed reducing the time scale to 
approximately 3 hours (Pacak et al., 2011). In this chapter the rapid protocol outlined 
by Pacak was applied to isolate collagen from R. pulmo jellyfish. Modifications were 
made including use of different acids (sodium citrate and acetic acid) as well as 
extraction in the presence and absence of pepsin. 
 
It has previously been reported that acid plays a key role in collagen solubility due to 
the excess H+ ions that are present, allowing water access to collagen fibres’ held by 
either electrostatic swelling or lyotropic hydration (Kiew and Don, 2013). Acid 
hydrolysis of collagen is typically carried out using organic acids such as acetic, 
citric and lactic acids as it is seen as more efficient than the use of inorganic acids 
such as hydrochloric acid, as well as being capable of solubilising non-crosslinked 
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collagens (Schmidt et al., 2015). Extractions were executed using two common 
organic acids; sodium citrate and, more popularly used in research and industrial 
settings, acetic acid.  
 
Collagen can be identified from FTIR, a non destructive, vibrational spectroscopic 
technique due to characteristic peaks that represent amide I (~1600-1700cm-1), amide 
II (~1549-1560cm-1) and amide III (~1240cm-1) (Belbachir et al., 2009). FTIR 
analysis of collagen extracted via acetic acid or sodium citrate gave peaks that were 
not within those previously reported for jellyfish collagen, in line with structural 
alterations in carboxyl group composition, vibrational banding related to N-H and C-
N bending/stretching and/or the crucial triple helical structure. These findings are 
consistent with Riaz et al, who found differences in all three amide peaks and 
attributed these to both structural differences between animals and isolation protocols 
(Riaz et al., 2018). This suggests that acid extraction alone may have altered the 
structure of jellyfish collagen during the isolation process, confirmed by the brittle 
material that was produced once solutions had been freeze-dried. 
 
Although acid extraction is an efficient method for obtaining collagen it should be 
noted that dilute acids are incapable of breaking mature crosslinks (Delgado et al., 
2017). The use of alkaline solutions has been tested however the loss of post-
translationally modified amino acids reduces the applicability of the collagen for 
commercial use (Yang and Shu, 2014). The use of proteolytic enzymes have been 
used in order to break mature crosslinks and increase the yield of collagen obtained 
from extraction (Schmidt et al., 2015). Pepsin is a proteolytic enyme that cleave the 
non-helical telopeptides regions from collagen molecules removing any 
intermolecular crosslinks and increasing the solubility of collagen in tissues (Duan 
and Sheardown, 2005). Regardless of the acid chosen for extraction, results show 
that the addition of a pepsin digest increased the yield of collagen. Extraction using 
sodium citrate isolated an average of 5.55% material, which increased to 6.83% with 
the addition of pepsin whereas acetic acid extraction isolated an average of 1.9% of 
material from jellyfish that increased to 7.2% when using pepsin.  
 
FTIR analysis of acid extracted collagen in the presence and absence of pepsin have 
shown similar spectra suggesting that enzymatic hydrolysis does not affect the 
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structure of collagen during isolation (Schmidt et al., 2015). However, studies 
comparing acid solubilised collagen and pepsin solubilised collagen have shown shift 
in FTIR spectra indicative of the isolation of a more stable triple helix (Riaz et al., 
2018). FTIR spectra obtained from isolation experiments show changes in amide 
peaks between acid extraction and acid with pepsin extraction. Sodium citrate 
extraction with pepsin saw a change in FTIR spectrum however the peaks witnessed 
were still out of the range identified in previous jellyfish collagen spectra and 
maintained a brittle physical property when freeze dried. This indicated that sodium 
citrate is not a suitable acid for the extraction of jellyfish collagen as it is not efficient 
potentially changes the structure of the protein during isolation (Schmidt et al., 
2015). On the other hand, acetic acid extraction using pepsin saw a shift in spectrum 
results so all peaks were found within the ranges previously documented for jellyfish 
collagen indicating that structural integrity was maintained during isolation (Riaz et 
al., 2018). However, once freeze dried the material proved difficult to resuspend 
causing us to believe that isolation of collagen contained contaminants. 
 
The addition of salts such as sodium chloride decreases protein solubility in a 
process termed salting out. This additional stage in isolation allows collagen to be 
precipitated out of solution for easier collection through centrifugation (Wahl and 
Czernuszka, 2006). Acetic acid extraction, in the absence of pepsin and the addition 
of a salting out stage isolated a soft, white material similar to that of mammalian 
collagen when freeze-dried. The presence of residual salt in collagen solution may be 
problematic, as it has previously been reported that the presence of NaCl decreased 
the thermal stability and affected the rheological properties of the protein (Duan et 
al., 2013). Salt precipitation using acetic acid revealed an amide I peak at 1685cm-1 
and the change may be due to carboxyl and amine groups forming new bonds, amide 
II at 1554cm-1 and amide III at 1243cm-1, with the last two peaks in the range found 
from previous jellyfish collagen studies. Although the yield of collagen was lower 
than pepsin extraction protocols, peaks from FTIR spectra for collagen obtained from 
salting out indicate the potential presence of the triple helix. Freeze dried material 
had a soft, white appearance in line with the physical characteristics of mammalian 
collagen showing that this extraction protocol produced a purer final product than 
previous extractions that were tested (Deyl et al., 2003).  
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The ability to mould or fabricate collagen into different forms is a characteristic that 
makes the protein highly desirable, with films, sponges and hydrogel constructs each 
being developed for tissue engineering and drug delivery (Lee and Shin, 2007). The 
adaptability of collagen into different forms is a characteristic that makes the protein 
highly desirable by different industries (Payne and Veis, 1988). Collagen obtained 
from an alternative source must prove to be malleable for different applications.  
 
Sponges are classified as porous structures that are defined by their interconnectivity 
and pore size, which affect cell migration, nutrient waste exchange and matrix 
deposition (Krimm and Bandekar, 1986). On the other hand, hydrogels are described 
as a network of polymer chains that are hydrophilic and possess the ability to retain a 
large amount of water (Cheng et al., 2017b). In vivo, collagen molecules undergo 
fibrillogenesis and aggregate to form supramolecular structures. Fibrillogenesis can 
be induced in vitro by mimicking physiological conditions such as exposing isolated 
collagen to neutral solutions and body temperature (Khan and Khan, 2013).  
 
In this study, collagen isolated from R. pulmo jellyfish were fabricated into sponge 
scaffolds using chemical crosslinking and lyophilisation as previously demonstrated 
with R. esculentum jellyfish collagen (Lee and Shin, 2007). Gelling properties of 
collagen are highly dependent upon the hydroxyproline and proline content of 
collagen molecules with mammalian collagen exhibiting a high imino acid 
(hydroxyproline and proline) content (Hoffman, 2002). Hydrogel formation from 
collagen obtained by marine species may be more difficult to achieve unaided as 
imino content from these animals has been shown to be significantly reduced 
compared to mammalian sources (Tronci et al., 2013). Hydrogels have received 
attention for cartilage repair as they can be injected non-invasively into the injury 
site, fill defects of different sizes and contain a homogenous mixture of cells in 
comparison to sponge scaffolds (Hoyer et al., 2014). The major disadvantage to 
hydrogel use in tissue engineering is their inherent mechanical weakness due to 
excessive water retention. This can be overcome by increasing the crosslinking 
density however this may compromise cell viability (Hashim et al., 2015).  
 
In vivo, collagen forms crosslinks in both enzymatic and non-enzymatic manners that 
are essential in the characteristic tensile strength that the protein exhibits (Chung and 
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Burdick, 2008). Due to the lower proline and hydroxyproline content documented in 
marine animals, fewer corsslinks are formed when compared to mammalian tissues, 
leading to less stable molecule and overall a lower denaturation temperature. 
Crosslinks can be efficiently recreated in vitro using physical and chemical methods 
(Bryant and Anseth, 2002). The chemical crosslinker EDC is a popular choice used 
during scaffold fabrication (Vickers et al., 2004). EDC is a zero length crosslinker 
and conjugates carboxyl groups to primary amines without becoming a part of the 
final bond. EDC reacts with carboxylic groups to form O-acylisourea, an 
intermediate that is displaced by nucleophilic attack from primary amino groups. 
Primary amine groups form amide bonds with carboxyl groups and the EDC by-
product is released as a soluble urea derivative that can be washed away, outlined in  
Figure 3.22 (Ahmad et al., 2015).  
 
 
Figure 3.22: EDC crosslinking reaction. Carboxyl groups react with primary amine 
groups via EDC formed intermediate to form amide bonds (Subhan et al., 2015). 
 
Although EDC results in a lower crosslinking density than other methods that have 
been researched it is favoured due to previous reports that it causes low levels of 
cytotoxicity (Suchy et al., 2015). However, further research into EDC crosslinking 
has shown that cell viability of lymphoma cells is inversely proportional to EDC 
concentration (Song et al., 2006). As found in the literature, EDC was used as the 
chosen chemical crosslinker for fabrication of JCol, RTCol and BGel scaffolds to aid 
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in mechanical and thermal properties (Rao and Winter, 2009).  Scaffolds were 
crosslinked using a range of concentrations to test effects of crosslinking density on 
scaffold characteristics in future downstream analysis.  
 
The success of sponge scaffold fabrication from jellyfish collagen is indicative of the 
use of these constructs in cartilage tissue engineering. Previously, collagen sponges 
produced from bovine sources have shown their potential in cartilage tissue 
engineering, exhibiting cell viability and cartilage specific matrix (Glowacki and 
Mizuno, 2007). More recently, jellyfish collagen scaffolds have been analysed for 
their chondrogenic potential. R. esculentum jellyfish sponge scaffolds were found to 
redifferentiate human nasal septal chondrocytes following loss of phenotype from 
monolayer culture (Bermueller et al., 2013) and R. pulmo collagen successfully 
differentiates human MSCs along a chondrogenic lineage (Pugliano et al., 2017). 
 
Current 3D tissue models involve monolayers of cells or cells embedded into 
hydrogels or sponges. Collagen gels, although biocompatible, still lack the desired 
mechanical properties due to the differences in fibril density (Hoyer et al., 2014). 
Cells interact with collagen via integrins that recognise specific motifs, in particular 
GFOGER (Ahmad et al., 2015). Davidenko and colleagues assessed the affect of 
crosslinking density on platelet adherence to collagen scaffolds. Platelets bind to the 
collagen peptide sequence GFOGER through the α2β1 integrin. Crosslinking with 
EDC requires the carboxyl group, in this case focused on the E (glutamic acid) of the 
peptide sequence, inhibiting integrin interaction and in turn decreasing the amount of 
cells attached to the scaffolds (Thoreson et al., 2015). It is important for cells to 
adhere to collagen scaffolds in large quantities as high stem cell density, in cartilage 
tissue engineering, is thought to encourage chondrogenic differentiation due to cell-
cell communication aiding in the expression of cartilage matrix specific proteins 
(Bax et al., 2017).  
 
Scaffolds produced for tissue engineering and modified by a crosslinking agent 
should strike a balance between thermal stability and susceptibility to degradation 
(Leitinger, 2003). The triple helical nature of collagen aids with the formation of 
networks that are held together through a combination of hydrogen bonds and Van 
der Waals forces that stabilise structures and enhance the mechanical and thermal 
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properties of the protein (Davidenko et al., 2015). As previously discussed the 
decreased amount of imino acids present in marine collagen leads to a lower 
denaturation temperature (Chung and Burdick, 2008). It is well documented that 
collagen derived marine species have a lower denaturation temperature than 
mammals due to their reduced proline and hydroxyproline content however 
crosslinking of the material can increase its stability (Davidenko et al., 2015). 
Denaturation of collagen alters the macromolecular structure of the molecule from a 
triple helix to random coil formation associated with gelatin (Subhan et al., 2015). 
This change in structure also leads to changes in cell binding domains whereby the 
GFOGER motif is lost and RGD becomes the primary integrin binding domain 
(Karim and Bhat, 2009).  
 
Differential scanning calorimetry is an effective tool used to measure phase 
transitions that occur as a result of heat energy released or absorbed by a sample 
(Cheema and Brown, 2013). The endotheromic or exothermic event is determined by 
the area under the peak whilst the maximum height of the peak is seen as the 
maximum heat capacity that occurs at phase transitions such as protein unfolding 
(Siljander et al., 2004). Hoyer previously showed that denaturation temperature of 
native collagen isolated from R. esculentum could be increased by crosslinking using 
EDC (Barczyk et al., 2010). Crosslinking with varying concentrations EDC revealed 
that JCol scaffolds are thermally stable at 37°C equalling the thermal stability shown 
by RTCol and BGel scaffolds.  
 
Whilst thermal stability plays an important role for future applications such as 
implantation into the human body degradation of scaffolds is essential for 
regenerative medicine as the guide new tissue formation before allowing remodelling 
and replacement (Wu et al., 2017). Degradation of native tissue ECM is often 
indicative of injury or disease however during the remodelling process the ECM can 
be broken down to release active peptides that aid in homeostasis and include 
peptides with antimicrobial, chemoattractant and angiogenic properties (Durowoju et 
al., 2017).  
 
In vivo, collagen is cleaved by proteolytic enzymes belonging to the MMP and 
ADAMTs families (Hoyer et al., 2014). Seven Clostridium hitolyticum (CHC) like 
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collagenases have been identified at low levels in human tissues and are found 
tightly bound to collagen (Zhang et al., 2014a). These enzymes are divided into 2 
classes where the first class cleaves collagen molecules at the N and C terminals 
before degrading the collagen into smaller fragments whereas the second class 
cleaves at the centre of the collagen molecule before further degradation (Badylak et 
al., 2008). Degradation of scaffolds can be assessed in vitro using collagenase 
obtained from CHC, which has been shown to cleave collagen into small fragments. 
In vitro degradation studies using collagenase from this species has been shown to 
correlate to in vivo degradation rates and therefore results obtained from this assay 
can be seen a preliminary data for degradation behaviour (Lu et al., 2011). A variety 
of collagenase concentrations have been used in the assessment of degradation from 
125U/ml (Mookhtiar and Wart, 1992) to 390U/ml (Gorgieva and Kokol, 2011).  All 
scaffolds treated with 300U/ml of collagenase were degraded over the course of 12 
hours indicating that the extent of crosslinking did not cause resistance against 
degradation and that if implanted degradation would be likely to occur in vivo.  
 
Tissue engineering requires scaffold structures that can either be preloaded with cells 
or allow for cellular infiltration following implantation into the injury site or risk 
being impractical (Alberti and Xu, 2016). Various methods can be used in order to 
obtain a porous scaffold including salt leaching, phase separation and freeze-drying. 
In the instance of freeze-drying, hydrated scaffolds are frozen before being placed in 
a freeze drier where the ice is sublimated into the gas phase (Alberti and Xu, 2016). 
The walls of the pores are formed when a thin film of material forms at the edge of 
the ice and grows. Additionally, when acetic acid is used, as can be the case with 
collagen solutions, the ice takes on a dendritic formation yielding an interconnected 
pore structure (Ng et al., 2009). Pore size produced by this method can be varied 
depending on different elements, for instance, the viscosity of the solution and the 
water to polymer ratio, whereas pore structure is dependent on the freezing 
temperature. Producing pores through freeze-drying is a favourable method as it 
removed the need of multiple washes and allows direct use of polymer solutions 
(Bružauskaité et al., 2016).  
 
The freeze-drying process was used to fabricate scaffolds from R. pulmo collagen 
using a 96-well plate as a mould (Caliari et al., 2015). Scaffolds produced in this way 
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formed sponge like structures that, upon analysis with SEM, displayed a highly 
interconnected porous structure that is consistent with literature and suitable for the 
maintenance of cell attachment, migration and diffusion of nutrients and waste 
(Jafari-Sabet et al., 2016). SEM analysis also showed JCol scaffolds exhibiting an 
average pore size between 54-63μm at different crosslinking concentrations, which 
was larger than RTCol scaffold and smaller than BGel scaffolds. The difference in 
pore size between marine and mammal sources may be due to differences in the 
collagen amino acid composition causing differences in the viscosity of solutions 
produced during extraction. Previous studies have found that scaffolds intended for 
chondrogenic purposes showed enhanced chondrogenic differentiation with small 
(20-150μm) pore size whilst large (250-500μm) pore size enhance ECM deposition 
and chondrocyte proliferation (Davidenko et al., 2015) showing that all scaffolds 
fabricated would not only be suitable for cell invasion but for applications in 
cartilage repair. 
 
Cells in human tissues respond to mechanical signals that determine cellular 
function, stem cell differentiation and homeostasis. Changes in mechanical 
properties of tissues lead to the onset of disease and so tuning the mechanical 
properties of scaffolds is important for correct tissue formation (Yamada et al., 
2014). It is thought that the force carrying capacity can be increased via the 
compression of the gel. Plastic compression allows for fibril density to be increased 
through the removal of fluid from hyper hydrated gels. Pressure is applied to any gel 
face and the primary fluid leaving surface continuously restricts the outflow of fluid. 
As the collagen gel becomes denser, through packing, the flow of fluid is blocked 
and so the process is self-limiting (Matsiko et al., 2015). With an overall aim to 
produce constructs that are biomimetic, PC collagen constructs have been shown to 
have tensile properties similar to some native tissues due to their increased protein 
concentration and interaction between fibrils bringing us closer to that goal (Cheema 
and Brown, 2013). Inconsistent with reports in current literature, which has used 
plastic compression of mammalian collagen for ocular surface (Mi et al., 2010) and 
tendon (Garvin et al., 2004) tissue engineering, JCol constructs did not plastically 
compress during this study. However plastic compression has been carried out on 
hydrogels and research has not used this technique on sponge structures (Jansen et 
al., 2015). Cartilage is described as a biphasic tissue that displays a creep and stress 
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response to loading (Cheema and Brown, 2013). The failure of the scaffold to 
plastically compress may be advantageous as increased fibril crosslink density has 
been associated with stiffer cartilage affected by conditions such as aging and 
diabetes (Neel et al., 2006).  
 
In conclusion, the presented data shows that a rapid extraction protocol for the 
isolation of collagen from R. pulmo jellyfish is possible, yielding 0.7% protein from 
native jellyfish tissue. This is further validated by incorporation into Jellagen 
production facility, a crucial step in commercial expansion. Isolation using acetic 
acid and salt precipitation yielded a soft, white material that gave amide I, II and III 
peaks that are characteristic of collagen. Further validation of the protein showed that 
alpha bands appeared in expected regions when subjected to gel electrophoresis and 
MSA of peptides aligned to triple helical repeats found in human collagen. Jellyfish 
collagen was found to be manipulated into sponge scaffold structured with the use of 
EDC chemical crosslinking that stabilised structure and thermal properties to 37°C 
and could be digested using bacterial collagenase, indicating that breakdown is likely 
to occur in vivo. These findings suggest that jellyfish collagen scaffolds should be 
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4.1 Introduction  
 
In order to be considered biocompatible, a material must have the ability to perform 
a specific application in a foreign host, whilst eliciting an appropriate host response. 
Traditional mammalian collagen matrices are known to help natural cell-matrix 
interactions and are not seen to be cytotoxic (Antoni et al., 2015). Appropriate cell-
material interactions are crucial, aiming to ensure cellular adhesion as well as the 
maintenance of cell specific viability and proliferative capacity in contact with an 
exogenous collagen material. These properties are crucial to the successful use of 
biomaterials in tissue regeneration (Carletti et al., 2011).  
 
It is essential to characterise cellular viability and any potential phenotypic 
differentiation once a given candidate collagen structure is obtained. Material 
biocompatibility testing is routinely conducted in both in vitro and in vivo 
investigations, using both 2D (basic structure) and 3D (biomaterial specific 
structures) (Helmus et al., 2008). The assessment of cell viability can be undertaken 
in various ways including exclusion dyes such as trypan blue or those that gauge 
metabolic activity, as is the case for tetrazolium based methods (Martin-Piedra et al., 
2014).  
 
Alongside aiding cellular proliferation, collagen may have an effect on the 
morphology of certain cells. An important process in embryogenesis and cancer 
metastasis is an epithelial to mesenchymal transition (EMT; (Colas et al., 2012). 
During this process epithelial cells, which usually express E-cadherin, lose their 
apico-basal polarity and adhesive qualities and gain an increased motility and ability 
to remodel the stroma they are surrounded by. They also switch their cadherin 
expression, with an increase in N-cadherin expression observed (O'Brien-Ball and 
Biddle, 2017). Collagen type I has been found to induce EMT in certain cell types 
including that of lung, breast and pancreatic carcinomas (Medici and Nawshad, 
2010).  
 
Another appropriate response, is that of the host immune system, a key aspect when 
investigating materials for tissue engineering (Naahidi et al., 2017). It is possible to 
predict major biocompatibility issues in terms of the host immune system in vitro 
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using donor blood cells (Joubert et al., 2016). In this chapter, the suitability of 
collagen films extracted from the edible jellyfish, Stomolophus nomurai meleagris as 
a matrix support for mammalian cell culture was tested using human fibroblasts, 
endothelial cells and smooth muscle cells. Previously, all cell types have been shown 
to have a higher viability on jellyfish collagen when compared to tissue culture 
plastic over a 10-day period (Song et al., 2006).  
 
4.1.1 In vitro immunogenicity   
 
Immunogenic testing is ideally done within small animals such as rats and rabbits 
(Ghasemi and Dehpour, 2009). Scaffolds produced from various materials have been 
tested in order to investigate their ability to elicit an immune response. In the case of 
bovine and human osteochondral grafts, subcutaneous implantation into collagen 
sensitive mice has previously been carried out before conducting ELISPOT and 
ELISA assays. ELISPOT assays examine the cellular immune response measuring 
induction of IFN-ϒ, IL-2, IL-4 and IL-5, whilst ELISA assays measure humoral 
mediated immune response measuring IgG1, IgG2a, total IgG and IgM from blood 
samples (Kawalec-Carroll et al., 2006). 
 
In the absence of an animal house at Swansea University, appropriate in vitro 
methods were sought for this project. Previous work with non-mulberry silk 
scaffolds were tested for their immunogenicity with the use of human dendritic cells 
being assessed for their maturation and cytokine release (Musson et al., 2015). 
However monocyte-derived dendritic cell activation is time-consuming and 
complicated. Previous work within the Thornton group at Swansea University has 
assessed the immunogenicity of biomaterials using whole blood samples before 
analysing for specific leukocyte and platelet activation markers using fluorescence 
activated cell sorting (FACS) and building a cytokine release profile from blood 
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4.1.2 In vitro immune surveillance 
 
Although the immune system plays a key role in limiting infection and responding to 
injury it may mean rejection of implanted scaffolds leading to problematic 
consequences (Boehler et al., 2011). Divided into innate and adaptive responses 
(Parkin and Cohen, 2001), the human immune system provides provision for an 
immediate host defence, with the innate immune system encompassing cells such as 
neutrophils, monocytes and macrophages, depicted in Figure 4.1, whereas the 
adaptive immune response is considered a more sophisticated antigen specific 















Figure 4.1: Host reponse to implanted biomaterials. A schematic detailing the 
immune response following the implantation of a biomaterial. Serum proteins adhere 
to the surface of the material and inflammatory cells such as neutrophils and 
macrophages are recruited to the site of injury. Mature macrophages also secrete pro-
inflammatory cytokines to aid in acute and chronic inflammation. After a period of 
days, macrophages will begin the healing process by secreting anti-inflammatory 
cytokines. Within weeks to months the adaptive immune response is triggered 
through antigen recognition via T lymphocytes and B lymphocytes. The end stage of 
the immune response upon implantation either leads to resolution or the formation of 
a fibrotic capsule (Kim et al., 2016). 
 
Upon the triggering of an immune response a characteristic cascade of events occurs. 
First, blood proteins adhere to the material before inflammation occurs (Anderson et 
al., 2008). Inflammation causes the recruitment of various cells including neutrophils 
and macrophages with the end result usually leading to fibrosis in the area of 
implantation (Jones, 2008). Fibrous encapsulation of the implanted material often 
leads to failure of the implant as in addition to the immune system effectively 
supplying protection against a foreign body it also isolates the material from 
surrounding tissue leading to issues with native tissue integration as well as access to 
nutrients for continued growth and development (Anderson et al., 2008). Whilst 
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matrices produced from synthetic materials can be modulated so that they do not 
elicit an immune response this is often not the case with matrices fabricated with 
natural materials as they contain a higher degree of ‘non self’ signals (Nilsson et al., 
2007). The extent of the immune response that is caused is dependent on a number of 
factors that include the degree of injury caused during implantation, the implantation 
location and the amount of provisional matrix that has been formed (Anderson et al., 
2008).  
 
4.1.3 Collagen immunogenicity  
 
Collagen was once considered to be non-immunogenic however the increase in 
interest in its use as a biomaterial has uncovered some characteristic immunological 
behaviours, believed to be due to the presence of noncollagenous proteins and cell 
remnants after extraction (Lynn et al., 2004). Any immune response elicited by 
collagen is due in part to target epitopes that reside on the telopeptide region of 
tropocollagen molecules. The immune response can also be influenced by factors 
including the helical composition of collagen and the amino acids presented on the 
surface (Gorgieva and Kokol, 2011). These factors in turn lead to a variation in the 
immunological properties between polymerised collagen and its non-polymerised 
counterpart as the accessibility of the epitopes decreases upon polymerisation 
(Parenteau-Bareil et al., 2010). 
 
4.1.4 Chapter hypothesis 
 
The hypothesis for this chapter is that marine collagen is a biocompatible biomaterial 
that allows for cell adhesion, viable proliferation and consistent morphological 
stability, in both immortalised and primary cell cultures from a variety of 
mammalian sources. This hypothesis is tested, in the first instance, using a 2D smear 
of collagen on plastic culture media. Immortalised cell lines and primary cells are 
seeded onto these collagen surfaces and monitored over time for their cellular 
phenotypes linked to immunogenicity and functional phenotypes. Secondly, collagen 
isolated from R. pulmo is fabricated to sponge scaffold structure as shown in section 
3.2.5.1 and subjected to in vitro immune analysis to define the in vitro immune 
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response elicited by R.pulmo derived collagen, compared to current research and 
clinical grade collagen sources.  
 
4.1.4.1 Aims and objectives 
 
The aims and objective to test this hypothesis are as follows; 
 
 Coat tissue culture plates with collagen isolated from R. pulmo (using 
methodology from Chapter 3), rat tail collagen, and gelatin. 
 Assess a variety of secondary (human endometrial cancer cell lines) cells for 
adhesion, viability and proliferation rate over a 96 hour period, benchmarking 
jellyfish derived collagen against the research and clinical grade alternatives. 
 Using light microscopy and ImageJ, assess cell type specific shape changes 
indicative of morphological differentiation over a 96 hour period. 
 Conduct an in vitro assay for biocompatibility and immune response elicited 
by jellyfish derived collagen comparing to rat tail collagen, bovine collagen 
and bovine gelatin, using blood cells isolated from a healthy volunteer cohort 
and established platelet (CD42b) and leukocyte (CD62L, CD11b and fMLPr) 
cell activation markers as well cell death (DRAQ7).  
 Analyse blood serum samples via ELISA to build a cytokine release profile. 
 
4.2 Results  
 
Collagen is used in both 2D cell culture and as a 3D scaffold for supported 3D 
culture methods, sometimes to simulate organotypic environments in in vitro culture 
(Duval et al., 2017). In addition, collagen is a suitable source of scaffolding material 
in regenerative medicine approaches such as cartilage, heart valves and treatment of 
corneal defects (Parenteau-Bareil et al., 2010).  
 
Stated simply as ‘the ability of a biomaterial to perform its function without eliciting 
local or systemic responses’, the biocompatibility of jellyfish derived collagen was 
assessed here using multiple in vitro methods (Ratner, 2011). 2D culture (using 
smears of collagen immobilised on a standard plastic culture dish) were assessed 
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initially, before using in vitro immune cell response model using healthy volunteers 
(13/WA/0190). A range of cellular subtypes were used to screen for 
biocompatibility, providing proof for proof of concept data aligned with applications 
markets agreed with Jellagen, UK.  
 
4.2.1 Collagen supported 2D culture  
 
Cells within the body exist within specific microenvironments, combined with 
collagen based matrix support mechanisms to underpin tissue architecture (Schindler 
et al., 2006).  
 
In order to assess the suitability of jellyfish derived collagen for plastic culture vessel 
coating, to better simulate the supported microenvironment during cell culture, 
Corning plastic dishes were coated (overnight at 4°C) with 30ug/ml of sterile, 
extracted (using protocol outlined in section 2.3.5) collagen. The vessels were then 
washed and used for the culture of a series of mammalian cell types, for a total of 4 
days, while monitoring cell viability, proliferation and morphology compared to a 
plastic only culture control. Research grade rat-tail collagen (RTCol) coated plates 
were used as a positive control and bovine gelatin (BGel) negative, as comparisons 
for jellyfish specific collagen (JCol). The experimental procedure used is shown in 
Figure 4.2.    
 
 





Figure 4.2: Experimental procedure to assess jellyfish collagen suitability for 
coated 2D culture. 
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4.2.1.1 Human endometrial stromal cell culture 
 
Human endometrial stromal cells (hESC) are essential in the process of human 
reproduction, undergoing decidualisation an endometrial differentiation process that 
prepares the tissue for human blastocyst implantation (Dunn et al., 2003). During 
decidualisation stromal cells undergo a MET process to provide support for the 
invading embryo (Zhang et al., 2013). In vitro experiments have shown that 3D 
culture of hESC cells is a closer physiological model to the in vivo environment than 
when cultured in 2D due to their response to hormone stimulation and withdrawal 
(Schutte and Taylor, 2012).  
 
Human stromal cell lines (hESC) were cultured in the presence and absence of 
collagen sources to assess their proliferative capacity in vitro. Live/dead staining 
(CFSE/EthD2 ratio) was used to assess cellular viability over a 4 day period using In 
Cell microscopy (Ramirez et al., 2011). Cells were then counterstained with Hoescht 
in order to monitor cellular proliferation (Mozdziak et al., 2000). Representative 
images for hESC cells are shown in Figure 4.3, grown on RTCol, BGel and JCol 
compared to the plastic control.  
 
4.2.1.2 Cellular viability  
 
Live/dead staining showed the effect of collagen coating on hESC cell viability over 
the four day culture period compared to the plastic only control. In Cell microscopy 
images multiple fields of view (20-per well) of hESC cells cultured in a 24 well plate 
on day 1, 2, 3 and 4 of the 4 day culture period. Collated live/dead staining is shown 
in Figure 4.3, taken on day 2 of culture. 
 




Figure 4.3: Live/dead staining of hESC cells. hESC cells cultured on plastic (A), 
RTCol (B), JCol (C) and BGel (D) were stained using hoescht, CFSE and EthD-2 
and imaged using In Cell microscopy (x20 magnification) to assess viability over a 
period of 4 days. Individual cells were identified with hoescht nuclear stain (seen in 
blue). Live cells were identified by CFSE (depicted in green) whilst dead were 
shown by EthD-2 (depicted in red). Scale bars equal to 0.1mm.  
 





Figure 4.4 : hESC cell viability in coated culture vessels. hESC cells seeded onto 
RTCol, JCol and BGel coated culture dishes were compared to plastic only control. 
Direct comparison is shown between the plastic control and RTCol (B); JCol (C); 
BGel (D). All data shown is from a minimum of 3 independent biological repeats, 
statistical significance shown according to a Mann Whitney U test (*p<0.05; 
**p<0.01; ***p<0.001). 
 
Figure 4.4 (A) shows the comparison of hESC cell viability when grown on plastic 
compared to RTCol coated plates over four days. A decrease in viable cell number 
was observed at day 2 on plastic, followed by increased viability on day 3 and 4; 2 
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and 4 fold, respectively. RTCol cultured cells also exhibited increased viable cell 
number over each day of the culture period. On day 1 viable cells are higher in 
number on plastic compared to RTCol, 3,620 and 2,556, respectively, however on 
day 2, 3 and 4 RTCol cultured cells are increased compared to their plastic cultured 
counterparts. Dead cells for plastic and RTCol plates are similar in number and do 
not appear to increase during the culture period with cell numbers ranging from 103 
to 41 dead cells on plastic and 89 to 74 dead cells on RTCol over the 4 days. 
Differences in viable and dead cells between both culture conditions were not proven 
to be significant on any day of culture.  
 
A comparison to hESC grown on plastic and JCol is shown in Figure 4.4 (B). Viable 
cells on JCol show the same trend as those grown on RTCol with an increase in cell 
number over the 4 days. Day 1 viable cell number shows that plastic exhibits more 
viable cells than JCol however JCol boasts more viable cells than plastic over day 2, 
3 and 4 with this difference being significant (p=0.05) on day 2 with values of 2,781 
and 4,597 viable cells for plastic and JCol, respectively. Despite JCol exhibiting 111 
dead cells on day 4 of culture whilst plastic culture only showed 41 dead cells no 
significant difference was noted when comparing culture conditions.  
 
Figure 4.4 (C) shows viability of cells grown on BGel compared to plastic. Viable 
cells grown on BGel follow the same trend as other materials where the number of 
cells increases over 4 days. Day 1 shows plastic exhibiting a higher number of viable 
cells than BGel however on day 2 BGel shows a significant increase in viable cell 
number compared to plastic (p=0.05). On day 3 and 4 plastic cells are increased in 
number compared to those grown on BGel. On day 4 of culture 41 cells were shown 
to be dead on plastic whilst BGel displayed 119 cells however no significant 
difference was seen on any day when comparing conditions.  
 
4.2.1.3 Cellular morphology 
 
Cell shape is a measurement of circularity, using imageJ standard algorithm, with a 
circularity of 1 being epithelial in nature and 0 being mesenchymal. Data shown in 
Figure 4.5 was used to assess the morphological differentiation of hESC cells over 
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the chosen culture period. Standard light microscopy (Zeiss) was used in order to 
monitor hESC cell shape and morphology during the culture period (days 1, 2, 3 and 
4) of the 4 day culture period. Images taken at x10 magnification on an inverted light 
microscope were used, shown in Figure 4.5, with cell boundaries defined using 
imageJ. A minimum of 30 cells were identified from a minimum of 3 independent 
biological repeats and used to collate cell shape data.  
 
 
Figure 4.5: hESC cell morphology. hESC cells grown on plastic (A), RTCol (B), 
JCol (C) and BGel (D) were imaged with a light microscope (x10 magnification) 
over a 4 day culture period to assess any changed in morphology. Scale bars equal to 
0.1mm. 





Figure 4.6 : hESC cell circularity in coated culture vessels. hESC cells seeded 
onto plastic (B), RTCol (C), JCol (D) and BGel (E) coated culture dishes. All data 
shown is the media +/- min/max from a minimum of 3 independent biological 
repeats, statistical significance is shown according to Mann Whitney U test 
(*p<0.05; **p<0.01; ***p<0.001).  
 
Figure 4.6 (A) shows the circularity of hESC cells seeded onto plastic culture dishes 
over a 4 day culture period. On day 1 hESC cells exhibit an average circularity value 
of 0.27 that decreases significantly (p=0.001) on day 2 to 0.22. When comparing cell 
circularity on day 3 and day 4 to day 1, both days exhibited a higher cell circularity 
value, both p<0.001, signifying a more circular cell morphology. hESC cells seeded 
on RTCol coated plates were assessed for their morphology, shown in Figure 4.6 
(B). When compared to day 1 cells circularity decreases on day 2 however the 
difference is not seen as significant however on day 3 and 4 the circularity of hESC 
cells increases from 0.19 on day 1 to 0.62 on day 3 and day 4 (p<0.001 in both 
cases). The same trend is seen for hESC cells grown on JCol coated plates, Figure 
4.6 (C) where cell circularity increases significantly (p<0.001) on day 3 and day 4 
when compared to day 1 rising from 0.23 to 0.63 and 0.57, respectively. Figure 4.6 
(D) shows circularity on cells cultured on BGel coated dishes. The same trend is 
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observed as seen on RTCol and JCol coated plated. On day 1 a circularity value of 
0.2 was observed for hESC cells grown on BGel. Cells assessed on day 3 were 
shown to exhibit an increased circularity value of 0.61 (p<0.001) when compared to 
day 1 and the same significant increase was also witness on day 4 with cells 
expressing an average value of 0.66 (p<0.001).  
 
4.2.2 Human endometrial epithelial cell culture  
 
Human endometrial epithelial cells (Ishikawa) are derived from Type I Endometrial 
cancer biopsies and are commonly used for the investigation of Endometrial Cancer 
(EC). Ishikawa cells cultured in the presence and absence of collagen sources were 
assessed for cellular viability, proliferation and morphology over a 4 day period 
using In Cell microscopy. Representative images are shown in Figure 4.7, grown on 
RTCol, BGel and JCol compared to the plastic control.  
 
4.2.2.1 Cellular viability  
 
Ishikawa cell viability was assessed over a 4 day period using live/dead staining after 
culture on collagen coated plates and compared to a plastic control. In Cell 
microscopy of Ishikawa cells cultured on 24 well plates were taken on each day of 
the 4 day period and data collated, shown in Figure 4.8, with representative images 
taken on day 2 of culture.  
 




Figure 4.7: Live/dead staining of Ishikawa cells. Ishikawa cells cultured on plastic 
(A), RTCol (B), JCol (C) and BGel (D) were stained using hoescht, CFSE and EthD-
2 and imaged using In Cell microscopy (x20 magnification) to assess viability over a 
period of 4 days. Individual cells were identified with hoescht nuclear stain (seen in 
blue). Live cells were identified by CFSE (depicted in green) whilst dead were 
shown by EthD-2 (depicted in red). Scale bars equal to 0.1mm.  
 





Figure 4.8 : Ishikawa cell viability in coated culture vessels. Ishikawa cells seeded 
onto RTCol, JCol and BGel coated culture dishes were compared to plastic only 
control. Direct comparison is shown between the plastic control and RTCol (B); JCol 
(C); BGel (D). All data shown is from a minimum of 3 independent biological 
repeats, statistical significance shown according to a Mann Whitney U test (*p<0.05; 
**p<0.01; ***p<0.001). 
 
Representative images of Ishikawa cells taken by In Cell microscopy are shown in 
Figure 4.7. Figure 4.8 (A) shows a comparison of viability of Ishikawa cells on 
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plastic and RTCol coated plates. Cells cultured under both conditions increased in 
number over 4 days. An increase in the number of plastic cultured viable cells was 
seen on day 2 when compared to RTCol at 13,280 and 8,642 cells, respectively, 
however on day 3 and 4 RTCol cultured cells outnumbered those grown on plastic. 
These differences were not shown to be statistically significant. The number of dead 
cells between both culture conditions was similar over the course of 4 days and did 
not exhibit any significant difference with both plastic and RTCol exhibiting 140 and 
146 dead cells on day 4, respectively. Ishikawa cells grown on plastic were 
compared to cells grown on JCol to assess viability, shown in Figure 4.8 (B). The 
same trend in JCol is observed as seen in RTCol cultured cells with day 2 showing a 
lower number of viable cells when compared to plastic and day 3 and 4 showing an 
increased cell count. Count for Ishikawa cells stained for death remained similar 
across culture conditions over 4 days. Differences witnessed in cell viability between 
plastic and JCol cultured cells were not proved to be significant. Figure 4.8 (C) 
depicts comparison between BGel coated plates and plastic control. Viable cell count 
of Iskikawa cells grown on BGel is lower on day 2, 3 and 4 when compared to 
plastic cultured cells. Dead cells identified on BGel coated plates appeared to be 
significantly higher on day 3 at 173 (p=0.05) and day 4 at 258 (p=0.05) when 
compared to plastic at 98 and 140 on day 3 and day 4, respectively.  
 
4.2.2.2 Cellular morphology 
 
Cell shapes of Ishikawa cells were monitored over the culture period using a 
standard light microscope. Images taken at x10 magnification, representative images 
seen in Figure 4.9, were assessed for their circularity, using ImageJ software. A 
minimum of 30 cells were assessed from 3 independent biological repeats and used 
to collate cell shape data, depicted in Figure 4.10.  
 




Figure 4.9: Ishikawa cell morphology. Ishikawa cells grown on plastic (A), RTCol 
(B), JCol (C) and BGel (D) were imaged with a light microscope (x10 magnification) 
over a 4 day culture period to assess any changed in morphology. Scale bars equal to 
0.1mm. 
 





Figure 4.10 : Ishikawa cell circularity in coated culture vessels. Ishikawa cells 
seeded onto plastic (B), RTCol (C), JCol (D) and BGel (E) coated culture dishes. All 
data shown is the media +/- min/max from a minimum of 3 independent biological 
repeats, statistical significance is shown according to Mann Whitney U test 
(*p<0.05; **p<0.01; ***p<0.001).  
 
Ishikawa cells cultured on plastic for four days were assessed for their circularity and 
data collated, shown in Figure 4.10 (A). Cells maintained a similar cell circularity 
value over day 1, 2 and 3 with values of 0.59, 0.61 and 0.62, respectively. Ishikawa 
cells on day 4 possessed a significantly lower (p=0.001) circularity value of 0.57 
when compared to cells on day 1. Figure 4.10 (B) shows circularity values of cells 
cultured on RTCol. A slightly different trend is seen than when compared to cells 
grown on plastic. Day 1, 2 and 3 exhibit similar circularity values however cells on 
day 4 express a significantly higher (p=0.032) circularity value of 0.60 when 
compared to day 1 cells with circularity of 0.56. Figure 4.10 (C) shows the 
circularity of Ishikawa cells cultured on JCol coated plates over 4 days with no 
significant difference observed over the course of the culture period. Cells cultured 
on BGel, Figure 4.10 (D), expressed similar average cell values on day 1 and 2 at 
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0.57 and 0.6, respectively. Day 3 cell circularity values were shown to be 
significantly higher (p=0.001) at 0.65 when compared to day 1 whilst day 4 cells also 
showed an increased value but was not seen to be significant in comparison to day 1. 
 
4.2.3 Type II endometrial epithelial cell culture  
 
Type II EC is characterised by dedifferentiation of tissues (Yokomizo et al., 2017). 
This is observed in vitro by a heterogeneous, mixed population of cells exhibiting 
both epithelial and mesenchymal morphological features in HEC50 cells (RBGO, 
2017, data not shown). In order to assess if this is a plastic culture vessel  effect or 
indeed a cellular phenotype of type II cancer, HEC50 cells were cultured on plastic 
and compared to growth on RTCol, BGel and JCol respectively.  
 
4.2.3.1 Cellular viability  
 
Live/dead staining showed the effect of collagen coating on HEC50 cell viability 
over the 4 day culture period and compared to the plastic only control. In Cell 
microscopy images of 20 fields of view per well of HEC50 cells cultured in a 24 well 
plate on day 1, 2, 3 and 4 of the 4 day culture period. Collated live/dead staining, 
taken on day 2 of cultres, is shown in Figure 4.11.  
 




Figure 4.11: Live/dead staining of HEC50 cells. HEC50 cells cultured on plastic 
(A), RTCol (B), JCol (C) and BGel (D) were stained using hoescht, CFSE and EthD-
2 and imaged using In Cell microscopy (x20 magnification) to assess viability over a 
period of 4 days. Individual cells were identified with hoescht nuclear stain (seen in 
blue). Live cells were identified by CFSE (depicted in green) whilst dead were 
shown by EthD-2 (depicted in red). Scale bars equal to 0.1mm.  
 





Figure 4.12 : HEC50 cell viability in coated culture vessel. HEC50 cells seeded 
onto RTCol, JCol and BGel coated culture dishes were compared to plastic only 
control. Direct comparison is shown between the plastic control and RTCol (B); JCol 
(C); BGel (D). All data shown is from a minimum of 3 independent biological 
repeats, statistical significance shown according to a Mann Whitney U test (*p<0.05; 
**p<0.01; ***p<0.001). 
 
Representative images of HEC50 cells culture on different substrates are shown in 
Figure 4.11. Figure 4.12 (A) shows cells cultured on plastic compared to RTCol 
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coated plates over 4 days. Both culture conditions show an increase in viable cell 
number over the culture period with number of cells higher in plastic on day 1 (622) 
and 2 (11082) compared to RTCol at 395 and 8297, repectively and viable cell count 
higher in RTCol coated plates on day 3 (27494) and 4 (35884) when compared to 
plastic at 17661 and 28860, respectively.  Cells stained for death had similar values 
for both culture conditions and increased over the culture period. Figure 4.12 (B) 
compared plastic control to cells cultured on JCol and Figure 4.12 (C) to BGel 
coated plates. The same trend is seen whereby a higher number of viable cells are 
seen on day 1 and 2 on plastic culture compared to JCol and BGel and a lower 
number of viable cells is observed on day 3 and day 4 on plastic when compared to 
JCol and BGel. Dead cells were seen to higher in number by day 4 of culture JCol 
and BGel at 379 and 387 cells, respectively when compared to 272 cells when 
cultured on plastic alone. Despite the difference no statistical significance was 
observed.  
 
4.2.3.2 Cellular morphology 
 
Data shown in Figure 4.13 is used to assess the morphological differentiation of 
HEC50 cells over the chosen culture period. Light microscopy was used in order to 
monitor HEC50 cell shape and morphology during the culture period of the 4 days. 
Images, shown in Figure 4.13, taken through a x10 magnification objective mounted 
in an inverted light microscope and taken on day 2 of culture were used, and cell 
boundaries defined using ImageJ. A minimum of 30 cells were identified from a 
minimum of 3 independent biological repeats and used to collate cell shape data.  
 




Figure 4.13: HEC50 cell morphology. HEC50 cells grown on plastic (A), RTCol 
(B), JCol (C) and BGel (D) were imaged with a light microscope (x10 magnification) 
over a 4 day culture period to assess any changed in morphology. Scale bars equal to 
0.1mm. 
 





Figure 4.14 : HEC50 cell circularity in coated culture vessels. HEC50 cells 
seeded onto plastic (B), RTCol (C), JCol (D) and BGel (E) coated culture dishes. All 
data shown is the media +/- min/max from a minimum of 3 independent biological 
repeats, statistical significance is shown according to Mann Whitney U test 
(*p<0.05; **p<0.01; ***p<0.001).  
 
Figure 4.14 (A) depicts circularity values for HEC50 cells culture upon plastic 
dishes for 4 days. Values of cell circularity on day 1, 2 3 and 4 are similar with slight 
changes at 0.61, 0.66, 0.70 and 0.68, respectively, and show no significant difference 
when compared to day 1. HEC50 cells grown on RTCol, shown in Figure 4.14 (B), 
do not follow the same trend. Cells on day 1 exhibit an average circularity value of 
0.55 but this value increases significantly on day 2 to 0.63 (p=0.004), day 3 to 0.62 
(p=0.004) and day 4 to 0.62 (p<0.001) when compared to day 1. Figure 4.14 (C) 
shows cell circularity for HEC50 cells cultured on JCol showing no significant 
difference in circularity values over the 4 day culture period when compared to day 1 
as the cells exhibit similar values at 0.58, 0.58, 0.60 and 0.57, respectively. The same 
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trend is seen in cell cultured on BGel, shown in Figure 4.14 (D) where cells on day 1 
express a circularity value of 0.62 and cells on day 2, 3 and 4 possess similar values 
of 0.62, 0.61 and 0.66, respectively, and are not shown to be significantly different 
when compared to cells at day 1.  
 
4.2.4 Bovine chondroprogenitor cell culture  
 
Regenerative medicine approaches in cartilage repair, for prevalent diseases such as 
OA, are based on the use of stem and progenitor cell populations as source for cell 
based repair mechanisms (Rohban and Pieber, 2017). Autologous repair mechanisms 
use in situ mesenchymal stem cell populations or tissue-specific chondroprogenitor 
cell populations, usually in the presence (MACI) or absence (ACI) of a collagen 
scaffold (Dunkin and Lattermann, 2013). Development of these strategies relies 
heavily on the availability and compatibility of collagen scaffold materials both as a 
scaffold for implantation and in culture to ensure the proliferation of progenitor cells 
to the required numbers needed for enhanced chondrogenesis or repair (Iwasa et al., 
2009). It is essential that these cells be close to native form during expansion to 
maintain their chondrogenic potential (Khan et al., 2009).  
 
Bovine chondroprogenitors are used to model stem cell therapies in OA repair 
strategies, to optimise proliferative and differentiation conditions in vitro, prior to 
potential implantation (Marcus et al., 2014). In order to assess the suitability of JCol 
in this process, bovine CP populations were extracted from MCP joints using an 
established differential fibronectin adhesion assay (Dowthwaite et al., 2004). Clonal 
expansion (to P4) preceded seeding onto plastic culture vessels coated with JCol. 
Once again, as a comparison RTCol and BGel were used as benchmarks for research 
and clinical grade collagen respectively. During early culture (a course of 4 days) the 
CPs were monitored for viability, proliferation and morphological transformation 
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4.2.4.1 Cellular viability  
 
The effect of collagen coating on bovine CPs cell viability was assessed using 
live/dead staining over a period of four days and compared to a plastic only control. 
In Cell microscopy images of 20 fields per well of CPs were taken on day 1, 2, 3 and 
4 of the culture period. Figure 4.15 shows collated live/dead staining taken on day 2.  
 
 
Figure 4.15: Live/dead staining of bovine CP cells. CP cells cultured on plastic 
(A), RTCol (B), JCol (C) and BGel (D) were stained using hoescht, CFSE and EthD-
2 and imaged using In Cell microscopy (x20 magnification) to assess viability over a 
period of 4 days. Individual cells were identified with hoescht nuclear stain (seen in 
blue). Live cells were identified by CFSE (depicted in green) whilst dead were 
shown by EthD-2 (depicted in red). Scale bars equal to 0.1mm.  
 





Figure 4.16 : Bovine CP cell viability in coated culture vessels. Bovine CP cells 
seeded onto RTCol, JCol and BGel coated culture dishes were compared to plastic 
only control. Direct comparison is shown between the plastic control and RTCol (B); 
JCol (C); BGel (D). All data shown is from a minimum of 3 independent biological 
repeats, statistical significance shown according to a Mann Whitney U test (*p<0.05; 
**p<0.01; ***p<0.001). 
 
Representative images, taken by InCell microscopy, and analysed for cell viability 
on plastic, RTCol, JCol and BGel coated plates are highlighted in Figure 4.15. 
Figure 4.16 (A) shows the comparison of cell viability of bovine CP cells when 
cultured on plastic and RTCol over a 4 day period. At day 1, live cell number is 
similar between both culture conditions. Both culture conditions show the same trend 
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with an increased number of cells over four days however at day 2, 3 and 4, the 
number of viable cells grown on plastic is increased compared to those grown on 
RTCol with day 4 exhibiting a total of 25,406 viable cells on plastic and 18,456 on 
RTCol coated plated. Bovine CP cell death was similar when cultured on both plastic 
and RTCol at 41 and 35 on day 4 of culture, respectively. No significant differences 
were observed in the number of live or dead cells at each day under these culture 
conditions. Bovine CPs grown on plastic and JCol were compared for cell viability, 
shown in Figure 4.16 (B). The same trend is seen where the number of viable cells 
increases whilst the number of dead cells remain similar over 4 days. JCol appears to 
have an increased number of viable cells every day with a smaller difference 
observed when compared to plastic (29,707 and 25,406 on day 4 of culture, 
respectively) however these difference were not shown to be significant. A final 
comparison to plastic was made using BGel coated plated, indicated in Figure 4.16 
(C). Viable cells grown on BGel coated plates did not see the same trend as plastic 
control, with a decrease in number seen on day 2, from 2,158 to 1,581, before 
increasing on day 3 and 4. No significant difference was observed in viable cells 
between plastic and BGel culture conditions. Similar values were observed for 
bovine CP cell death on day 2 and 4 however a significant level of cell death was 
witnessed on day 1 at 376 cells (p=0.05) and 3 at 85 cells (p=0.05) on BGel coated 
plates when compared to plastic.  
 
4.2.4.2 Cellular morphology 
 
Circularity of bovine CP cells were assessed over the course of 4 days. Data shown 
in Figure 4.17 were attained on day 2 of culture and morphology with light and cell 
boundaries defined using ImageJ. A minimum of 30 cells were identified from a 
minimum of 3 independent biological repeats and used to collate cell shape data.  
 




Figure 4.17: Bovine CP cell morphology. CP cells grown on plastic (A), RTCol 
(B), JCol (C) and BGel (D) were imaged with a light microscope (x10 magnification) 









Figure 4.18 : Bovine CP cell circularity in coated culture vessels. Bovine CP cells 
seeded onto plastic (B), RTCol (C), JCol (D) and BGel (E) coated culture dishes. All 
data shown is the media +/- min/max from a minimum of 3 independent biological 
repeats, statistical significance is shown according to Mann Whitney U test  
(*p<0.05; **p<0.01; ***p<0.001).  
 
Figure 4.18 (A) shows cell circularity of bovine CP cells cultured on plastic dishes 
over the course of 4 days. Cell circularity on day 1 of culture is 0.39, which 
significantly increases on day 2 (p=0.032) to 0.4. Circularity values on day 3 and 4 
show no significant difference when compared to day 1, showing bovine CPs 
maintain a similar morphology in plastic culture. Circularity of cells cultured on 
RTCol are shown in Figure 4.18 (B) and show differences from day 1, 2, 3 and 4 
with circularity values observed at 0.42, 0.41, 0.49 and 0.47 with only day 4 proven 
to be a significant increase in circularity (p=0.09) when compared to day 1. Figure 
4.18 (C) shows CPs cultured on JCol where no significant differences were observed 
between cells cultured over the course of 4 days. The same trend is seen in Figure 
4.18 (D) where cells grown on BGel coated plates show no significant difference in 
cell circularity over the culture period when compared to day 1 of culture.  
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4.2.5 In vitro immunogenicity 
 
The immunogenic response elicited by the JCol scaffold moulded in Chapter 3 was 
assayed. In order to assess the effect of JCol on platelet activation, leukocyte 
activation and cell death, a series of CD markers were identified and used to gate 
platelet, neutrophil, monocytes and T-cells by cell number (CD42B, CD11B, 
FMLPR and DRAQ7) and/or median fluorescent intensity (CD62L) respectively. In 
each instance JCol scaffolds were compared to RTCol and bovine collagen (BCol) as 
research and clinical grade collagen sources, respectively, as well as BGel as a 
negative control (denatured collagen source).  
 
EDC, used in Chapter 3, to control scaffold structural integrity and porosity has been 
shown to be toxic to cells at concentrations above 1% (Thoreson et al., 2015). In 
order to assess the effect of EDC concentration on platelet activation, leukocyte 
activation (using CD62L, CD11B, FMLPR) and cell death (DRAQ7), 0.25%, 0.5% 
and 1.0% EDC crosslinked scaffolds were assessed. Each collagen source was 
assessed at each concentration of EDC to ensure comprehensive screening and 
identify any potential issue with the crosslinker chosen.  
 
4.2.5.1 Platelet activation 
 
4 beta-phorbol-12-myristate-13-acetate (PMA), routinely used to induce platelet 
activation and subsequent shielding of CD42b in human donor models (Jerushalmy 
et al., 1988). In order to assess donor suitability for platelet activation, three donor 
blood samples were exposed to PMA (2 hours) and stained for CD42b (Figure 4.19). 
Panel A shows the scatter plot and resultant histogram from the control donor blood 
data while Panel B indicates the altered scatter graph and histogram in the presence 
of PMA. As a result of proprietary FACS analysis software (Kaluza, UK), this data is 
then collated to a scatter graph summarising the individual donor effect and median 
across donor cohort (Figure 4.19, Panel C).  
 





Figure 4.19: Platelet activation in the presence and absence of PMA. Blood from 
three healthy donors was analysed FACS for CD42b expression, expressed as a 
scatter plot and histogram (A) and compared to PMA stimulated blood (B). Analysis 
of FACS data for unstimulated and stimulated blood samples were obtained with 
Kaluza (C). Data shown are individual values plotted as a dot plot with median 
values depicted as a line. No statistical comparison is conducted due to low donor 
number. 
 
Figure 4.19 (A) shows FACS scatter diagram from a single healthy volunteer 
depicting gating of platelets stained for CD42b and representative histogram showing 
platelet population within the defined gates. Figure 4.19 (B) shows FACS scatter 
diagram and histogram of a platelets from a single healthy volunteer after treatment 
with PMA depicting movement of platelets out of the predefined gates. Figure 4.19 
(C) shows individual donor variation in % gated platelets with a decreased in gated 
values being observed in the PMA treated blood samples when compared to the 
baseline.  
 
Three healthy donors were recruited to this study and their whole blood samples 
incubated in the presence and absence of the scaffold materials. Following a 2 hour 
incubation period the blood was collected, stained for CD42b (FITC) and processed 
for FACS analysis (see Figure 4.20).  





Figure 4.20 : Platelet activation in the presence of collagen scaffold material. 
 
Following whole blood incubation from three donours, JCol platelet activation was 
compared directly to that of RTCol, BCol and BGel sources at 0.25% (A); 0.5% (B) 
and 1% (C) EDC cross linker. As a positive control PMA was used to stimulate 
platelet activation in each case. All data shown are individual values plotted as a 
scatter plot with median values depicted as a line. No direct statistical comparison is 
conducted due to the low donor number.  
 
Figure 4.20 (A) shows individual donor variation in their %-gated platelets, with one 
donor consistently showing increased platelet % following incubation with RTCol, 
BCol, JCol and BGel respectively. Despite this a clear trend observed where Jcol 
exhibits increased platelet % compared to the other collagen sources, indicating 
decreased platelet activation in this scaffold sub type, at this concentration of EDC. 
Figure 4.20 (B), which is 0.5% EDC shows a slight difference in trend where JCol 
and RTCol exhibit a similar number of % gated platelets whilst BCol and BGel 
exhibit a lower number of % gated cells indicating an increase in platelet activation 
in these latter scaffolds. Figure 4.20 (C) shows JCol exhibits an increase % number 
of platelets compared to other scaffold materials at 1% EDC crosslinker 
concentration. 
 
4.2.5.2 Leukocyte activation; innate immune response  
 
Leukocyte activation, in the form of neutrophil and monocyte recruitment to the site 
of implantation is considered an early or innate immune response (Chaplin, 2010). 
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Both cell types have been shown to shed CD62L or L-selectin and are thought to 
mediate migration and adhesion at the site of inflammation (Yang et al., 2011). In 
addition both cell types are known to express increased levels of CD11b, known to 
mediate migration and adhesion to the material or foreign/invading object (Muller, 
2013). Finally, fMLPr is used as a further marker indicative of leukocyte activation 
and cytokine release in the presence of an implanted material, with increased 
detection signifying a stronger immune cell response (Pan et al., 2000).  
 
4.2.5.2.1 LPS established baseline  
 
LPS is a known stimulant of the human immune system, used as a positive control to 
demonstrate active immune cells during in vitro immunogenic screening (Alexander 
and Rietschel, 2001). In order to establish the immune response capability of each 
donor, LPS was added for a 2 hour period prior to whole blood staining for CD62L, 
CD11b and fMLPr.  In the presence of CD62L, CD11b and fMLPr staining, 
neutrophil and monocyte cells were identified from the FACS trace by gating 
according to CD15+ and CD14+ mean fluorescent staining respectively, as used by 
Radley and colleagues (Radley et al., 2017). Figure 4.21, shows the neutrophil 
(CD15+) specific CD62L, CD11b and fMLPr stimulation in the presence of LPS. 





Figure 4.21: LPS induced donor specific neutrophil cell response. Whole blood 
samples were stained for CD62L, CD11b and fMLPr to indicate neutrophil specific 
response in the presence of LPS. Specific neutrophil responses were identified using 
cell type specific stains CD15+. Panels A, B and C indicate the CD62L, CD11b and 
fMLPr neutrophil specific response as a FACS scatter graph compared to control and 
Kaluza analysed summation respectively. All data shown as individual scatter 
readings or summarised donor cohort.  
 
Figure 4.21 (A) shows FACS scatter graphs depicting the change in gating of 
neutrophils (CD15+) stained for CD62L from unstimulated and LPS stimulated 
blood from a single healthy donor. Data from three healthy patients were summated 
in a dot plot showing individual donor variation in their median fluorescence 
intensity and shows that LPS stimulated blood shows a decrease in median 
fluorescence intensity of CD62L when compared to baseline unstimulated blood. 
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Figure 4.21 (B) shows the change in gating of neutrophils stained for CD11b from a 
single healthy donor, depicted as a FACS scatter graph. Summarised data from three 
healthy donors is shown in the dot plot expressing individual donor variation in % 
gated cells, with LPS stimulated blood exhibiting an increase in % gated cells 
expressing CD11b when compared to unstimulated blood. Figure 4.21 (C) shows 
FACS scatter graphs depicting the change in gating for fMLPr stained neutrophils 
from unstimulated and stimulated blood. Individual donor variation in % gated cells 
from three healthy donors shows a small decrease in the % gated neutrophils 
expressing fMLPr when compared to unstimulated blood.   





Figure 4.22: LPS induced donor specific monocyte cell response. Whole blood 
samples were stained for CD62L, CD11b and fMLPr to indicate monocyte specific 
response in the presence of LPS. Specific neutrophil responses were identified using 
cell type specific stains CD15+. Panels A, B and C indicate the CD62L, CD11b and 
fMLPr neutrophil specific response as a FACS scatter graph compared to control and 
Kaluza analysed summation respectively. All data shown as individual scatter 
readings or summarised donor cohort.  
 
Figure 4.22 (A) shows a change in gating of monocytes (CD14+) stained for CD62L 
from unstimulated and LPS stimulated blood. Data from three donors were 
summarised as a dot plot exhibiting individual donor variation in median 
fluorescence intensity, with LPS stimulated blood showing a decrease in median 
fluorescence intensity of CD62L when compared to baseline blood. Figure 4.22 (B) 
shows FACS scatter graphs depicting the change in gating of monocytes stained for 
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CD11b. Data from three donors were summated in a dot plot showing individual 
donor variation in % gated cells and shows that LPS stimulated blood has an 
increased number of % gated monocytes expressing CD11b when compared to the 
unstimulated counterpart. Figure 4.22 (C) depicts the change in gating of monocytes 
related to their expression of fMLPr from a single donor. A dot plot collated from 
three donors shows individual donor variation in % gated cells and shows a decrease 
in the % gated monocytes expressing fMLPr in LPS stimulated blood when 
compared to unstimulated blood samples.  
 
4.2.5.2.2 Neutrophil specific activation  
 
Whole blood from the three donors was then exposed to the RTCol, BCol, JCol and 
BGel scaffolds over a period of 2 hours, prior to collection, staining with CD62L, 
CD11b as well as fMLPr and counter stained with CD15+ to identify specific 
neutrophil activation. Data shown in Figure 4.23 depicts the donor cohort median 
activation for neutrophil specific CD62L, CD11b and fMLPr activation in the 
presence of 0.25, 0.5 and 1.0% EDC cross linker (Figure 4.23).  
 





Figure 4.23: Neutrophil activation in the presence of collagen scaffolds. Specific 
neutrophil (CD15+) activation was detected through levels of CD62L (A); CD11b 
(B) and fMLPr (C), following a 2 hour incubation with RTCol, BCol, JCol and BGel 
scaffolds respectively. All marker stains were also analysed as a function of EDC 
cross link percentage and are shown here as three panels, (i 0.25%), (ii 0.5%) and (iii 
1%). All data shown as summarised donor cohort responses following Kaluza 
collation; median value depicted a line in each variable and sample type. 
 
Figure 4.23 (Ai) shows individual donor variation in their median fluorescence 
intensity following incubation with RTCol, BCol, JCol and BGel at 0.25% 
crosslinking concentration. RTCol exhibits a higher median fluorescence intensity 
value than when compared to other scaffold material, indicating decreased shedding 
of CD62L in blood incubated with RTCol at this EDC concentration. Figure 4.23 
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(Aii), at 0.5% EDC, shows a difference in trend where RTCol and BGel exhibit 
similar values in median fluorescence intensity whilst a decreased median 
fluorescent intensity is observed in BCol and JCol samples. Figure 4.23 (Aiii) shows 
RTCol, BCol and JCol to have similar median fluorescence intensity values whilst 
BGel exhibits a decrease in value at 1% EDC concentration. Figure 4.23 (Bi) shows 
donor variation in % gated neutrophils showing an increase in neutrophil percentage 
following incubation with RTCol, BCol, JCol and BGel, respectively. A trend is 
observed where RTCol exhibits a lower number of % gated neutrophils expressing 
CD11b when compared to BCol, JCol and BGel at 0.25% EDC concentration 
indicating decreased neutrophil activation for this specific scaffold material. Figure 
4.23 (Bii) shows BCol and JCol have similar % gated neutrophils, which are 
increased when compared to RTCol and BGel at 0.25%. Figure 4.23 (Biii) shows % 
gated neutrophils expressing CD11b following incubation with scaffolds at 1% EDC 
concentration. A similar trend is observed where RTCol exhibits a decreased number 
of % gated neutrophils when compared to BCol, JCol and BGel. Figure 4.23 (Ci) 
shows individual donor variation in in % gated neutrophils stained for fMLPr 
following incubation with RTCol, BCol, JCol and BGel at 0.25% crosslinker 
concentration. A trend is observed where RTCol and JCol exhibit a decreased % 
gated neutrophils when compared to BCol and BGel, indicating an increase in 
neutrophil activation in the former scaffold subtypes at this concentration. Figure 
4.23 (Cii) shows a difference in trend with RTCol and BCol showing increased % 
gated neutrophils when compared to JCol and BGel counterparts at 0.5% crosslinker 
concentration. Figure 4.23 (Ciii) depicts % gated neutrophils expressing fMLPr 
following incubation with scaffolds crosslinked with 1% EDC. At this concentration 
RTCol and BGel show a decreased in % gated neutrophils in comparison to BCol 
and JCol, indicating the former scaffold materials have an increase in neutrophil 
activation. 
 
4.2.5.2.3 Monocyte specific activation  
 
Donor whole blood exposed to RTCol, BCol, JCol and BGel scaffolds (2 hours) 
were stained with CD62L, CD11b as well as fMLPr and counter stained with CD14+ 
to identify specific monocyte activation, with all data depicted in Figure 4.24. 






Figure 4.24: Monocyte activation in the presence of collagen scaffolds. Specific 
monocyte (CD14+) activation was detected through levels of CD62L (A); CD11b 
(B) and fMLPr (C), following a 2 hour incubation with RTCol, BCol, JCol and BGel 
scaffolds respectively. All marker stains were also analysed as a function of EDC 
cross link percentage and are shown here as three panels, (i 0.25%), (ii 0.5%) and (iii 
1%). All data shown as summarised donor cohort responses following Kaluza 
collation; median value depicted a line in each variable and sample type. 
 
Figure 4.24 (Ai) shows variation between individual donors in median fluorescence 
intensity after incubating blood with scaffolds fabricated from RTCol, BCol, JCol 
and BGel crosslinked at 0.25%. When compared to other scaffold subtypes, RTCol 
exhibits increased median fluorescence intensity for CD26L indicating a decrease in 
monocyte activation compared to other tested materials at this crosslinker 
Chapter 4                                                                   Biocompatibility & Immunogenicity 
 
 175 
concentration. Figure 4.24 (Aii) shows median fluorescence intensity of monocytes 
stained for CD62L at 0.5% EDC concentration. A change in trend is observed with 
RTCol, BCol and JCol expressing lower median fluorescence intensity values that 
BGel. Figure 4.24 (Aiii) shows a difference in trend again with RTCol and BCol 
expressing similar median fluorescence intensity values whilst JCol and BGel 
express similar, increased median fluorescence intensity values at 1% EDC 
concentration, indicating and increase in monocyte activation in the former scaffold 
materials. Figure 4.24 (Bi) shows individual donor variation in % gated monocytes 
stained for CD11b following incubation with RTCol, BCol, JCol and BGel. At 
0.25% EDC concentration, BCol exhibits the highest value of % gated monocytes 
when compared to other scaffold materials whilst RTCol shows the lowest % gated 
monocytes. Figure 4.24 (Bii) shows a similar trend at 0.5% EDC concentration with 
BCol exhibiting increased % gated, RTCol and BGel showing similar values and 
JCol exhibiting the lowest % gated monocytes indicating that JCol has a decreased 
level of monocyte activation compared to its counterparts. Figure 4.24 (Biii) shows 
% gated monocytes expressing CD11b following incubation with scaffolds at 1% 
EDC concentration. RTCol exhibits a decreased number of % gated monocytes when 
compared to BCol, JCol and BGel. Figure 4.24 (Ci) shows % gated monocytes 
stained for fMLPr following incubation with RTCol, BCol, JCol and BGel at 0.25% 
EDC concentration. A trend is observed where RTCol, BCol and JCol similar 
increased expression in % gated monocytes when compared to BGel. Figure 4.24 
(Cii) shows a difference in trend where BCol expresses and increased % gated 
monocytes, BCol and JCol exhibit similar values and RTCol exhibits the lowest 
value of % gated monocytes stained for CD11b at 0.5% crosslinker concentration. 
Figure 4.24 (Ciii) depicts % gated monocytes expressing fMLPr following 
incubation with scaffolds crosslinked with 1% EDC. At this concentration a change 
in trend occurs once again with BCol, JCol and BGel expressing similar increase 
values in % gated monocytes compared to RTCol at this crosslinker concentration. 
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4.2.5.3 Leukocyte activation; adaptive immune response  
 
Leukocyte activation, in the form of T-cell recruitment to the site of implantation is 
considered a later, or adaptive immune response (Chaplin, 2010). T-cells function to 
recognise antigens bound to major histocompatibility (MHC) molecules to help 
discriminate from non-self (Kennedy, 2010). CD62L, CD11B and fMLPr are also 
accepted markers for T cell activation and are monitored here in T-cells specifically 
through counter staining using antibodies (APC-Vio770) to identify CD3+ cells.  
 
In order to establish the capability of the specific T cell populations in the peripheral 
blood donor cohorts, CD62L, CD11B and fMLPr expression was monitored 
following LPS incubation (2 hours). Following the establishment of this baseline 
response (shown in Figure 4.25), the scaffold materials were each assessed for T-cell 
activation profiles. 





Figure 4.25: LPS induced donor specific T-cell responses. Whole blood samples 
were stained for CD62L, CD11b and fMLPr to indicate T-cell specific response, 
using CD3+ stains in the presence of LPS. Panels A, B and C indicate the CD62L, 
CD11b and fMLPr T-cell specific response as a FACS scatter graph compared to 
control and Kaluza analysed summation respectively. All data shown as individual 
scatter readings or summarised donor cohort.  
 
Figure 4.25 (A) depicts a change in gating of T-cells (CD3+) stained for CD62L 
from unstimulated and LPS stimulated blood from a single healthy donor. Data from 
three healthy donors were summated in a dot plot showing individual donor variation 
in their median fluorescence intensity and show LPS stimulated blood has a 
decreased median fluorescence intensity of CD62L when compared to baseline, 
unstimulated blood. Figure 4.25 (B) shows a change in gating for T-cells stained for 
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CD11b from a single healthy donor. Data summated in a dot plot showing individual 
donor variation in % gated T-cells shows similar values between that of unstimulated 
and LPS stimulated blood. Figure 4.25 (C) shows FACS scatter plots depicting the 
change in gating for fMPLr stained T-cells from unstimulated and LPS stimulated 
blood. Individual donor variation in % gated from three healthy donors shows a 
decrease in % gated T-cells expressing fMLPr in LPS stimulated blood when 
compared to the unstimulated control.  
 
 
Figure 4.26, shows the T-cell specific response (CD3+) through CD62L, CD11b and 
fMLPr stimulation in the presence of RTcol, BCol, JCol and BGel in turn, across the 
three EDC % cross linking concentrations respectively.   





Figure 4.26: T-cell activation in the presence of collagen scaffolds. Specific T-cell 
activation was detected through levels of CD62L (A); CD11B (B) and FMLPr (C), 
following a 2hr incubation with RTCol, BCol, JCol and BGel scaffolds respectively. 
All marker stains were also analysed as a function of EDC crosslink percentage and 
are shown here as three panels, (Ai 0.25%), (Aii 0.5%) and (Aiii 1%). All data 
shown as summarised donor cohort responses following Kaluza collation; median 
value depicted a line in each variable and sample type. 
 
Figure 4.26 (Ai) shows individual donor variation in their median fluorescence 
intensity following incubation with RTCol, BCol, JCol and BGel at 0.25% 
crosslinking concentration. RTCol, JCol and BGel exhibit similar values for T-cell 
median fluorescent intensity whilst BCol exhibits decreased median fluorescence 
intensity when compared to the other scaffold materials. At 0.5% EDC 
concentration, Figure 4.26 (Aii), there is a change in trend with BCol, JCol and 
BGel expressing similar median fluorescence intensity values and RTCol showing 
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decreased median fluorescence intensity for CD62L indicating T-cell activation in 
the latter material compared to other subtypes. Figure 4.26 (Aiii) shows BCol and 
JCol exhibit similar decreased median fluorescence intensity than RTCol and BGel 
at 1% EDC concentration. Figure 4.26 (Bi) shows individual donor variation in % 
gated T-cells stained for CD11b, with one donor consistently showing increased 
platelet % following incubation with RTCol, BCol, JCol and BGel at 0.25% EDC 
concentration. A trend is established with RTCol, BCol, JCol and BGel % gated T-
cells exhibit similar low values. Figure 4.26 (Bii) shows the same trend with all 
scaffold materials showing decreased % gated T-cells stained for CD11b at 0.5% 
EDC concentration. Figure 4.26 (Biii) shows the same trend at 1% EDC 
concentration where RTCol, BCol, JCol and BGel express a similar, low % gated T-
cell population. Figure 4.26 (Ci) shows individual donor variation in % gated T-cells 
stained for fMLPr following incubation with RTCol, BCol, JCol and BGel at 0.25% 
crosslinker concentration. A trend is seen where RTCol, BCol and JCol express 
similar % gated T-cells whilst BGel exhibits increased % gated T-cells stained for 
fMLPr. This trend is seen again at 0.5% EDC concentration (Figure 49 Cii) and at 
1% EDC concentration (Figure 4.26 Ciii). 
 
4.2.5.4 Leukocyte cell death   
 
The initiation of the immune system in response to a biomaterial leads to the 
activation of various different cell types. Immobilised platelets recruit neutrophils 
and monocytes, which in turn activate and recruit T-cells to the surface of the 
biomaterial. This build up of cells can induce cell death causing a defective cellular 
immune response (Radley et al., 2017). DRAQ7 is an anthracycline derivative that 
exclusively stains dead cells, capitalising on membrane permeability and binding to 
nuclear DNA (Akagi et al., 2013). 
 
In order to establish whether scaffold materials at any given EDC concentration were 
causing excessive cell death, blood samples were stained with DRAQ7 following 
incubation with RTCol, BCol, JCol and BGel. A baseline was established with the 
use of healthy donor blood and LPS stimulated blood, seen in Figure 4.27.  
 





Figure 4.27: LPS induced specific cell death. Whole blood samples were stained 
with DRAQ7 to indicate cell death in the presence and absence of LPS stimulation. 
LPS stimulated cellular response is shows as a flow cytometric histogram compared 
to control and Kaluza analysed summation for neutrophils (A), monocytes (B) and T-
cells (C), respectively. All data shown as individual readings or summarised donor 
cohort.   
 
Figure 4.27 (A) shows a change gating in neutrophil (CD15+) stained for DRAQ7 
from a single healthy donor in the presence and absence of LPS stimulation showing 
a broader peak with LPS stimulation indicative of cell death. Data from three healthy 
donors were summated in a dot plot showing individual donor variation in their % 
gated neutrophils. Increased % gated neutrophils are seen in LPS stimulated samples 
compared to control. Figure 4.27 (B) shows a histogram depicting a change in gating 
of monocytes stained with DRAQ7 in the presence and absence of LPS. A shift in 
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the gating is seen towards the left indicating cell death in LPS treated blood. 
Summated data from three patients shows an increase in % gated monocytes in 
stimulated blood compared to its unstimulated counterpart. Figure 4.27 (C) exhibits 
the same trend when observing T cells (CD3+). Flow histograms show a change in 
gating indicative of increased cell death when observing a single healthy patient after 
treatment with LPS. A dot plot accounting for individual donor variation in % gated 
T-cells stained for DRAQ7 shows and increased percentage when comparing LPS 
stimulated blood to unstimulated baseline blood.  
 
Figure 4.28, shows the neutrophil (CD15+), monocyte (CD14+) and T-cell (CD3+) 
specific cell death response through DRAQ7 staining in the presence of RTcol, 
BCol, JCol and BGel in turn, across the three EDC % cross linking concentrations 
respectively.  
 





Figure 4.28: Leukocuyte cell death in the presence of scaffold structures. 
Leukocyte cell death in the presence of scaffold structure (A) neutrophils (B) 
monocytes (C) T cells 
 
Figure 4.28 (Ai) shows individual donor variation in % gated neutrophils following 
incubation with RTCol, BCol, JCol and BGel at 0.25% crosslinker concentration. A 
trend if observed in which there is an increasing value in % gated neutrophils 
expressing DRAQ7 from RTCol, BCol, JCol and BGel, respectively, and BGel 
showing the more increased value. Figure 4.28 (Aii) shows a difference in trend 
with one donor consistently showing increased % gated neutrophils at 0.5% EDC 
concentration however median values of all scaffold sub types are similar. Figure 
4.28 (Aiii) shows BCol exhibiting increased % gated neutrophils expressing DRAQ7 
when compared to other scaffold materials at 1% EDC concentration. Figure 4.28 
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(Bi) shows increased % gated monocytes stained for DRAQ7 in BCol culture when 
compared to other materials at 0.25% EDC concentration. Figure 4.28 (Bii) depicts 
similar % gated monocyte values for RTCol, BCol and JCol at whilst an increased % 
gated monocyte value is seen for BCol at 0.5% EDC concentration. A slight change 
in trend is seen at 1% EDC crosslinking concentration, depicted in Figure 4.28 (Biii) 
with similar % gated values seen for RTCol, BCol, JCol whilst increased % gated 
value is seen for BGel at this concentration. Figure 4.28 (Ci) shows individual donor 
variation in % gated T cells stained for cell death with DRAQ7 following incubation 
with scaffolds crosslinked at 0.25%. A trend is observed where BCol has increased 
% gated monocytes compared to other scaffold subtype that exhibit similar, lower 
values. The same trend is observed in Figure 4.28 (Cii) where BCol has increased % 
gated T cells compared to all other scaffold materials tested. Figure 4.28 (Ciii) 
shows a change in trend at 1% crosslinker concentration where RTCol and BGel 
have similar decreased % gated T cells when compared to BCol and JCol at this 
concentration.  
 
4.2.5.5 Cytokine release profile 
 
Cytokines, released upon activation of immune cells, are key modulators in 
inflammation and can be categorised as either pro-inflammatory or anti-
inflammatory (Turner et al., 2014). In order for the immune system to function in an 
orderly manner, cytokine release is regulated in cascades responding to initial 
inflammatory response followed by another cascade in order to allow for the reaction 
to subside (Lacy and Stow, 2011).  
 
4.2.5.5.1 Pro-inflammatory cytokine – interleukin 6 
 
Interleukin 6 (IL-6) is seen as a pro-inflammatory cytokine that is involved in the 
activation of the immune system (Scheller et al., 2011). Although IL-6 plays a 
prominent role in immune initiation it is also prevalent in chronic disease showcasing 
its role in both acute inflammation during innate immune response and in the 
development of the humoral response including T cell activation (Gabay, 2006). In 
order to establish if RTCol, BCol, JCol and BGel scaffolds crosslinked at varying 
Chapter 4                                                                   Biocompatibility & Immunogenicity 
 
 185 
concentrations released an increased concentration of IL-6, blood from healthy donor 
volunteers was incubated with scaffolds for a 2 hour period before further 24 hour 
incubation with media in the presence and absence of LPS. Following centrifugation 




Figure 4.29: IL-6 release profile in the presence of scaffolds. Whole blood serum 
samples incubated in media in the absence (A, C, E) and presence of LPS (B, D, F) 
was subjected to ELISA to obtain concentration of IL-6 released. All data shown is 
the standard deviation from a minimum of 3 independent biological repeats, 
statistical significance shown according to a paired Mann Whitney U test (*p<0.05; 
**p<0.01; ***p<0.001). 
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Figure 4.29 (A) and (B) show the IL-6 concentration for scaffolds crosslinked at 
0.25% EDC concentration from unstimulated and stimulated samples, respectively. 
In unstiumlated culture conditions (A), RTCol, BCol, JCol and BGel all show a 
significant (p<0.001) increase in the average IL-6 concentration in blood serum after 
24-hour incubation when compared to baseline donor blood samples. The addition of 
LPS to culture conditions (B) sees a change in trend where RTCol shows no 
significant difference in IL-6 concentration compared to baseline blood whereas 
BCol and BGel both show a significant increase (p=0.020 and p=0.002) and JCol 
exhibits a further significant difference (p<0.001) at this crosslinking concentration. 
Figure 4.29 (C) shows IL-6 concentration for scaffolds crosslinked at 0.5% EDC 
concentration in the absence of LPS. At this concentration RTCol shows no 
significant difference in IL-6 levels when compared to baseline blood however, BCol 
(p<0.001), JCol  (p<0.001) and BGel (p=0.028) all display significant increase in 
their IL-6 concentration when compared to blood incubated in the absence of a 
scaffold. Figure 4.29 (D) displays data from the LPS stimulated samples crosslinked 
at 0.5% EDC and show a similar trend to the unstimulated counterpart. Once again it 
is observed that RTCol has no significant difference in IL-6 concentration when 
compared to baseline blood samples whilst BCol (p=0.005), JCol (p=0.002) and 
BGel (p=0.029) all display a significant increase in IL-6 concentration following 24-
hour incubation. Figure 4.29 (E) depicts IL-6 concentration in blood serum samples 
following incubation of scaffolds crosslinked with 1% EDC. At this concentration 
both RTCol and BGel show no significant difference in concentration when 
compared to baseline blood samples however BCol (p<0.001) and JCol (p=0.036) 
exhibit significant increased levels of IL-6. Figure 4.29 (F) shows IL-6 
concentration of blood serum samples in the presence of LPS and displays a 
difference in trend with RTCol (p<0.001) and BCol (p=0.012) showing a significant 
increase in concentration whilst JCol and BGel show no significant difference when 
incubated with scaffolds at 1% EDC concentration.  
 
4.2.5.5.2 Anti-inflammatory cytokine – interleukin 10 
 
Interleukin 10 (IL-10) is a potent anti-inflammatory cytokine that inhibits specific 
immune specific cells limiting the damage sustained by tissues (Couper et al., 2008). 
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IL-10 is produced by nearly all leukocytes including monocytes, macrophages and T 
cells. The interaction of IL-10 with other anti-inflammatory molecules enables the 
inhibition of allergic responses as well as enhancing the regulatory function of T 
cells (Iyer and Cheng, 2012). All scaffolds crosslinked with 0.25%, 0.5% and 1% 
EDC were incubated with human blood for 2 hours before transferring blood to 
media in the presence and absence of LPS for a further 24 hour incubation period. 
On completion of incubation, blood serum was collected and subjected to ELISA to 
obtain IL-10 concentrations and create a release profile.  
  





Figure 4.30: IL-10 release profile in the presence of scaffolds. Whole blood serum 
samples incubated in media in the absence (A, C, E) and presence of LPS (B, D, F) 
was subjected to ELISA to obtain concentration of IL-6 released. All data shown is 
the standard deviation from a minimum of 3 independent biological repeats, 
statistical significance shown according to a paired Mann Whitney U T test 
(*p<0.05; **p<0.01; ***p<0.001). 
 
Figure 4.30 (A) depicts IL-10 concentration in blood serum samples following 
incubation of scaffolds crosslinked with 0.25% EDC in the absence of LPS. At this 
EDC concentration no significant difference was observed with any scaffold material 
(RTCol, BCol, JCol and BGel) when compared to baseline blood samples. Figure 
4.30 (B) shows IL-10 concentration of blood serum samples in the presence of LPS 
and displays a difference in trend with RTCol (p=0.012), JCol (p=0.003) and BGel 
(p>0.001) exhibiting a significant increase in the serum IL-10 concentration whilst 
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BCol showed no significant difference in comparison with baseline LPS stimulated 
blood. Figure 4.30 (C) and 4.30 (D) show the IL-10 concentration for scaffolds 
crosslinked at 0.5% EDC concentration from unstimulated and stimulated samples, 
respectively. In unstiumlated culture conditions (C), BCol, JCol and BGel all no 
significant difference in IL-10 concentration after 24-hour incubation when 
compared to baseline donor blood samples, whilst RTCol appears to show a 
significant decrease in IL-10 concentration (p=0.033). The addition of LPS to culture 
conditions (D) sees a change in trend where JCol exhibits no significant difference 
when compared to baseline blood but RTCol (p=0.019), BCol (p=0.045) and BGel 
(p<0.001) display significant increase in IL-10 concentration levels compared to 
baseline. Figure 4.30 (E) shows IL-10 concentration for scaffolds crosslinked at 1% 
EDC concentration in the absence of LPS. At this concentration BCol, JCol and 
BGel display no significant difference in serum IL-10 concentration when compared 
to the baseline sample whilst RTCol exhibits a significant decrease in IL-10 
concentration (p=0.031). Figure 4.30 (F) displays data from the LPS stimulated 
samples crosslinked at 1% EDC and show a similar trend to the unstimulated 
counterpart. At this concentration, when compared to baseline samples, RTCol 
exhibits no significant difference whereas BCol (p=0.023). JCol (p=0.004) and BGel 
(p<0.001) exhibit a significant increase in IL-10 concentration when compared to 




Following successful scalable isolation of JCol solutions in Chapter 3, the objective 
of this chapter was to assess JCol biocompatibility. Defined as the ability of a 
material to perform with an appropriate host response, JCol biocompatibility was 
assessed here in two ways. Firstly in assessing its effect on cellular viability and 
phenotypic stability using a host of human cancer cell lines and progenitor 
populations isolated from bovine donors. Secondly, JCol biocompatibility was 
assessed in terms of inducing a potential human immunogenic response, assaying for 
in vitro effects of JCol sponge scaffolds on peripheral blood mononuclear cells 
(PBMC) isolated from healthy human donors. JCol solution coated cell culture 
plastics demonstrated compatibility with human derived functional epithelial and 
mesenchymal cell line populations, maintaining cellular viability, proliferation rate 
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and morphology in short term culture. No adverse affects were witnessed in 
comparison to mammalian sources of research grade collagen. Similarly, no 
significant activation of isolated PBMC cells were observed across a spectrum of 
innate and adaptive immune cells, in an in vitro immunogenicity model. 
Significantly, in line with the initial inflammatory response observed in the critical 
first 1-7 days post biomaterial implantation, PBMC cell cytokine release profiles in 
the presence of JCol scaffolds were found to be comparable to commercial bovine 
collagen sources. These results indicate that jellyfish derived collagen solutions are 
compatible with both coated plate cell culture and potential regenerative medicine 
approaches. 
 
Cell culture support matrix 
 
The ECM is a dynamic structure that is intimately linked to cellular behaviour such 
as proliferation, morphology and viability (Liberio et al., 2014). Integrins expressed 
by cells allow for the attachment of cells to ECM components, such as collagen, 
generating intercellular signalling cascades that control gene expression patterns. The 
microenvironment in which a cell exists therefore is an important determinant of it’s 
functional development (Damsky and Ilic, 2002). Isolated ECM components such as 
collagen, elastin, fibronectin, laminin, vitronectin and even ECM peptides have been 
used in tissue culture to better mimic in vivo cell behaviour (Liberio et al., 2014).  
 
Collagen, as the main component of connective tissue, has become an integral 
addition to cell culture practices for basic coating and gel preparations, enabling 
attachment cells to be grown (Somaiah et al., 2015b). Collagen coated tissue culture 
plates are used for cell attachment, growth and differentiation for many cell 
applications, providing rapid cell attachment, rapid recovery and healthy cell growth 
(Cooke et al., 2008). These plates are found in research labs for projects such as 
controlled differentiation of human embryonic stem cells and induced pluripotent 
stem cells into cells that resemble adult mesenchymal stem cells (Liu et al., 2012).  
 
The influence of JCol on cellular function was initially tested here, in a ‘pseudo’ 3D 
environment. Routine tissue culture plastics were coated with JCol using methods 
previously employed by Sewing and colleagues (Sewing et al., 2017). Both the 
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epithelial and mesenchymal cells grown on the JCol lawns adhered, proliferated and 
exhibited a wide distribution of cellular shape, indicative of biocompatible substrate. 
This may be due in part, to the non-mammalian peptide presentation (shown in 
Chapter 3) and or potential variations in triple helical structure, once again observed 
in Chapter 3, albeit in a sponge scaffold confirmation.  The structure of collagen 
coated onto plates, both from the collagen source and the method of coating, has 
been shown to play an important role in material driven cell responses (Plant et al., 
2009). Denatured collagen binds cells via the αvβ3 integrin through recognition of 
the RGD peptide (Elliot et al., 2005). Cell response on denatured collagen has shown 
to have spread morphology and develop actin stress fibres compared to intact fibrillar 
collagen (Plant et al., 2009).  
 
Epithelial cells are attached to the basement membrane, which signals for cell 
survival, proliferation and differentiation as well as cues that enable the cells to 
establish polarity (Lee and Streuli, 2014). Loss of cell polarity is associated with 
tumour initiation and is thought to be due, in part, to defective ECM turnover (Lee 
and Vasioukhin, 2008). Data obtained from R. pulmo collagen coated plates show 
that epithelial cancer cells remain viable and retain their proliferative capacity over a 
4-day culture period. More importantly, using shape index as an indicator, the 
morphology of multiple cell types were seen to remain stable over the culture period. 
The importance of collagen binding motifs in cancer is highlighted by research that 
shows that vinculin may be important in the suppression of tumour metastasis as it 
reduces cell motility (Goldmann et al., 2013).  Cell migration relies upon contractile 
forces and causes the alteration of cell shape to a more elongated form allowing 
movement through pores (Friedl and Gilmour, 2009). 
 
The effect of collagen coating on cellular function may also be dependent on the time 
of cells cultured on the material. In vitro culture of cancer stem cells (CSCs) from 
cancers such as breast, ovarian and colon has been established using serum-free 
media, changing their anchorage-dependent nature to non-adherent and causing 
CSCs to form 3D spheroids (Arab-Bafrani et al., 2016). The culture of CSCs on 
collagen type I coated substrates has shown phenotypic maintenance of cells and 
increased expression of the CSC characteristic surface marker CD133 (Kirkland, 
2009). Whilst lymphnode carcinoma of the prostate (LNCaP) cells, a prostate cancer 
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cell line, were shown to display a round morphology and aggregate on collagen IV-
coated cultures however they exhibited lower cell viability when compared to 
laminin, fibronectin and poly-amino acid coating (Liberio et al., 2014). On the other 
hand, bone marrow derived MSCs showed enhanced proliferation, cell adhesion and 
viability on collagen I culture dishes compared to traditional tissue culture plastic 
(Somaiah et al., 2015a). 
 
Cells adhere to the ECM via large protein complexes termed focal adhesions 
(Maziveyi and Alahari, 2017). Actin filaments of stress fibres are found attached to 
the β subunits of integrins via adapter proteins such as vinculin and vimentin (Lodish 
et al., 2000b). The clustering of integrins forms focal adhesions with the connection 
between ECM and cells allowing for signals to be bidirectionally transmitted 
(Radinsky et al., 2002). HESC cells were the only cells to exhibit a significantly 
rounder morphology on day 3 and 4 all coated plates when compared to day 1. This 
may be due to a high cell density within the individual well rather than an effect of 
collagen coating. Human MSCs have been shown to take on a round morphology at 
higher cell densities even when seeded on soft substrates leading to the belief that 
cell morphology is governed not only by cell-matrix interactions but also cell-cell 
interactions (Venugopal et al., 2018). Pseudo 3D models produced by collagen 
coating have also been found to induce apical-basal polarity, which does not 
naturally occur in all cell types and therefore may change cell spreading and 
migration which may be another reason why HESC cells exhibited changes in 
morphology (Duval et al., 2017).  
 
Chondrocytes undergo dedifferentiation during in vitro expansion exhibiting 
fibroblast morphology and altering collagen expression from type II to type I (Lee et 
al., 2017). The differentiation potential of these cells is lost with the increasing 
number of passages, which is needed in order to obtain the high cell number needed 
for cartilage repair strategies (Mark et al., 1977). R. esculentum collagen was been 
used to coat plates and assess the phenotypic stability of chondrocytes. Porcine 
chondrocytes were found to maintain the characteristic ovoid morphology showing 
that jellyfish derived collagen behaved in a similar fashion to vertebrate collagen 
type II in the stability of cell morphology (Sewing et al., 2017). Van den Dolder and 
Jansen worked on the culture of rat bone marrow derived cells on collagen-coated 
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titanium meshes and found that cells decreased proliferation and stimulated 
osteoblastic differentiation compared to uncoated titantium mesh (Dolder and Jansen, 
2006). Other studies have demonstrated that collagen-coated microcarriers enhance 
cell attachment and can maintain long term expansion of embryonic stem cells 
(McKee and Chaudhry, 2017a). 
 
Culture of cells in 2D for in vitro expansion and analysis can often alter the function 
of cells. Primary human hepatocytes have been shown to lose hepatic function hours 
after 2D culture in vitro (Bell et al., 2018), embryonic stem cells (ESCs) have 
exhibited altered shape and gene expression (McKee and Chaudhry, 2017b) and 
pluripotent stem cells grown in collagen-coated culture flasks cause undesired 
gradients in media components, gas and waste (Kropp et al., 2017). Culture of cells 
on collagen coating may be improved by the addition of other ECM proteins to 
enhance biological complexity and better mimic the native 3D environment however 
this was beyond the scope of the project (Grun et al., 2009).  
 
JCol in vitro immunogenicity 
 
The immune response is a sophisticated biological reaction to foreign bodies 
(Andorko and Jewell, 2017). Divided into two phases, innate immunity is a rapid 
response involving leucocytes and cytokines whilst adaptive immunity requires T 
and B lymphocytes that can take days or weeks to develop (Parkin and Cohen, 2001). 
Biomaterials used for scaffold fabrication must not only have an architecture and 
mechanical integrity conducive for cell growth and differentiation but also avoid the 
elicitation of an immune response (Brown and Badylak, 2014). The failure of a 
scaffold to integrate into native tissue due to an adverse immune response can cause 
inflammation, infection and potentially necrosis of the tissue (Velnar et al., 2016).  
 
Animal models are routinely used in the development of constructs for tissue 
engineering; both in primary experiments and stages before clinical application 
(Zorlutuna et al., 2013). Immunogenicity testing is typically carried out using mice 
however these animals are too small to properly evaluate the tissue that is formed so 
larger animals such as rabbits should instead be used for analysis of regenerated 
tissue formation (Ikada, 2006). The use of animal models does however raise ethical 
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issues with researchers having to justify the use of animals by the purpose of the 
research having a clear significance to increasing scientific knowledge (Ghasemi and 
Dehpour, 2009). Immunogenicity can be evaluated through in vitro examinations to 
give preliminary results to support how a biological system may respond to a 
scaffold structure, which in turn, would give some justification towards moving to a 
more expensive, ethically challenging animal model (Hartung and Daston, 2009). 
 
When designing an in vitro immunogenicity model, it is important to follow the 
guidelines stated by the International Organisation of Standardisation for biological 
evaluation of medical devices (Musson et al., 2013). The protocol outlines clear 
guidance for in vitro tests, which requires direct contact of cells to the material 
followed by quantitative or qualitative analysis of cell viability. This allows 
researchers to have a large degree of freedom when designing their experiments in 
terms of the chosen cell types and additional analysis (Scheideler et al., 2013). Most 
in vitro models consider varying aspects of both innate and adaptive immune systems 
using flow cytometry, from activation of immune cells to the concentration of 
cytokines released following exposure to the biomaterial of interest (Musson et al., 
2013). 
 
Radley and colleagues investigated the immunogenic potential of biomaterials as 
ventricular assist devices. Using FACS analysis and ELISAs and whole blood 
samples to assess cell death, activation of immune cells and cytokine release (Radley 
et al., 2017). The use of whole blood for immunogenicity testing is believed to be 
indicative of in vivo immune response as these assays aim to replicate the response 
involving immune cells such as neutrophils, monocytes and T-cells (Joubert et al., 
2016). 
 
The native mammalian response to tissue injury is well documented and can be 
categorised into different phases, outlined in Figure 4.31 (Brown and Badylak, 
2014). Following tissue injury or insult, platelets are activated and form a provisional 
fibrin clot that signals for further cell migration (Broughton et al., 2006). Neutrophils 
are recruited to the site of inflammation and phagocytose any foreign material as 
well as signalling for the recruitment of macrophages, which are pro-inflammatory in 
their phenotype, secreting cytokines for further leukocyte recruitment (Barrientos et 
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al., 2008). The secretion of cytokines subsequently initiates a proliferative phase at 
the injury site that exhibits the production and deposition of new ECM forming 
granulation tissue (Brown and Badylak, 2014). The final stage of the healing process 
is remodelling where MMPs degrade and remodel the tissue leading to either scar 





Figure 4.31: Schematic of established phases in wound healing. Initial 
inflammation decreases over time as regeneration of tissue occurs (Corradetti et al., 
2017) 
 
Blood is usually the first biological fluid to come into contact with tissue-engineered 
devices (Jones, 2008). The blood-material interface triggers a number of reactions 
including protein adsorption to the construct and platelet activation that may lead to 
coagulation and thrombosis (Andorko and Jewell, 2017). Collagen is seen as an 
important protein involved in the early stages of platelet activation during thrombosis 
(Morishige et al., 2011). Data from this chapter shows that platelet activation occurs 
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in whole blood samples incubated with JCol scaffolds, however it was not as 
prominent as platelets stimulated with PMA. Comparable platelet activation occurred 
in all scaffolds tested, with comparable results between JCol and mammalian 
collagen sponge scaffolds. 
 
Collagen is thought to be a suitable biomaterial for tissue engineering applications as 
it has previously been shown to exhibit low levels of immunogenicity (Lynn et al., 
2004). Biomaterials composed of collagen and/or other native ECM components 
have been successful in the regeneration of functional tissues in both preclinical and 
clinical stages (Dziki et al., 2017). Intact, collagen triple helical structures are 
thought to contain telopeptide regions (Exposito et al., 2010). The R.pulmo 
extraction process described in Chapter 3, without pepsin digest, is thought to result 
in maintenance of the telopeptide region (Schmidt et al., 2015).  Epitopes present at 
telopeptide region of tropocollagen molecules have been shown to be responsible for 
the initiation of an immune response, both in vivo and in vitro (Lynn et al., 2004). 
The conformation of the triple helix therefore, as well as the subsequent 
fibrillogenesis, may influence the immunogenic potential of collagen, possibly 
through controlling the accessibility of antigenic determinants (Parenteau-Bareil et 
al., 2010).  
 
Jellyfish-derived collagen has previously been tested for its immunogenic properties 
and in vivo data has shown responses comparable to bovine collagen and gelatin 
(Song et al., 2006). However, jellyfish-derived collagen that maintained telopeptides 
displayed enhanced production of immune markers including IgM and IgG in human 
peripheral blood lymphocytes and cytokines release. This data indicates that 
structural composition of collagen plays a role in the immunogenic properties of the 
biomaterial (Nishimoto et al., 2008).  
Data obtain in this experiment demonstrates that activation of neutrophils and 
monocytes occurs in blood incubated with scaffold structures however response from 
JCol scaffolds are comparable with that elicited from commercial and research grade 
BCol scaffolds and RTCol scaffolds, respectively. Within 24-48 hours of scaffold 
implantation, neutrophils begin to infiltrate the construct and undertake various roles 
in the innate immune response (Anderson et al., 2008). Typically, these cells are 
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tasked with clearing pathogens via phagocytosis and recruiting other immune cell 
types to the site of injury (Cravedi et al., 2017). As well as clearing the implant of 
any pathogens, neutrophils are also responsible for beginning the degradation of 
biomaterial implants via MMPs and proteinase 3 and releasing cytokines to modulate 
the continuation of the immune response (Soehnlein, 2012).  
Monocytes also play a role in the initiation of the inflammatory response through 
phagocytosis of pathogens and the release of inflammatory cytokines (Parihar et al., 
2010). Stimulation of monocytes can cause differentiation into macrophages that 
continue the progression the immune response (Jakubzick et al., 2017).  The 
excessive accumulation of monocytes has been associated with the aggravation of 
diseases such as multiple sclerosis and arthritis (Linker et al., 2009).  
 
IL-6 is a pleiotropic pro-inflammatory cytokine primarily produced by monocytes 
and macrophages but can also be secreted by neutrophils, T and B cells (Horii et al., 
1988). IL-6 has multiple functions including the differentiation of myeloid cells, 
activation of natural killer cells and affecting the adaptive immune response by 
stimulating the differentiation of T-cells (Striz et al., 2014). The IL-6 cytokine data 
shown here, indicates that scaffolds produced by jellyfish collagen cause a 
significant increase in IL-6 production compared to baseline blood however it should 
be noted that levels of IL-6 production are similar to those produced by bovine 
collagen, currently commercially available, and therefore we believe the response 
caused by JCol could be overcome in vivo. With regards to the final application of 
jellyfish collagen scaffolds in cartilage tissue engineering, interestingly, anti-IL-6 
antibodies have been shown to inhibit damage to joints and improve joint function in 
patients suffering with rheumatoid arthritis (Buckland, 2013). The results obtained 
from this study indicate that the levels of IL-6 should not be disruptive to tissues 
within the native joint therefore causing no increase in damage via IL-6 signalling 
pathway.  
 
J774.1 cells, a mouse macrophage-like cell line, have previously been used in 
conjunction with collagenase treated Nemopilema nomurai jellyfish collagen to show 
enhanced immunostimulatory properties, particularly in the production of IL-6 (Putra 
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et al., 2014). This, once again, suggests that the conformation of collagen molecules 
is important in the immunogenicity of the material.  
 
The adaptive immune response is stimulated by the innate phase, which causes the 
proliferation and differentiation of T- and B-cells (Pennock et al., 2013). The 
primary role of T-cells is the destruction of infected cells however they are also able 
to recognise peptide fragments on antigen presenting cells such as macrophages and  
dendritic cells (Chaplin, 2010). T-cells are able to discriminate between self and non-
self via MHC molecules (Bjorkman, 1997). The T-cell activation data from in vitro 
tests in this project show that T-cell activation levels were similar to baseline blood 
when whole blood was incubated with scaffolds from BCol, RTCol, BGel and JCol.  
 
IL-10 is an anti-inflammatory cytokine that was originally associated with T-cells 
however recent research has discovered that IL-10 secretion can occur in a number 
of immune cells including monocytes/macrophages (Magombedze et al., 2015). The 
IL-10 data collected from our study is most likely to occur from secretion of 
monocytes as the time frame suggests that the adaptive immunity would not have 
taken effect. IL-10 has been shown to inhibit the differentiation of monocytes to 
dendritic cells and repress expression of inflammatory cytokines such as IL-1 and IL-
6 (Mosser and Zhang, 2009). Results of IL-10 data from this work show that it is 
expressed at much lower concentration (~0 – 60,000pg/ml) compared to IL-6 (~0 – 
350,000pg/ml). The relative expression levels of cytokines may be due to the time 
frame in which the immune response occurs. Initial IL-6 expression is likely to 
occur, as inflammation is one of the key events that primarily occur in the immune 
response cascade. The lower expression of IL-10 may be contributed to the fact that 
inflammation has not been sustained over a long time period, becoming chronic, and 
therefore the need for an increased anti-inflammatory response is not yet required. 
More specifically, our IL-10 data showed that JCol scaffolds increased IL-10 
production compared to baseline blood in LPS stimulated samples indicating that 
jellyfish collagen may have an additive effect upon immune response with LPS, 
however IL-10 production was comparable to that of commercial bovine collagen.  
 
It is important to note that materials can be modified to enhance the 
immuosuppresive capabilities (Andorko and Jewell, 2017). Synthetic materials are 
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often seen to elicit immune response upon implantation however this has been 
rectified through coating with native ECM material (Dziki et al., 2017). Studies have 
shown that polypropylene meshes coated with porcine dermal hydrogels reduced 
macrophage recruitment and formed loose connective tissue following ECM 
degradation (Wolf et al., 2014). ECM hydrogel coating of polypropylene fibres also 
decreased the amount of collagen deposition around the site of implantation leading 
to better integration of implant and native tissue (Faulk et al., 2014).  
 
The augmentation of biomaterial-based scaffold, using cytokines in the immune 
cascade, can also be considered to potentially enhance the regenerative capacity of 
the construct. IL-4 is regarded as a pro-remodelling cytokine and meshes coated with 
IL-4 have exhibited a reduction in the formation of a fibrotic capsule, allowing for a 
better tissue-implant interface (Hachim et al., 2017). Preliminary in vitro 
immunogenicity results from this study seem to suggest that jellyfish collagen has a 
similar immunogenic effect on cells as bovine collagen, indicating that 
immunomodulation of the material is currently unnecessary. However, 
immunomodulation may be of interest following potential in vivo testing of jellyfish 
collagen scaffolds for cartilage tissue engineering, to enhance regeneration, as a 
shortened rehabilitation period is ideal for cartilage repair (Dunkin and Lattermann, 
2013).    
 
Notably, MSCs have been shown to modulate the immune response upon 
implantation into biological systems (Fahy et al., 2015). In vitro studies of MSCs 
have shown their capability of supressing T-cell proliferation, regardless of the donor 
source leading to the belief that MSCs would be capable of dampening of evading 
the adaptive immune response (Abdi et al., 2008). Promisingly, in vivo clinical trials 
using MSC based cell therapy have displayed accelerated recovery of patients 
suffering with severe cases of graft versus host disease, however a limited number of 
studies have followed up on these results (Blanc et al., 2004). Nevertheless, it is 
important to understand that multiple components of the tissue engineering triad can 
affect the biocompatibility and immunogenicity of the final engineered tissue 
(O'Brien, 2011). 
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In conclusion, this chapter shows that multiple cell types remain viable and maintain 
their proliferation rate when grown on jellyfish collagen coated plates, with cells 
cultured in this way also exhibiting phenotypic stability. Preliminary data was 
obtained by in vitro testing of immunogenicity, using human whole blood samples, 
showing clearly that JCol scaffolds have comparable platelet and leukocyte 
activation compared to RTCol and BCol scaffolds, considered research and 
commercial grade materials, respectively. Cytokine release profiles for pro-
inflammatory IL-6 and anti-inflammatory IL-10 also showed comparable results 
across scaffold structures. These results show that R. pulmo derived jellyfish 
collagen scaffolds can be moulded into a stable structure that shows little in vitro 





























Once seen as a disease brought on by ‘wear and tear’ recent research has shown that 
OA is a multifactorial disease, taking into account factors such as genetics, ethnicity 
and physical activity (Musumeci et al., 2015). OA is an age-related disease resulting 
in pain, loss of joint mobility and disability, with its prevalence expected to rise as 
life expectancy increases, especially in the western world (Blalock et al., 2015). 
Affecting the entire synovial joint OA is characterised by the loss of articular 
cartilage (Amoako and Pujalte, 2014).  
 
Combinations of abnormal mechanical loading and synovial inflammation are known 
to cause deregulation in chondrocytes that populate articular cartilage, causing a shift 
in the equilibrium of anabolic and catabolic processes in ECM remodelling 
(Goldring and Goldring, 2007). This shift, leading to cartilage tissue breakdown due 
to defective homeostasis results in a loss of tissue function. In addition, 
chondrocytes, the principal cellular components begin to undergo phenotypic change 
such as hypertrophy and osteophyte formation occurs (Goldring and Goldring, 2007). 
In cases where chondrocytes undergo epiphyseal differentiation, they begin to 
express collagen type X, symptomatic of calcified tissue formation, leading to 
vascular invasion and loss of resistance against compression (Saito and Kawaguchi, 
2010).  
 
As cartilage has a limited capacity for self repair most partial and full thickness 
lesions require surgery. The choice of surgery is dependent on the type of lesion and 
surgical preference (García-Carvajal et al., 2013). As chondrocytes are characterised 
by their inability to migrate through matrix, early surgical approaches include 
microfracture and autologous chondrocyte implantation (ACI) (Windt et al., 2013), 
where the aim is to bring an exogenous source of cells to fill defects, either beneath 
the subchondral bone plate or autologous cells from joint cartilage. A two-step 
procedure, ACI requires the harvesting of the patients chondrocytes from a non 
weight-bearing portion of cartilage. Cells are then expanded for four weeks before 
being implanted into the defect and covered with a periosteal flap (McCarthy et al., 
2016). Chondrocytes obtained in this manner can however lead to donor site 
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morbidity, while chondrocytes cultured in monolayer have been known to de-
differentiate into a fibroblastic phenotype (Vinod et al., 2017). 
 
5.1.1 Matrix assisted environment 
 
Articular cartilage is avascular and contains a high extracellular matrix to cell ratio 
(Fox et al., 2009). The ECM, consisting of collagen and proteoglycans, provides an 
environment within tissues that supports cellular differentiation and function; 
impacting upon cellular behaviour by regulating processes such as gene expression, 
homeostasis and regeneration (Liu et al., 2017). It is accepted that the ECM provides 
particular cellular cues, sets physical boundaries for developing tissues and plays a 
particularly important role in the differentiation and maturation of multiple cell types 
during development. Interaction between cells and matrix can either occur through 
direct contact or through the matrix bound morphogens and growth factors 
(Behonick and Werb, 2003).  
 
Matrix-assisted autologous chondrocyte implantation (MACI) is a regenerative 
medicine technique that is similar to ACI, with the addition of a matrix scaffold, to 
support guided tissue formation (Jacobi et al., 2011). Autologous chondrocytes are 
harvested and expanded to an appropriate number before being seeded into a 
biocompatible, biodegradable and mechanically suitable 3-dimensional (3D) scaffold 
structure (O'Brien, 2011). After four weeks of supported 3D cell culture, the scaffold 
is cut to size and implanted into the defect (Nixon et al., 2015).  
 
By providing a more physiological growth environment, the use of a 3-dimensional 
matrix is believed to minimise the chance of cell de-differentiation and increase the 
chondrogenic potential of the implant (Niethammer et al., 2016). A number of 
collagen-based scaffolds are currently commercially available for MACI procedures 
including MACI, Novocart3D and CaRes. MACI is a type I/III collagen membrane 
whilst Novocart 3D is a chondroitin sulphate containing biphasic sponge, both of 
which are seeded with autologous cells and cultured before implantation. On the 
other hand, CaReS is a type I collagen gel where cells can be immediately mixed 
following harvesting and implanted after two weeks of culture (Chicatun et al., 
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2017). Five year follow up studies following patients that have received MACI 
surgery for cartilage defects in the knee reported satisfactory and improved pain and 
movement from 58% to 98% of patients (Basad et al., 2014). 
 
With MACI proving a successful surgical option, a myriad of materials have been 
tested for their cartilage producing properties in search for clinically relevant 
biomaterials (Jacobi et al., 2011). Synthetic polymers such as polylactic acid, agarose 
and alginate based hydrogels and protein based matrices fabricated from collagen 
and gelatin have all been tested for their capability for inducing chondrogenic 
differentiation to form cartilage, following seeding with cell sources and short-
medium term culture (Armiento et al., 2018). In vitro studies have routinely used 
pellet culture (matrix-free) as a control 3D model for the induction of chondrogenesis 
in MSCs (Watts et al., 2013). In this chapter, R.pulmo derived collagen is fabricated 
into a scaffold matrix and tested for its suitability in supporting chondroprogenitor 




Chondrogenesis is a dynamic process that occurs during the development of 
vertebrates where cells undergo a specific differentiation process to form cartilage. 
Hyaline cartilage, composed of clusters of chondrocytes, originates from condensed 
mesenchymal tissues and is the precursor for endochondral bone development 
(Zuscik et al., 2008). The various stages of the process, including joint patterning, 
interzone formation, cavitation and morphogenesis are dependent upon a myriad of 
growth factors (Handorf et al., 2015).  
 
When considering chondrogenic differentiation of stem cells, a critical component is 
the transforming growth factor beta (TGFβ) family, which was once described as 
cartilage-inducing factor (Yu et al., 2012). The TGFβ superfamily contains a number 
of TGFβ isoforms as well as bone morphogenetic proteins (BMPs). The isoforms 
bind to ligands that activate type 1 (BMP) and 5 (TGFβ) activin-like kinase receptors 
(ALKs), which in turn phosphorylate SMAD proteins that translocate to the nucleus 
and modulate cell-specific gene expression, outlined in Figure 5.1 (Kroon et al., 
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2015). Previous developmental studies have shown a high level of TGFβ2 and 
TGFβ3 to be present in articular cartilage, whilst expressing a much lower level of 
TGFβ1. However in vitro experiments have shown that immature cartilage explants 




Figure 5.1: Schematic representation of signalling crosstalk for chondrocyte 
differentiation (Mariani et al., 2014) 
 
The use of TGFβ1 as a growth factor to promote chondrogenesis may be ideal as it 
prevents terminal differentiation and formation of hypertrophic cells along with the 
over-expression of collagen X, associated with the formation of calcified cartilage 
(Wang et al., 2014). Pellet cultures treated with TGFβ1 have shown to be larger and 
contain greater amounts of collagen type II as well as DNA content than their 
counterparts lacking the growth factors; further strengthening the argument that 
TGFβ1 is a suitable growth factor for cartilage regeneration (Goldberg et al., 2005). 
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5.1.3 Different matrix types 
 
A number of mammalian collagen-based materials are commercially available and 
used for MACI cartilage repair, however, research efforts are still focussed into 
finding suitable, sustainable sources of collagen that will aid in enhanced 
chondrogenesis (Jeuken et al., 2016). Previous studies have utilised jellyfish collagen 
from the jellyfish species Rhopilema esculentum as a scaffold material for cartilage 
repair. Both bodies of work produced a 3-D matrix that required crosslinking to 
maintain stability before seeding their preferred cell types; human bone marrow 
derived mesenchymal stem cells for cartilage repair. Culture of human MSCs on R. 
esculentum collagen scaffolds with chondrogenic media lead viable cells throughout 
the scaffold and an increase in chondrogenic markers such as COL2, ACAN and 
SOX9 (Hoyer et al., 2014).  
 
5.1.4 Cell source 
 
Within the clinical setting, chondrocytes are used routinely for cartilage restoration 
with both ACI and MACI using autologous chondrocytes to repair damaged tissue, 
correlating with better pain management and increased range of motion within the 
joint (Munirah et al., 2010). Using chondrocytes however, can be problematic due to 
their low proliferative capacity, leading to larger portions of cartilage being taken 
from healthy areas, increasing the chance of donor site morbidity. In addition, 
chondrocytes tend to dedifferentiate and produce collagen type I, characteristic of 
mechanically inferior fibrocartilage that is unsuitable for functional joint repair 
(Phull et al., 2016).  
 
Cartilage tissue maintains a population of progenitor cells at the articular surface 
which are thought to be involved in appositional growth and are capable of 
chondrogenic differentiation (Marcus et al., 2014). The advanatges of such a 
progenitor population are two-fold; as a result of maintained niche-specific 
expression repertoire they maintain the ability to undergo chondrocyte differentiation 
and drive enhanced chondrogenesis and they are also compatible with culture 
expansion in large numbers (Jayasuriya and Chen, 2015b). In ovo studies involving 
Chapter 5                                                                                     Enhanced Chondrogenesis 
 
 207 
bovine-derived chondroprogenitor cells have previously been engrafted into the wing 
bud of a juvenile chick and found to produce tissue specific matrix, further 
highlighting the plasticity of chondroprogenitor cells and their ability to form 




The hypothesis for this chapter states that R. pulmo derived collagen scaffolds 
support bovine chondroprogenitors to undergo chondrogenesis (with TGFβ1 
treatment) and will enhance cartilage production when compared to a non-matrix 
assisted (pellet) culture, under the same conditions. 
 
5.1.5.1 Aims and objectives 
 
The aims and objectives to test this hypothesis are as follows; 
 
 Isolate chondroprogenitor cells from immature bovine cartilage and 
characterise these cells for plasticity by undergoing chondrogenesis, 
osteogenesis and adipogenesis in a 2D environment 
 Undertake 21 day induction of chondrogenesis of cells with and without 
TGFβ1 in collagen scaffolds and pellet culture 
 Assess structural properties of pellet and scaffold culture compared to native 
bovine cartilage using SEM 
 Characterise ECM composition of scaffold and pellet culture compared to 
native bovine cartilage through analysis of hydroxyproline content, sulphated 
GAG content and collagen deposition via biochemical assays and histological 
staining 
 Assess cartilage specific-gene expression of scaffold and pellet cultured 









Tissue engineering is a multidisciplinary field that requires a supporting structure 
with a 3D architecture, an appropriate cell source and media constituents to affect a 
functional differentiation to support new tissue formation (O'Brien, 2011). Collagen 
scaffold fabrication must take into account the porosity to enable cell invasion, 
nutrient diffusion and, in the case of this application, chondrogenesis. Stem cells 
have gained favour as a suitable cell source in regenerative medicine due to their 
plasticity, availability and lack of donor morbidity (Makris et al., 2015). The TGFβ 
family are known to have an extensive role in skeletal and cartilage formation, with 
TGFβ1 expression found at proliferative and upper hypertrophic zones whilst the 
tissue undergoes endochondral ossification (Grimaud et al., 2002).  
 
5.2.1 Bovine chondroprogenitor isolation and culture 
 
Chondroprogenitor cells isolated from articular cartilage have been show to have tri-
lineage capability in vito and in ovo (Dowthwaite et al., 2004). The use of progenitor 
cells for cartilage regeneration is thought to circumvent issues that arise from using 
fully differentiated chondrocytes such as dedifferentiation and limited cell expansion 
in vitro (Marcus et al., 2014). Furthermore, the presence of growth factors and ECM 
molecules such as TGFβ and matrilin-3, have been shown to promote 
chondrogenesis in chondroprogenitor cells, with matrilin-3 also showing inhibition 
of hypertrophy, a common issue in cartilage regeneration (Jayasuriya and Chen, 
2015a).  
 
Due to an abundant supply and less stringent ethical implications bovine cartilage 
was chosen as the tissue source (Reinholz et al., 2004). The animal tissue used in this 
study was obtained from healthy animals entering the food chain, classified as food 
grade material that is discarded during food processing.  
 





Figure 5.2: Bovine metacarpophalangeal joint. MCP joint obtained from 
immature bovine legs. Annotated areas of the joint depict regions from which 
cartilage was taken for chondroprogenitor isolation.  
 
Following harvesting, the immature bovine legs were washed and decontaminated 
prior to MCP joints being opened to access the cartilage. Sections of cartilage were 
obtained from the medial and lateral condyle as well as the condylar ridge for 
digestion and isolation of chondroprogenitor cells as well as for histological staining 
and biochemical analysis, as depicted in Figure 5.2.  
 
5.2.1.1 CP isolation and tri-lineage potential  
 
Chondroprogenitors have a capacity to self-renew in vivo, in order to maintain a 
resident progenitor population to facilitate growth and repair. This capability to self-
renew enables chondroprogenitors to form colonies in 2D culture, where each 
individual colony is formed through repeated replication of an original cell 
(Jayasuriya & Chen 2015). Colonies comprised of over 32 cells, representing colony-
forming cells, were isolated from each other and expanded in basal culture media as 
monoclonal populations and prepared for tri-lineage assessment.  
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Stem cells possess the ability of multi-lineage differentiation (Ullah et al., 2015). The 
minimum criteria for classification of MSCs is outlined by the International Society 
of Cellular Therapy and includes display of specific cell surface markers, plastic 
adherence and the ability to differentiate into adipocytes, chondrocytes and 
osetoblasts in vitro (Dominici et al., 2006). Figure 5.3 shows images of 




Figure 5.0.3: Images of chondroprogenitor cells during trilineage differentiation 
and stained cells after 21 days of culture. Chondroprogenitor cells were imaged at 
day 0 and 21 of chondrogenic, osteogenic and adipogenic culture. At day 21 cells 
were fixed and stained with Alcian Blue, Alizarin Red and Oil Red O to confirm 
differentiation into chondrogenic, osteogenic and adipogenic lineages, respectively. 
Scale bars show 0.1mm.  
 
Figure 5.3 shows images of chondroprogenitor cells during tri-lineage 
differentiation. During chondrogenesis cells are plastic adherent and have a primarily 
fibroblastic morphology at day 0. By day 10 of chondrogenic culture, cells 
proliferate and maintain close contact with some cells losing their fibroblastic shape 
and becoming more rounded. At day 21, many cells can be seen to maintain a 
circular morphology, continue to maintain close contact to each other and clusters of 
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cells are visibly stained with alcian blue confirming the production of extracellular 
matrix associated with chondrogenesis. Cells undergoing osteogenesis kept a 
fibroblastic morphology as well as being plastic adherent at day 0. Similar to 
chondrogenesis, cells underwent proliferation by day 10 and 21 and formed clusters 
where cells began to take on more circular morphology. When stained with alizarin 
red after 21 days of osteogenic differentiation to identify calcification, areas of cell 
cultures stained positively. When cells were subjected to adipogenic culture, at day 0 
they maintained a fibroblastic morphology as well as being plastic adherent in the 
same fashion as cells undergoing chondrogenic and osteogenic culture. At day 10, 
unlike the other lineages, cells did not appear to proliferate at the same rate and 
morphological changes were more prominent, changing from fibroblastic to 
triangular and by day 21 cells did not appear to undergo proliferation and kept a 
triangular shape. After fixation cells were stained with Oil Red O and vacuoles 
within cells were stained red indicating the presence of fatty acid deposits.  
 
5.2.2 3D enhanced chondrogenesis  
 
In order to facilitate the production of cartilage for regenerative medicine cells must 
undergo chondrogenic differentiation. The use of TGFβ1 is well documented as a 
growth factor to induce chondrogenesis and is used in vitro due to the role of the 
TGFβ superfamily in chondrogensis during development (Wang et al., 2014). 
Chondrogenic differentiation has previously been proven to be enhanced in a 3D 
culture environment when compared to 2D culture (Watts et al., 2013). The signature 
for in vitro enhanced chondrogenesis includes the production of collagen type II, 
aggrecan and SOX9 following 21 days of culture (Khan et al., 2009). Analysis of 
these characteristics can be accomplished in various ways including histological and 
biochemical examination as well as qPCR to quantify gene expression.  
 
In this chapter, the assessment of enhanced chondrogenesis was carried out following 
isolation of bovine CPs, cell seeding into scaffold or pellet and 21 days of culture in 
chondrogenic media in the presence and absence of TGFβ1, outlined in Figure 5.4. 





Figure 5.4: Approach for enhanced chondrogenesis. CPs isolated from bovine 
MCP joints were characterised and allowed to culture for 21 days in pellet or 
scaffold culture in the presence or absence of TGFβ. Following completion of the 
culture period, constructs were analysed using biochemical analysis, histology and 
qPCR to give an enhanced chondrogenic profile.  
 
5.2.2.1 Scaffold characteristics for 3D culture 
 
Cellular function and tissue regeneration is closely related to pore size and so the 
fabrication of scaffolds with desirable pore size is fundamental step in tissue 
engineering (Zhang et al., 2014b). As shown in section 3.2.5.1.1 sponge scaffolds 
produced by JCol are highly porous and interconnected structures.  EDC is a well 
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characterised chemical crosslinking reagent that forms a network of crosslinks within 
collagen scaffolds and increases mechanical stability of the construct (Ma et al., 
2014). Scaffolds fabricated 1% EDC crosslinker concentration were chosen for 
chondrogenesis in agreement with work previously conducted by Hoyer and 
colleagues (Hoyer et al., 2014). 
 
In order to determine which EDC crosslinking concentration would be appropriate 
for 3D chondrogenesis studies, scaffolds crosslinked with 1%, 0.5% and 0.25% EDC 
were seeded with bovine CPs and cultured for 7 days. Scaffolds were then fixed, 
embedded in paraffin wax and stained with haematoxylin before being imaged with a 
light microscope, shown in Figure 5.5. 
 
 
Figure 5.5: Early seeding studies using scaffolds with decreasing EDC crosslink 
concentrations. Bovine CPs seeded into scaffolds crosslined at 1%, 0.5% and 0.25% 
EDC and cultured for 7 days in chondrogenic media. Scaffolds were stained with 
haemotoxylin and eosin and imaged at x10 (A, B and C) and x40 (D, E and F). Scale 
bars show 0.1mm.  
 
Figure 5.5 (A) is a low magnification (x10) image of a scaffold seeded with bovine 
CPs and stained with haematoxylin following 7 days of culture. The porous structure 
of the scaffold is maintained. When imaged at a higher magnification (Figure 5.5 
(D)) circular cells are seen in close proximity to ribbons of collagen. Scaffolds 
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crosslinked with 0.5% EDC and imaged at low magnification are seen in Figure 5.5 
(B). The porous structure of the scaffold was maintained however areas of the 
scaffold appeared to have contracted. At higher magnification, Figure 5.5 (E), 
circular cells stained with haematoxylin were present and attached or near to 
collagen ribbons in the same fashion as cells seen in scaffolds crosslinked at 1% 
EDC. Figure 5.5 (C) shows scaffolds crosslinked at 0.25% and stained with 
haematoxylin. At this concentration the scaffold exhibited the most contraction 
during the 7-day culture period altering the pore size within the scaffold. At x40 
magnification, Figure 5.5 (F), a higher amount of cells can be seen compared to 1% 
and 0.5% crosslinked scaffolds they had a circular morphology and are attached to 
collagen ribbons in a similar manner to the other scaffolds.  
 
Following preliminary results, it was decided that scaffolds crosslinked with 1% 
EDC would be taken forward for chondrogenesis studies as cells were found to 
invade the structure and minimal contraction of the scaffold occurring during culture. 
 
JCol scaffolds were fabricated to a sponge support and crosslinked using 1% EDC. 
This resulted in a freeze-dried product with an average porosity of 54.76um ±4.72 





Figure 5.6: Average pore size and pore structure of JCol scaffolds. Average pore 
size of JCol scaffolds (A) and pore structure imaged at x200 magnification using 
SEM (B) crosslinked at 1% EDC concentration. 
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5.2.3 Cellular invasion and proliferation 
 
Related to pore size, the permeability of a scaffold allows for cellular invasion and 
distribution as well as allowing for the diffusion of nutrients and waste, as well as the 
formation of essential cell-cell contact (Ashworth et al., 2016). Bovine CP cultures 
were seeded onto the scaffolds and assessed for their invasion and proliferation 
capacity. Haematoxylin and eosin (H&E) staining is a standard stain used for 
histological examination of tissues allowing for the identification of tissue 
morphology and distribution (Chan, 2014).  
 
5.2.3.1 Native bovine punch biopsy baseline 
 
As a benchmark for enhanced chondrogenesis in vitro immature bovine MCP 
derived hyaline articular cartilage was stained using H&E. Immature joint punch 
biopsies (6mm) were washed in PBS, fixed in 10% NBF and wax embedded before 
being sectioned (7um) and stained with H&E. Sections were then imaged using a 




Figure 5.7: Hemotoxylin and eosin staining of immature bovine cartilage. Native 
immature bovine cartilage was stained using hematoxylin and eosin and imaged at 
low magnification (x4) (A) with superficial (S), middle (M) and deep (D) zones 
labelled. High magnification images (x40) were taken of the superficial (B), middle 
(C) and deep (D) zones. Scale bars are equal to 0.1mm. 
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Figure 5.7 (A) shows the full depth of a section of native immature bovine cartilage 
obtained from the MCP joint and imaged at low magnification (x4). The depth of the 
cartilage is approximately 0.9mm at the thickest section and the width of the section 
of tissue is approximately 5.1mm and stained pink throughout. Figure 5.7 (B) shows 
the superficial zone of the cartilage at high magnification (x40). Cellular content is 
easily identified in this region, appearing as a dark pink colour, exhibiting a more 
flattened and discoid morphology. Superficial zone cells seem to maintain a closer 
proximity to each other with visible pink background staining of the tissue. The 
middle zone of the cartilage, seen in Figure 5.7 (C), also displays prominently pink 
stained cells that have a more circular morphology compared to those in the 
superficial zone. This zone exhibits numerous cells that are further spaced apart 
compared to the superficial zone, while there is no visible staining of the tissue. 
Figure 5.7 (D) is a high magnification image of the deep zone of cartilage tissue. 
Cells again in pink, maintain a circular morphology and are sparse in appearance 
when compared to the other zones. Staining of the tissue is also consistently visible 
in the deep zone. 
  
5.2.3.2 Scaffold assisted CP invasion 
 
Culture-medium equilibrated scaffolds were seeded with 0.5x106 immature 
chondroprogenitor cells and cultured in 24 well plates for 21 days (Corradetti et al., 
2016). In order to assess cell distribution throughout scaffold and pellet cultures 
following 21 days of chondrogenesis, constructs were fixed, embedded and sectioned 
before staining with H&E. Sections were assessed using light microscopy and 
imaged at low and high magnification. 
 





Figure 5.8: Hematoxyline and eosin staining of JCol scaffolds after 21 days of 
chondrogenic culture supplemented with TGFβ1. JCol scaffolds (in the saggital 
plane) were stained using hematoxylin and eosin and imaged at low magnification 
(x4) after 21 days of culture using chondrogenic media containing TGFβ1 with 
superficial (S), middle (M) and deep (D) zones labelled. High magnification images 
(x40) were taken of the areas representing the superficial (B), middle (C) and deep 
(D) zones. Scale bars are equal to 0.1mm. 
 
Figure 5.8 (A) shows a JCol scaffold in the saggital plane stained with hematoxylin 
and eosin and imaged at low magnification (x4) following CP seeding 21 days of 
chondrogenic culture with TGFβ1. The length of the scaffold is approximately 
4.5mm from superficial to deep zone. The width of the scaffold differed at different 
points, with an approximate width of 2.4mm at 1mm depth into the scaffold and 
1.43mm at 3.2mm depth. A network of collagen can be seen stained in pink at this 
magnification with a more intense staining seen around some of the edges of the 
scaffold.  
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A high magnification image of the area thought to represent the superficial zone, 
seen in Figure 5.8 (B), shows intense pink staining of the tissue. Some cells can be 
seen stained pink and are circular in morphology unlike those found in native 
cartilage that appear more disc-like in shape. The area believed to represent the 
middle zone, depicted in Figure 5.8 (C), shows collagen ribbons stained red with 
areas nearby stained a less intense pink colour. The cells in this area are circular in 
shape and maintain close contact. Figure 5.8 (D) shows a high magnification image 
of the area believed to be the deep zone. In a similar fashion to the middle zone, 
collagen ribbons are stained red with nearby areas stained less intensely. No cells are 




















Figure 5.9: Hematoxylin and eosin staining of JCol scaffold after 21 days of 
chondrogenic culture without TGFβ1. JCol scaffolds in the saggital plane were 
stained using hematoxylin and eosin and imaged at low magnification (x4) after 21 
days of culture using chondrogenic media in the absence TGFβ1 with superficial (S), 
middle (M) and deep (D) zones labelled. High magnification images (x40) were 
taken of the areas representing the superficial (B), middle (C) and deep (D) zones. 
Scale bars are equal to 0.1mm. 
 
Figure 5.9 (A) shows a low magnification (x4) image of a JCol scaffold following 
21 days of chondrogenic culture without TGFβ1. At this resolution a network of 
collagen ribbons can be seen, stained pink, throughout the scaffold, which is 
approximately 5.86mm in length and 3.01mm in width. The width of the scaffold is 
more uniform unlike the scaffold with TGFβ1 treatment. Figure 5.9 (B) is a high 
magnification (x40) image of an area representing the superficial zone. Unlike 
TGFβ1 treatment scaffolds collagen ribbons were stained in red but at a decreased 
intensity and cells can be seen clearly stained in pink. The morphology of these cells 
is a mix of circular and discoid shapes maintaining close contact to one another. The 
middle zone of the scaffold, Figure 5.9 (C), depicts red stained collagen ribbons 
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with large unstained areas between them when compared to the same zone of TGFβ1 
treatment scaffolds. No cells appear to be visible within this zone showing a 
difference between untreated scaffold in comparison to treated scaffold and native 
tissue. Figure 5.9 (D) shows the deep zone of the scaffold imaged at high 
magnification. Staining of the deep zone of this scaffold highlights the collagen 





Figure 5.10: Hematoxylin and eosin staining of chondroprogenitor cells in pellet 
culture with TGFβ1. Pellets were stained and imaged at low magnification (x10) 
following 21 days of chondrogenic culture with TGFβ1 (A). High magnification 
images (x20) were taken of the edge of the pellet (B) and the centre (C). Scale bars 
equal to 0.1mm.  
 
Figure 5.10 (A) is a low magnification (x10) image of chondroprogenitor cells 
following 21 days of chondrogenesis in pellet culture in the presence of TGFβ1. The 
pellet is approximately 1.32mm in length and 0.94mm in width and has not kept a 
typical spherical shape. Faint pink staining is seen throughout the pellet however the 
intensity of staining is increase at the edges of the construct. The edge of the pellet is 
seen at high magnification (x20) in Figure 5.10 (B) a thin band of intense pink 
staining is seen at the edge before becoming more evenly distributed as it moves 
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away from the edge. Figure 5.10 (C) is an image of the centre of the pellet at high 
magnification. A large number of cells can be seen throughout the entire image 
unlike what is seen in the scaffolds where the cells appear in contact with collagen 




Figure 5.11: Hematoxylin and eosin staining of chondroprogenitor cells in pellet 
culture without TGFβ1. Pellets were stained and imaged at low magnification (x10) 
following 21 days of chondrogenic culture without TGFβ1 (A). High magnification 
images (x20) were taken of the edge of the pellet (B) and the centre (C). Scale bars 
equal to 0.1mm.  
 
Figure 5.11 (A) is a low magnification image (x10) of chondroprogenitor pellet 
culture in the absence of TGFβ1. The construct is approximately 1.06mm wide and 
1.02mm in length. The pellet has not kept a typical spherical structure and appears to 
be less structured than pellets treated with TGFβ1. Staining for cells can be seen 
throughout the construct however the intensity varies throughout with darker staining 
seen towards the edges of the pellet. Figure 5.11 (B) shows the edge of the pellet at 
high magnification (x20) where a thin band of intense staining can be seen and even 
cell distribution is witnessed below the band and through the centre of the pellet, 
highlighted in Figure 5.11 (C).  
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5.2.3.3 DNA quantification 
 
To assess whether scaffold and pellet culture systems were conducive towards cell 
proliferation, quantification of cell number was obtained following 21 days of culture 
in chondrogenic media. On the completion of culture all samples were subjected to 
papain digestion and DNA quantified using a picogreen assay, shown in Figure 5.12. 
Each mammalian cell is believed to contain approximately 7.7pg of DNA allowing 




Figure 5.12: DNA content of pellet and scaffold structures. DNA content of 
native immature bovine articular cartilage (A) was taken as a benchmark. After 21 
days of chondrogenic culture pellet and scaffold cultures with and without TGFβ1 
were analysed for their DNA content. All data shown is from a minimum of 3 
independent biological repeats, statistical significance shown according to a Mann 
Whitney U test (*p<0.05; **p<0.01; ***p<0.001). 
 
Figure 5.12 (A) shows DNA content of immature bovine articular cartilage obtained 
from the MCP joint via punch biopsy (6mm). The average DNA content from native 
tissue was 18.17μg  ± 1.12 and was used as a benchmark sample. The same number 
of cells were used to seed pellet as well as scaffold cultures. Figure 5.12 (B) depicts 
the DNA content of pellet and scaffold cultures following 21 days of chondrogenesis 
in the presence and absence of TGFβ1. Pellet cultures were shown to have 0.57ug of 
DNA, which was significantly lower when compared to scaffolds and TGFβ1 treated 
pellets and scaffolds, p=0.000, p=0.002 and p=0.000, respectively. DNA content for 
TGFβ1 treated pellets was 0.66ug, which was significantly lower than scaffolds in 
the absence and presence of TGFβ, p=0.000 for both. When analysed for DNA 
content, scaffolds in the presence and absence of TGFβ1 had 1.93ug and 1.41ug 
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DNA, respectively and TGFβ1 treated scaffolds exhibiting a significantly higher 




Figure 5.13: Cell number from pellet and scaffold structures following 
chondrogenesis. Cell number of native bovine articular cartilage was approximated 
from DNA content and used as a benchmark (A). Following 21 days of TGFβ1 
treated and untreated chondrogenesis pellet and scaffold cultures were analysed for 
cell numbed using DNA content. All data shown is from a minimum of 3 
independent biological repeats, statistical significance shown according to a Mann 
Whitney U test (*p<0.05; **p<0.01; ***p<0.001). 
 
Figure 5.13 (A) shows the cell number from 6mm punch biopsies of immature 
bovine MCP articular cartilage to be 235,999 ± 145,689. Cell number was also 
calculated for pellet and scaffold cultures in the presence and absence of TGFβ1, 
shown in Figure 5.13 (B). The trend displayed from cell number data is the same as 
DNA content. Pellet cultures exhibited an average cell number of 73,533, which was 
significantly lower than treated pellet (p=0.002) and scaffold (p=0.000) cultures and 
untreated scaffold (p=0.000) culture. The average cell number for treated pellet 
culture was 85,565 cells that were significantly lower than scaffolds in the presence 
(p=0.000) and absence (p=0.000) of TGFβ1. Scaffold cultures yielded a higher cell 
number after 21 days with untreated scaffold exhibiting 251, 219 cells and treated 
scaffolds exhibiting 184, 190 cells, displaying a significant difference between both 
conditions (p=0.011).  
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5.2.4 Proteoglycan synthesis 
 
Cartilage possesses a characteristically high amount of proteoglycan that plays 
various roles within the tissue from aiding in the initial assembly of the ECM to 
allowing for osmotic swelling following decompression (Knudson and Knudson, 
2001). Osmotic pressure is obtained due to the proteoglycans drawing cations into 
the tissue through their negatively charged GAGs that are added during post 
translational modification, providing compressive resistance (McNary et al., 2012). 
The degradation of proteoglycans within cartilage is a characteristic of osteoarthritis 
and causes the breakdown of cell-matrix communication and fibrillar networks as 
well as altering the biochemical properties of the tissue making it unfit for the 
purpose of absorbing impact (Stanton et al., 2011). 
 
Toluidine blue is a metachromatic dye that can be used to help identify the 
composition of tissues. Metachromasia is highly selective meaning that it can only 
stain certain structures within tissues by absorbing light at a different wavelength, 
changing the colour of the dye without altering chemical structures (Sridharan and 
Shankar, 2012).  
 
5.2.4.1 Native immature baseline 
  
Punch biopsies (6mm) from immature MCP joints were washed in PBS, fixed in 
10% NBF. 7μm sections of wax embedded tissues were strained with toluidine blue 
and imaged with a light microscope. 
 





Figure 5.14: Toludine blue staining of immature bovine cartilage. Native 
immature bovine cartilage was stained using toluidine blue and imaged at low 
magnification (x4) (A) with superficial (S), middle (M) and deep (D) zones labelled.. 
High magnification images (x40) were taken of the superficial (B), middle (C) and 
deep (D) zones. Scale bars are equal to 0.1mm. 
 
Figure 5.14 (A) shows a section of native immature bovine cartilage stained with 
toluidine blue. The approximate length and width of the section of tissue is 5.71mm 
and 1.14mm, respectively. Dark blue staining is seen throughout the tissue whilst 
some regions appear to have been stained in a less intensely. Figure 5.14 (B) shows 
the superficial zone of cartilage at high magnification (x40) stained in a dark blue 
colour. The middle zone of cartilage, Figure 5.14 (C), is stained in a paler blue 
colour than the superficial zone. White areas with faint blue staining indicate areas 
populated by a cell depicting that the middle zone contains numerous cells that are 
close together. Figure 5.14 (D) shows the deep zone of cartilage, which appears blue 
towards the middle zone and a light purple colour the further down the stained tissue 
section. The edge of the deep zone is a deep blue colour. Just as seen in the middle 
zone, unstained sections containing bright blue dots indicated space occupied by 
cells that appear circular in shape and seem to be sparser than in the middle zone.  
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5.2.4.2 Scaffold assisted matrix deposition 
 
Scaffold seeded with immature CP cells and cultured for 21 days. Following culture, 
constructs were washed, fixed, embedded and sectioned. The assessment of 
proteoglycan production and deposition was done via toluidine blue staining on 7μm 




Figure 5.15: Toludine blue staining of JCol scaffolds after 21 days of 
chondrogenic culture supplemented with TGF1. JCol scaffolds were stained 
using toluidine blue and imaged at low magnification (x4) after 21 days of culture 
using chondrogenic media containing TGFβ1 with superficial (S), middle (M) and 
deep (D) zones labelled.. High magnification images (x40) were taken of the areas 
representing the superficial (B), middle (C) and deep (D) zones. Scale bars are equal 
to 0.1mm. 
 
Figure 5.15 (A) is a low magnification (x4) image of a JCol scaffold after 
chondrogenic culture with TGFβ1 with an approximate length and width of 4.71mm 
and 2.77mm, respectively. At this magnification the network of collagen has been 
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stained blue, with darker staining seen up to 0.067mm before the staining becomes 
less intense. Unlike native tissue there are unstained areas throughout the scaffold 
whilst the edge of the scaffold has a deep blue stain that is 0.15mm thick. Figure 
5.15 (B) shows the superficial section of the scaffold at high magnification (x40) 
exhibiting a thick blue layer at the edge with some purple staining in areas surround 
the collagen ribbons. In the middle zone, Figure 5.15 (C), collagen and cells are 
stained in dark blue. Areas close to collagen ribbons are stained in a faint purple 
colour in a similar fashion to that of the superficial zone of the scaffold. Figure 5.15 
(D) depicts the deep zone of the scaffold. In this section the collagen is stained in 
dark blue as it has been throughout the entire construct however there does not 
appear to be any staining bridging collagen ribbons in the same fashion seen in the 




















Figure 5.16: Toludine blue staining of JCol scaffolds after 21 days of 
chondrogenic culture without TGFβ1. JCol scaffolds were stained using toluidine 
blue and imaged at low magnification (x4) after 21 days of culture using 
chondrogenic media in the absence TGFβ1 with superficial (S), middle (M) and deep 
(D) zones labelled. High magnification images (x40) were taken of the areas 
representing the superficial (B), middle (C) and deep (D) zones. Scale bars are equal 
to 0.1mm. 
 
Figure 5.16 (A) shows a JCol scaffold, imaged at low magnification (x4), without 
TGFβ1 treatment, with a length of 4.95mm and a width of 2.93mm at 1mm depth 
and 2.22mm at a depth of 3.72mm. The network of collagen is stained in blue 
throughout the entire scaffold with visible unstained gaps within the pores. Figure 
5.16 (B) depicts the superficial region of the scaffold with collagen stained in blue 
and the edge of the scaffold have a slightly thicker blue stain but this is not as 
prominent as the TGFβ1 treated scaffold. Figure 5.16 (C) shows the middle zone of 
the scaffold at high magnification (x40) with collagen stained in blue however the 
areas between collagen ribbons do not appear to be as intensely stained as those in 
the same zone of TGF treated scaffolds. The deep zone of the scaffold, shown in 
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Figure 5.16 (D), shows collagen ribbons stained in blue with no apparent staining in 




Figure 5.17: Toluidine blue staining of chondroprogenitor cells in pellet culture 
with TGFβ1. Pellets were stained with toluidine blue and imaged at low 
magnification (x10) following 21 days of chondrogenic culture in the presence 
TGFβ1 (A). High magnification images (x20) were taken of the edge of the pellet 
(B) and the centre (C). Scale bars equal to 0.1mm.  
 
Figure 5.17 (A) is a low (x10) magnification image of a pellet following 21 days of 
chondrogenesis in the presence of TGFβ1 that is approximately 1.43mm in length 
and 1.16mm in width. The pellet has not kept the spherical shape throughout the 
culture period but appears to be intact with staining visible through the entire 
construct. The edge of the pellet, seen in Figure 5.17 (B), is stained a dark blue 
indicating a high level of proteoglycan in these areas. Figure 5.17 (C) is the centre 
of the pellet imaged at high magnification (x20). In this area the staining is purple 
and less intense than at the edges indicating lower GAG content.  
 
 





Figure 5.18: Toluidine blue staining of chondroprogenitor cells in pellet culture 
without TGFβ1. Pellets were stained and imaged at low magnification (x10) 
following 21 days of chondrogenic culture in the absence of TGFβ1 (A). High 
magnification images (x20) were taken of the edge of the pellet (B) and the centre 
(C). Scale bars equal to 0.1mm.  
 
Figure 5.18 (A) is a low magnification (x10) image of pellet culture following 21 
days of chondrogenesis in the absence of TGFβ1 and stained with toluidine blue. The 
pellet is an irregular shape and measures 1.15mm and 0.65mm at the longest and 
widest points, respectively, and stained throughout. Figure 5.18 (B) is the edge of 
the pellet stained in a mixture of blue and purple staining indicating slightly weaker 
and uneven proteoglycan deposition when compared to TGFβ1 treated pellet. Figure 
5.18 (C) shows an area toward the centre of the pellet with variation in the intensity 
of staining. The staining appears in a gradient from intense blue at the centre and 
become a faint purple as it moves towards the edge showing the uneven production 
of proteoglycan.   
 
5.2.4.3 Glycosaminoglycan quantification 
 
To quantitatively assess GAG content a DMMB assay was conducted following 
completion of 21 days of chondrogenesis. Samples were digested enzymatically 
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using papain and GAG content of the digest determined using 1,9-dimethyl-
methylene blue (DMMB) dye. DMMB is a cationic dye that binds specifically to 
negatively charges sulphated glycosaminoglycans including chondroitin sulphate that 




Figure 5.19: Sulphated glycosaminoglycan content of pellet and scaffold 
cultures after 21 days of chondrogenesis. sGAG content of native immature 
cartilage (A) was determined and normalised per ug of DNA and used as a 
benchmark. Pellet and scaffold cultures treated and untreated with TGFβ during 
chondrogenesis were analysed for sGAG content (B). All data shown is from a 
minimum of 3 independent biological repeats, statistical significance shown 
according to independent samples T Test (*p<0.05; **p<0.01; ***p<0.001). 
 
Native immature bovine cartilage was used for a benchmark for sGAG content, 
Figure 5.19 (A). Analysis showed that the average sGAG content of bovine MCP 
joint cartilage was 100.03μg/μg of DNA ± 40.09. Figure 5.19 (B) shows the sGAG 
content from pellet and scaffold cultures following 21 days of chondrogenesis. Pellet 
cultures contained 7.68μg/μg of sGAG after 21 days that was significantly lower 
when compared to the TGFβ treated pellet and scaffold counterparts (p=0.000 and 
p=0.048, respectively). Pellet cultures treated with TGFβ during chondrogenesis 
exhibited the highest amount of sGAG at 38.21μg/μg, which was significantly 
increased compared to treated and untreated scaffolds (p=0.000 for both). Scaffolds 
that underwent chondrogenesis without growth factor treatment contained 9.28μg/μg 
whilst treated scaffold exhibited sGAG content of 16.39μg/μg with no significant 
difference found between the two culture conditions.  
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5.2.5 Collagen content 
 
Collagen is the most abundant protein in the ECM of articular cartilage and accounts 
for approximately two thirds of its dry mass (Eyre, 2002). Although type II collagen 
represents 90% of the collagen in the ECM other collagens are also present in small 
proportions and include collagen type III, IV, V, VI, IX and XI and enable the tissue 
to function by aiding the formation and stabilisation of the type II fibrillar network 
(Fox et al., 2009). 
 
Picrosirius red is a staining method used in order to identify fibrillar collagen 
networks (Lattouf et al., 2014). It is a linear anionic dye containing six sulfonate 
groups that associate to cationic collagen fibres, in particular reacting with amino 
groups of lysine, hydroxylysine and guanidine groups of arginine. This enhances 
collagen birefringence when viewed under polarised light (Montes and Junqueira, 
1991). The birefringence is specific to collagen and the amount of light absorbed by 
the dye is dependent on the orientation of collagen fibres (Bhutda et al., 2017). 
 
5.2.5.1 Native immature baseline 
 
Cartilage obtained from immature MCP joints (6mm punch biopsy) were washed, 
fixed and embedded in preparation for histological analysis. Section of native tissue 
were stained with picrosirius red and imaged using a light microscope with a 












Figure 5.20: Picrosirius red staining of native immature bovine cartilage. 
Immature bovine cartilage stained with picrosirius red imaged with a light 
microscope at low magnification (A) and high magnification (B) and with polarised 
light to show birefringence at low magnification (C) and high magnification (D). 
Scale bars equal to 0.1mm. 
 
Figure 5.20 (A) is a low magnification (x4) image of a section of native immature 
bovine cartilage stained with picrosirius red taken with a light microscope. The depth 
of the tissue is approximately 0.93mm at the thickest point and is stained entirely red. 
Figure 5.20 (B) is a high magnification (x20) image of the tissue focusing on the 
superficial and transition into the middle zone of the cartilage. The tissue is stained 
in red, indicating the collagen distribution through the tissue, with unstained regions 
representing areas populated by cells. Figure 5.20 (C) and Figure 5.20 (D) are the 
same images imaged under polarised light. Under polarised light native immature 
cartilage fluoresces a yellow colour at the very surface of the superficial zone and 
through the middle zone. The deep zone and a region of the middle zone, 
approximately 0.27mm, beneath the superficial zone do not appear to exhibit a lot of 
fluorescence although the high magnification image seen in Figure 5.20 (D) shows 
some fluorescence directly around areas where cells are present.  
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5.2.5.2 Scaffold assisted collagen content 
 
Scaffolds equilibrated in serum free media were seeded with 0.5x106 
chondroprogenitor cells and cultured for 21 days with chondrogenic media. 
Following the culture period, collagen deposition was assessed histologically via 




Figure 5.21: Picrosirius red staining of JCol scaffolds following 21 days of 
chondrogenic culture with TGFβ1. Low magnification (x4) image of JCol scaffold 
imaged with a polarised light microscope (A) with labelled superficial (S), middle 
(M) and deep (D) zones. High magnification (x20) images were taken of areas 
representing the superficial (B), middle (C) and deep (D) zones. 
 
Figure 5.21 (A) is a low magnification (x4) image of a JCol scaffold stained with 
picrosirius red following 21 days of chondrogenic culture with TGFβ1. The collagen 
network is stained throughout, with the majority of the scaffold fluorescing in red. 
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The scaffold has maintained its shape until 1.7mm where it begins to constrict for 
0.68mm before maintaining the original shape again. Figure 5.21 (B) shows the 
superficial zone of the scaffold at high magnification (x20). The superficial region 
gives off a yellow fluorescence similar to what is seen in native immature tissue. The 
middle zone, depicted in Figure 5.21 (C), show the edges of ribbons of collagen 
fluorescing in yellow whilst the majority of the network remains red in colour. The 
same pattern can be seen in the deep zone of the scaffold, Figure 5.21 (D). The 
collagen network in the deep zone appears to be broken towards the edge of the 




Figure 5.22: Picrosirius red staining of JCol scaffolds following 21 days of 
chondrogenic culture without TGFβ1. Low magnification (x4) image of JCol 
scaffold imaged with a polarised light microscope (A) with labelled superficial (S), 
middle (M) and deep (D) zones. High magnification (x20) images were taken of 
areas representing the superficial (B), middle (C) and deep (D) zones.  
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Figure 5.22 (A) is a low magnification image (x4) of a JCol scaffold cultured 
without TGFβ1 for 21 days. The overall collagen network does not appear to 
fluoresce with the same intensity as scaffolds treated with TGFβ1 and the shape of 
the scaffold has been altered during the culture period. A clear defined fluorescence 
is not seen across the entire superficial region as seen in native tissue and treated 
scaffolds. In the high magnification image of the superficial zone, Figure 5.22 (B), 
ribbons of collagen are seen in red with yellow fluorescence present at the edges of 
the protein. The pattern of fluorescence is similar in the middle and deep zones, 
shown in Figure 5.22 (C) and Figure 5.22 (D), respectively, at a decreased intensity. 
Pores appear the be larger throughout the scaffold when compared to growth factor 
treated scaffolds that only exhibited larger pores in the deep zone of the scaffold. At 
the deep zone, the scaffold does not appear to have held its integrity with broken 




Figure 5.23: Picrosirius red staining of chondroprogenitor cells in pellet culture 
with TGFβ1. Pellets were stained and imaged at low magnification (x4) with 
polarised light following 21 days of chondrogenic culture with TGFβ1 (A). High 
magnification images (x20) were taken of the edge of the pellet (B). Scale bars equal 
to 0.1m.  
 
Figure 5.23 (A) is a polarised light image of a pellet after 21 days of chondrogenesis 
in the presence of TGFβ1. The pellet has kept its spherical shape and measures 
approximately 1.93mm in width and 1.46mm in length. Yellow and green 
birefringence is seen around the edge of the pellet with less intense birefringence 
seen towards the centre. Figure 5.23 (B) is a high magnification image of the edge of 
the pellet highlighting the birefringence in this area, which is approximately 0.1mm 
in depth.  





Figure 5.24: Picrosirius red staining of chondroprogenitor cells in pellet culture 
without TGFβ1. Pellets were stained and imaged at low magnification (x4) with 
polarised light following 21 days of chondrogenic culture without TGFβ1 (A). High 
magnification images (x10) were taken of the edge of the pellet (B). Scale bars equal 
to 0.1mm.  
 
Figure 5.24 (A) is a low magnification polarised light image of a pellet following 21 
days of chondrogenesis in the absence of TGFβ1. The pellet has lost its spherical 
structure and is 2.74mm in length. The width of the pellet varies throughout the 
length with it measuring 1.48mm in width at 0.71mm and 0.92mm in width at 
1.52mm. Birefringence is seen along the edges of the pellet and is yellow in colour. 
Figure 5.24 (B) is a high magnification image of the edge of the pellet. The image 
depicts the yellow birefringence at the edge of the structure whilst the collagen fibres 
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5.2.5.3 Hydroxyproline quantification 
 
The collagen content from construct was quantified spectrophotometrically following 
21 days of culture. Papain digested samples were subject to hydroxyproline assay to 
quantify the amount of 4-hydroxyproline found in collagen of cartilage that aids in 
the stabilisation of the triple helix.  
 
 
Figure 5.25: Hydroxyproline content of pellet and scaffold cultures after 21 days 
of chondrogenesis. Hydroxyproline content of immature bovine cartilage (A) 
normalised per ug of DNA. TGFβ treated and untreated pellet and scaffold cultures 
were assessed for hydroxyproline content following chondrogenesis (B). All data 
shown is from a minimum of 3 independent biological repeats, statistical significance 
shown according to Mann Whitney U test (*p<0.05; **p<0.01; ***p<0.001).  
 
Figure 5.25 (A) shows hydroxyproline content of immature bovine cartilage 
normalised to DNA content to be 67.02ug/ug of DNA ± 16.50 and was used as a 
benchmark. Figure 5.25 (B) displays hydroxyproline content of pellet and scaffold 
cultures following 21 days of chondrogenesis. Untreated pellets were analysed and 
shown to have no hydroxyproline content that could be detected by the assay. TGFβ 
treated pellet (p=0.02) scaffolds (p=0.000) and untreated scaffolds (p=0.000) all had 
a significant increase in hydroxyproline content when compared to untreated pellets.  
The hydroxyproline content of TGFβ treated pellet culture was 7.62 ug/ug, which 
was significantly lower, compared to scaffold cultures with and without growth 
factor treatment (p=0.000 for both). When comparing TGFβ treated scaffolds and 
untreated scaffolds, no significant difference was observed with hydroxyproline 
content determined to be 350.57ug/ug and 335.25ug/ug, respectively.  
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5.2.6 Histology summary 
 
Following 21 days of chondrogenic culture, JCol scaffolds were stained for the 
presence of characteristic components of cartilage matrix GAGs and collagen. These 
were compared to native bovine cartilage to understand whether scaffold structures 




Figure 5.26: Summary panel of histological analysis of native tissue and JCol 
scaffolds with and without TGF1 treatment. 
 
Figure 5.26 is a summary panel of histology images showing the comparison of 
GAG content (Tol Blue) and collagen deposition (PSR) between native bovine 
articular cartilage and JCol scaffolds with and without TGFβ1 supplementation. In 
summary, Tol Blue staining of native cartilage is present throughout the biopsy 
sample compared to the appearance of a band of staining at the top of scaffold 
structures that is enhanced by growth factor treatment. PSR analysis of native 
cartilage shows a thin area of fluorescence at the superficial zone that can also be 
seen in treated scaffolds but is not observed as clearly in untreated scaffolds.  
 
5.2.7 Gene expression analysis 
 
Enhanced chondrogenesis in vitro is characterised by the expression of SOX9, 
ACAN and COL2A1, which are expressed during development of cartilage 
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(Yamashita et al., 2010). SOX9 establishes condensation and initiates 
chondrogenesis and regulates expression of COL2A1, which is a major component 




Figure 5.27: Fold change of SOX9 gene expression compared to native cartilage. 
Fold change of SOX9 gene expression of pellet and scaffold cultures following 21 
days of chondrogenesis in the presence and absence of TGFβ compared to immature 
native bovine cartilage.  
 
Figure 5.27 shows the fold change in gene expression of SOX9 from pellet and 
scaffold cultures following 21 days of chondrogenic culture in the presence and 
absence of TGFβ. Untreated pellet cultures showed a  decrease of SOX9 gene 
expression by a fold change of 14692.97 (min: 436.01; max: 28949.92; medium: 
14692.97) when compared to native bovine articular cartilage and exhibited the 
biggest decrease in SOX9 expression when compared to all other culture conditions. 
TGFβ treated pellet cultures displayed a decreased fold change of 5.66 (0.89; 10.42; 
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5.66) in comparison to native cartilage. When compared to all other conditions, 
growth factor treated pellet culture showed the smallest fold change in gene 
expression. Untreated scaffold cultures showed a decreased fold change in SOX9 
gene expression by 14.29 (8.68; 22.82; 14.29) whilst TGFβ treated scaffold cultures 
showed a decrease by 332.41 fold (14.45; 648.52; 332.41) when compared to native 




Figure 5.28: Fold change of COL2A1 gene expression compared to native 
cartilage. Fold change of COL2A1 gene expression of pellet and scaffold cultures 
following 21 days of chondrogenesis in the presence and absence of TGFβ compared 
to native immature bovine cartilage. 
 
Figure 5.28 shows the decrease in COL2A1 gene expression, expressed as fold 
change, of pellet and scaffold cultures in the presence and absence of TGFβ 
compared to native immature bovine cartilage. Pellets cultured without TGFβ 
displayed a decrease in COL2A1 gene expression by 939.86 (4.30; 1875.41; 939.86) 
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all other conditions. TGFβ treated pellets had a decrease in expression by 1564.04 
(24.77; 3103.31; 1564.04). The largest change in COL2A1 gene expression occurred 
in untreated scaffold cultures and decreased by 1860.31 (492.05; 2781.17; 1860.31) 
in comparison to native tissue whilst treated scaffold cultures only decreased by 





Figure 5.29: Fold change of ACAN gene expression compared to native 
cartilage. Fold change of ACAN gene expression of pellet and scaffold cultures 
following 21 days of chondrogenesis in the presence and absence of TGFβ compared 
to immature native bovine cartilage.  
 
Figure 5.29 displays the difference in ACAN gene expression, in terms of fold 
change, of pellet and scaffold cultures following 21 days of chondrogenic culture 
compared to native bovine articular cartilage. Untreated and treated pellet cultures 
showed an increase in ACAN gene expression by 53.49 (3.80; 103.17; 53.49) and 
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scaffold cultures without growth factor treatment showed a decrease in ACAN 
expression by 41.77 (3.18; 69.13; 41.77) whilst treated scaffold cultures showed less 





Figure 5.30: Fold change of RUNX2 gene expression compared to native 
cartilage. Fold change of RUNX2 gene expression of pellet and scaffold cultures 
following 21 days of chondrogenesis in the presence and absence of TGFβ compared 
to native immature bovine cartilage. 
 
Figure 5.30 shows the difference in RUNX2 gene expression, expressed as fold 
change, from pellet and scaffold cultures following 21 days of culture and compared 
to immature bovine cartilage. Pellet cultures show a decrease in RUNX2 expression 
by 6.02 (0.28; 11.76; 6.02) whilst TGFβ treated pellets were shown to increase gene 
expression by 36.07 (0.57; 71.56; 36.07) compared to native tissue. Treated pellets 
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expression. Scaffold cultures exhibited a decreased gene expression by 2.49 (0.19; 
1.71; 2.49) and TGFβ treated scaffold cultures showed the largest decrease in 
RUNX2 gene expression when compared to native bovine cartilage by 45.29 (0.19; 




Figure 5.31: Fold change of COL1A1 gene expression compared to native 
cartilage. Fold change of COL1A1 gene expression of pellet and scaffold cultures 
following 21 days of chondrogenesis in the presence and absence of TGFβ compared 
to native immature bovine cartilage.  
 
Figure 5.31 is the fold change difference in COL1A1 gene expression of pellet and 
scaffold cultures on completion of 21 days of chondrogenesis compared to bovine 
articular cartilage. All culture conditions tested showed an increase in COL1A1 gene 
expression. Untreated and growth factor treated pellet cultures showed an increase in 
gene expression by 4831.74 (0.01; 9662.48; 4831.74) and 1150.02 (1.37; 2298.68; 
1150.02), respectively, compared to bovine cartilage. Untreated scaffold cultures 
exhibited an increased gene expression by 2139.27 (782.35; 3074.63; 2139.27) 
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compared to immature bovine cartilage was witnessed in TGFβ treated scaffold 




Figure 5.32: Fold change of COL10A1 gene expression compared to native 
cartilage. Fold change of COL10A1 gene expression of pellet and scaffold cultures 
following 21 days of chondrogenesis in the presence and absence of TGFβ compared 
to native immature bovine cartilage.  
 
Figure 5.32 shows the decrease in COL10A1 gene expression, displayed as fold 
change, for scaffold and pellet cultures in the presence and absence of TGFβ 
compared to immature bovine articular cartilage. Pellet cultures in the absence of 
TGFβ expressed a decrease in gene expression by 36.2 (0.15, 72.25; 36.2) compared 
to native tissue. TGFβ treated pellet culture showed the lowest fold change in 
COL10A1 gene expression when compared to all other culture conditions at 13.99 
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expression by 27.81 (1.06; 73.05; 27.81) when compared to native tissue whilst 
TGFβ treated scaffold cultures exhibited the highest decrease in COL10A1 
expression at 60.29 (0.46; 174.92; 60.29).  
 
 
5.2.8 Protein expression 
 
Successful regeneration using tissue engineered constructs is dependent upon matrix 
remodelling and deposition by cells residing in scaffolds (O'Brien, 2011). 
Immunohistochemistry (IHC) is the identification of tissue constituents by antibody 
recognition of specific antigens (Shi et al., 2011).  
 
TGFB treated scaffolds were stained using bovine aggrecan and collagen type II and 
type I antibodies to evaluate whether bovine CPs had deposited matrix and undertake 









Figure 5.33: Immunohistochemistry of TGFβ1 treated scaffolds. Scaffolds were 
stained for chondrogenic markers collagen type II and aggrecan as well as collagen 
type I, typically found in fibrocartilage. Images with a light microscope at x20 
object. Scale bars are 50 μm. 
 
Figure 5.33 is a panel of immunohistochemistry images of TGFβ treated scaffolds. 
A no antibody control was used to account for any false positive (Figure 33 (D)). 
Figure 5.33 (A) and Figure 5.33 (C) representative staining of collagen type I and 
type II in scaffolds showing no staining by their respective antibodies. Figure 33 (B) 
shows staining of aggrecan within TGFβ1 treated scaffolds after chondrogenesis. 
Aggrecan antibody staining is apparent in areas around collagen ribbons indicating 
matrix deposition.  
 
5.3 Discussion  
 
The limited regenerative capacity of cartilage has lead to the development of 
different intervention techniques including the fabrication of cartilage that can be 
implanted into cartilage defects (Zhang et al., 2009). Although these surgical 
interventions have exhibited varying degrees of success, research into 
chondrogenesis has continued, in order to improve patient outcome and decrease the 
duration of rehabilitation (Redman et al., 2005). Current methods involve both 
cellular approaches and matrix-assisted approaches displaying advantages in 
chondrogenesis and cartilage production (Bernstein et al., 2009). An early proof of 
concept pre-clinical study is outlined in this chapter, demonstrating the suitability of 
inert, JCol scaffolds in combination with bovine CP populations, for a next 
generation regenerative medicine approach to cartilage repair capitalising on 
enhanced in vitro chondrogenesis.  
 
JCol scaffolds are a suitable environment for CP chondrogenesis. Cell invasion is 
observed through the construct apart from the ‘deep zone’ and cell content is higher 
than pellet culture, when starting with the same seeding concentration. Histological, 
biochemical and gene analysis shows that JCol scaffolds express genes typically 
associated with chondrogenesis and that matrix deposition is enhanced with TGFβ 
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although gene expression was lower than that observed in pellet culture. 
Hypertrophic markers were observed in scaffold cultures however they were 
expressed at lower levels compared to pellets indicating that cellular hypertrophy and 
osteogenesis may be less likely to occur in scaffold structures. These results indicate 
that JCol scaffolds are suitable for development in this space, with focus placed on 
the mechanical stability of structures and cell seeding efficiency for the homogenous 
deposition of matrix, which may lead to better functional tissue development. 
 
Sponge scaffold supported chondrogenesis  
 
1% EDC JCol sponge scaffolds were fabricated and seeded (density of 0.5x106) with 
bovine CPs, with cell invasion observed throughout the construct depth, meeting the 
requirement of high cell density favoured by in vitro chondrogenesis (Bornes et al., 
2016). No significant contraction occurred after the initial 7 days of culture. 
Contraction of gels has previously been shown to reduced cell attachment collagen 
synthesis both of which would be counterproductive for cartilage regeneration 
(Nakagawa et al., 1989).  
 
Following the full 21 day culture period, data obtained from pellet cultures showed a 
decrease in cell number from initial seeding thought to be caused by the generation 
of a hypoxic core at the centre of the dense structure causing uneven oxygen tension 
(Dexheimer et al., 2012). On the other hand scaffold cultures were shown to have a 
higher cell number although this was still below the initial cell seeding density. The 
porous structure of scaffolds allows for oxygen to be passed throughout the entire 
structures and so loss of cells in scaffold constructs may have occurred due to the 
efficiency of the seeding method. Cells were seeded at high density and low volume 
at the top of the scaffold and allowed to attach for 20 minutes before flooding with 
media potentially causing the loss of any unattached cells (Bueno et al., 2007). Cells 
may also have been lost if they were not able to attach to binding motifs present on 
JCol scaffolds causing anoikis (Lee et al., 2015).  
 
Scaffolds produced from type I and II collagen have been shown to promote 
chondrogenesis in vitro however degradation products released during remodelling 
of type II collagen may cause catabolic events to occur in vivo (Dewan et al., 2014). 
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A variety of commercially available scaffolds used in MACI procedures are 
composed of collagen (type I and III) or collagen hybrids including NeoCart and 




Table 5.1: Table of commercially available scaffolds for MACI procedures 
(Jeuken et al., 2016) 
 
Commercially available collagen based scaffolds have been used in MACI surgery 
with varying degrees of success (Iwasa et al., 2009). Although, they are typically 
shown to be superior to microfracture surgery in their repair capabilities in long term 
follow up studies there are still issues regarding cellular differentiation and the onset 
of hypertrophy in chondrocytes (Jeuken et al., 2016). Research with jellyfish derived 
collagen scaffolds has been shown to be a promising alternative matrix material with 
cells expressing chondrogenic markers (Hoyer et al., 2014), displaying higher cell 
viability and comparable in vivo immune response to  bovine collagen (Song et al., 
2006).Work outlined in Chapters 3 and 4 have shown that R. pulmo jellyfish collagen 
can be moulded into a scaffold structure and is biocompatible with cells, eliciting a 
response similar to commercially available collagen. 
 
As well as the biomaterial source for scaffold construction, cell source plays an 
important step in being able to produce the desired tissue type (O'Brien, 2011). CPs 
were used here, demonstrating an ability to undergo chondrocyte differentiation. In 
comparison, the use of chondrocytes has proven to have limitations including donor 
site morbidity, limited cell source and dedifferentiation during 2D in vitro expansion 
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before seeding into scaffolds (Li et al., 2015). Multipotent cells such as MSCs, while 
they have the capability to differentiate into osteogenic, chondrogenic and 
adipogenic lineages (Murray and Péault, 2015), are epiphyseal in nature if isolated 
from bone marrow, and usually produce chondrocytes that undergo terminal 
differentiation and hypertrophy (Williams et al., 2010). 
 
MSCs can be harvested from a number of other tissues due to their broad distribution 
throughout the human body, including adipose tissue, synovial tissue and umbilical 
cords (Williams et al., 2011). Cartilage repair research using such MSCs have given 
promising results with a high proliferative capacity, induction of a minimal immune 
response following implantation and good chondrogenic potential exhibiting 
COL2A1 and ACAN in culture (Zhang et al., 2009). Using an autologous population 
that can be harvested from the same injured joint, due to their clonogenic potential 
and culture proliferation however is advantageous. CPs obtained from cartilage are 
believed to be further along the stages of commitment to the chondrogenic lineage 
compared to MSCs (Jayasuriya and Chen, 2015a). Effective in vivo cartilage repair 
has been observed in caprine models where CPs gave similar results in terms of 
repair and integration as full depth chondrocytes (Williams et al., 2010). 
 
Enhanced chondrogenesis  
 
In developmental biology, chondrogenesis is the process by which chondrocytes 
arise from mesechymal progenitor cells and produce cartilage anlagen for developing 
bone (Goldring, 2012). The process begins through mesenchymal condensation to 
form anlagen where cells actively express ECM components and cell adhesion 
molecules including aggrecan and collagen type II (Boyce et al., 2018). At a certain 
cell per volume ratio, cells at the centre of the condensed structure cease proliferation 
and establish cartilaginous nodules (Berge et al., 2008). Formation of the anlagen is 
driven by Sonic Hedgehog (Shh) through interaction with the transmembrane 
receptors Patched 1 and 2 and the subsequent recruitment and activation of 
Smoothened and Gli transcription factors, respectively (Wilson and Chuang, 2010). 
 
The activation of this signalling system induces the expression of SOX9, which is 
critical during chondrogenesis and can be regulated by Notch signalling (Monsoro-
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Burq, 2005). Once SOX9 is activated chondrogenesis continues, the anlagen 
elongates, and endochondral ossification occurs where chondrocytes continue to 
express SOX9 but also express RUNX2 and Osterix, important transcription factors 
seen as critical for the skeleton mineralisaion and bone formation. They are 
responsible for causing enlargement of cells and expression of collagen type X as 
well as alkaline phosphatase, characteristics of hypertrophy and calcification 
(Nishimura et al., 2012).  
 
Chondrogenic media used in this chapter was supplemented with TGFβ1 to in order 
to stimulate chondrogenesis in line with research findings in literature. TGFβ and 
BMP families are essential in the initiation of chondrogenesis (Mariani et al., 2014). 
TGFβ signals via activin-like kinase (ALK) 1 and 5 to activate Smad pathways, 
outlined in Figure 5.1 (Finnson et al., 2008). Both pathways regulate the 
differentiation and phenotypic characteristics, to stabilise chondrocyte phenotypes 
(in the superficial and medial zones) or induce chondrocyte specific hypertrophic 
differentiation in the deep zone cartilage (Mariani et al., 2014). TGF 1 specifically, 
is considered an essential molecule in the anabolic processes in cartilage formation 
(Serra et al., 1997). Experiments involving TGFβ1 null mice showed no defect in 
cartilage formation however 50% of embryos underwent early termination 
suggesting a lethal effect due to the lack of TGFβ1 family (Wang et al., 2014).  
 
Differentiation of cells causes the loss and expression of different genes depending 
on the lineage that is to be created therefore analysis of specific gene expression 
profiles can indicate whether the desired tissue is being formed during regenerative 
medicine (Alberts et al., 2002). In this chapter, a panel of genes was chosen for 
analysis, that are present in chondrogenesis, shown in Figure 5.1, with hypertrophic 
marker (RUNX2, COL10A1) chosen as negative controls. 
 
SOX9 is considered the master regulator of chondrogenesis due to its role in 
proliferation and differentiation of cells via direct control of the expression of 
specific chondrogenic genes (Green et al., 2015). Most notably, SOX9 binds to a 48 
base pair enhancer region in COL2A1 and works with SOX5 and SOX6 to regulate 
aggrecan expression, leading to SOX9, COL2A1 and ACAN being seen as 
characteristic markers of chondrogenesis (Kupcsik et al., 2010). Data from this 
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project shows that pellet cultures had the highest SOX9 expression compared to JCol 
scaffold cultures. The chondrogenic potential of pellets is further witnessed by TGFβ 
treated cultures exhibiting the highest expression of ACAN and COL2A1. This may 
be due to pellet culture emulating condensation events that occur naturally during 
development through close cell-cell contact (Goldring, 2012).  
 
Developmental studies have also shown that SOX9 is upregulated in hypoxic 
conditions, which may occur at the centre of pellet structures (Yodmuang et al., 
2015). This is observed here, as pellet cultures stained with Toluidine Blue are 
labelled throughout whereas scaffold cultures show the most intense Toluidine Blue 
staining at the seeding interface, where the majority of cells are present. In a similar 
fashion to previous research with R. pulmo collagen in cartilage engineering, our data 
also showed an increase in SOX9 and ACAN expression in TGFβ treated scaffolds 
compared to the untreated counterpart displaying the additive effect of growth 
factors in regenerative medicine (Pugliano et al., 2017). Cell density is thought to be 
key in GAG accumulation with high cell density leading to increased production 
(Kobayashi et al., 2007). 
 
Pore size is a critical component when designing scaffolds for tissue engineering 
(Murphy et al., 2010). Although JCol scaffolds were proven to have an average pore 
size that is condusive to chondrogenesis (Matsiko et al., 2015) our results show 
chondrogenic genes are better expressed in pellets where cell-cell contact is apparent. 
Large pore sizes result in a decrease of surface area leading to reduction in ligand 
density for cell binding (Murphy et al., 2010). This may be the case with JCol 
scaffolds whereby cell attachment is lower and reduces cellular processes such as 
differentiation (O'Brien et al., 2005). The development of scaffolds with different 
pore sizes will help to further our understanding and enhance chondrogenesis.  
 
Collagen was observed in all culture conditions via polarised light microscopy from 
picrosirius red staining. Gene expression analysis of cells from different culture 
conditions displayed the type of collagen produced during differentiation. Untreated 
JCol scaffolds exhibited the highest expression of COL1A1 and one of the lowest 
expressions of COL2A1 compared to other culture conditions. The expression of 
COL1A1, typically seen in abundance in fibrocartilage, may be due to the 
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mechanical weakness of JCol scaffolds, with mechanotransduction signalling to cells 
for the production collagen suitable for the environment in which they are attached to 
(Kock et al., 2012). A decrease in COL1A1 was observed in JCol scaffolds treated 
with TGFβ treatment and is potentially linked to the upregulated expression of SOX9 
leading to expression of COL2A1.  
 
Type II collagen accounts for approximately 90% of the total dry weight of articular 
cartilage and aids in the tensile strength of the tissue (Bhosale and Richardson, 
2008). The production of the correct collagen type is important in order to produce a 
functionally relevant tissue for implantation (Roberts et al., 2009). Fibrocartilage is 
an inherently mechanically weaker form of cartilage that is predominantly composed 
of type I collagen (Hollander et al., 2003). The production of type I collagen in 
cartilage tissue engineered constructs would lead to a weaker cartilage and higher 
risk of readmission for surgery and therefore COL2A1:COL1A1 ratio is often seen 
as an important aspect of in cartilage regeneration (Albrecht et al., 2011). However, 
it should be noted that collagen type I is expressed in native immature articular 
cartilage in the superficial zone (Teshima et al., 2004). Immunohistochemistry of 
TGFtreated scaffolds did not show collagen type I or II to be present, following 
culture period however this may be due to the specificity of the antibody used and 
the inability to recognize epitopes presented on jellyfish collagen (Matos et al., 
2010). 
 
As a master regulator, SOX9 is also linked with the transcription regulation of 
RUNX2, inhibiting its expression during chondrogenesis (Zhou et al., 2006). 
RUNX2 is responsible for the maturation and hypertrophy of chondrocytes, which 
suggests that during skeletal development RUNX2 supresses SOX9 expression to 
allow for endochondral ossification and bone development (Cheng and Genever, 
2010). Once hypetrophic, chondrocytes express collagen type X which in turn 
influences the environment for matrix deposition and tissue mineralisation (Gu et al., 
2014). The overexpression of RUNX2 is also believed to play a role in the 
pathogenesis of OA as it induces the expression of MMP13 and ADAMTS5 that are 
responsible for the degradation of the cartilage matrix (Komori, 2018).  
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Interestingly, data from this project shows that untreated pellet cultures although 
displaying the highest SOX9 expression, also displayed the highest levels of RUNX2 
and COL10A1 suggesting more cells were beginning to undergo hypertrophy in 
comparison to other culture conditions. A decrease in RUNX2 and COL10A1 was 
observed in TGFβ1 treated pellet cultures showing the effect of TGFβ1 in 
chondrogenesis.  Treated and untreated scaffold structures show similar levels of 
RUNX2 expression, with TGFβ scaffolds showing a lower level of COL10A1 
expression compared to the untreated scaffold. Human MSCs cultured in jellyfish 
collagen scaffolds have previously been shown to upregulate COL10A1 gene 
expression following 3 weeks of chondrogenic culture (Hoyer et al., 2014). 
However, the reliability of COL10A1 as a hypetrophic marker in vitro has been 
questioned as previous research has shown that COL10A1 expression occurred 
earlier than COL2A1 expression in chondrogenic pellet culture (Mwale et al., 2006). 
The data here suggests that collagen scaffold support is needed to mitigate the 
temporal expression of these collagen variants, in line with that observed in 
developmental biology.  
 
Overall, this chapter demonstrates that JCol scaffolds are a suitable environment for 
chondrogenesis of bovine derived CPs. Cell invasion is observed through the 
construct, though does not appear apparent in the ‘deep’ zone, and cell content is 
higher than pellet culture. Histological, biochemical and gene analysis shows that 
JCol scaffolds express genes typically associated with chondrogenesis and that 
matrix deposition is enhanced with the use of growth factors such as TGFβ. 
Hypertrophic markers were observed in scaffold cultures however they were 
expressed at lower levels compared to pellets indicating that cellular hypertrophy 
may be less likely to occur in scaffold structures. These results indicate that JCol 
scaffolds should be developed further for regenerative medicine and tissue 
engineering of cartilage with focus placed on the mechanical stability of structures 
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6.1 Thesis Summary 
 
Collagen is an integral component of the ECM and contributes to the structural 
integrity of tissues as well as influencing multiple cellular functions (Frantz et al., 
2010). The deregulation of, or imbalance between anabolic and catabolic processes 
regarding the ECM is a contributing factor towards the development of disease 
(Bonnans et al., 2014). Although some tissues, such as skin, have the ability to 
regenerate after injury others lack the capability to do so and require intervention 
through tissue engineering strategies. Surgical techniques to repair damage which 
results from such disease processes have evolved from cellular and gene therapies, to 
matrix assisted implantation techniques that are beginning to rival allogneic 
implantation of donor material (Hosseinkhani et al., 2014).  
 
Traditionally mammalian derived collagens used in such repair approaches present 
widespread challenges, from environmental (farming), ethical, immunological and 
contamination considerations (Karim and Bhat, 2009). 3% of the population exhibit 
allergic reactions to bovine derived collagen (Lee and Lee, 2016). Collagens are a 
robust protein family, with a high degree of evolutionary conservation indicating a 
wider pool of sources being available (Exposito et al., 2002). In addition, synthetic 
variants that capitalise on collagen structural composition have been explored (Saha 
et al., 2007).  
 
Marine sources (from animals including fish, jellyfish and sea urchins) are becoming 
more prominent and further explored (Subhan et al., 2015). As well as overfishing 
leading to the decline of specific fish species, cold and warm water fish display 
differences in their collagen properties, indicating that fish may not be a suitable 
sustainable collagen source (Karim and Bhat, 2009). Particular interest has been 
given to jellyfish as their anatomy is largely composed of collagen and the increase 
in heat has caused seasonal blooms that are disruptive to both sea and terrestrial life 
(Brotz et al., 2012).  
 
R.Pulmo harvested collagen represents a possible alternative, inert and structurally 
compatible, next generation collagen source to furnish cleaner, more robust 
regenerative medicine approaches tailored made for individual applications. 
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Mammalian collagen isolation methods have proven to produce high yields whilst 
maintaining the triple helix structure, presenting cell binding motifs for attachment 
and providing mechanical strength for scaffolds (Exposito et al., 2010). Presented 
here is a large body of evidence; from triple helical structure, peptide sequence 
conservation and mammalian homology, to sponge scaffold fabrication and in depth 
characterisation, to support the adoption of such marine collagens in human 
regenerative medicine. JCol is biocompatible in that it supports non differentiated 
mammalian cell culture (in 2D and 3D), does not initiate an adverse immunogenic 





Figure 6.1: Schematic of experimental areas and outputs achieved in this 
project. 
 
Articular cartilage is a tissue with limited regenerative capacity and tissue trauma can 
lead to the development and progression of OA (Goldring and Goldring, 2007). 
Many commercially available polymer like scaffolds for procedures such as MACI 
exist, with collagen being favoured (Jeuken et al., 2016). JCol sponge scaffolds used 
as a natural matrix derivative support chondroprogenitor cell growth, chondrogenic 
differentiation and now need to be tested for integration with native tissue, in humans 
(Khan et al., 2008).  




6.2 JCol structural composition, isolation and sponge fabrication  
 
Maintenance of collagen structure following isolation is imperative as disturbance 
can cause loss of function (Bonnans et al., 2014). The development of a more 
efficient and rapid R. pulmo jellyfish collagen isolation method was fully optimised 
here and has since been adopted by our industrial partner (Pacak et al., 2011). 
Incorporating measurements for purity, yield and the conservation of all important 
amide I, II, III peaks using techniques such as FTIR enabled modified isolations, 
through the use of different acids, enzymatic digestion and salting out procedures 
(Schmidt et al., 2015).  
 
Acetic acid solubilisation followed by salting out with sodium chloride provides a 
collagen preparation re-suspended in acetic acid with maintained amide peaks 
supportive of a collagen sub type capable of triple helix structure formation. Altered 
electrophoretic patterns observed in the alpha1/2 bands compared to RTCol, where 
the migration was slower, provide an indication that this helical structure is altered in 
JCol (Addad et al., 2011). Peptide analysis preformed on 1-derived band showed 
sequence alignment with human collagen peptides that are imperative to triple helix 
structure, validating that our isolation method maintained the essential building 
blocks for a ‘collagen like’ triple helical structure. When fabricated to a 3D sponge, 
JCol collagen provided a larger pore size when compared to mammalian collagen 
sources, at each cross-linking concentration. The differences in structural 
composition of collagen between the species may lead to overall changes in aspects 
such as fibre diameter and density, which in turn causes changes in architecture and 
pore size (Lang et al., 2013). Certain pore sizes have been shown to favour specific 
regenerative applications and so these differences may prove to be advantageous 
however structural differences in collagen can also alter mechanical properties and 
therefore adjustments may be required to achieve a biomimetic matrix model (Yang 
and Kaufman, 2009). 
 
Collagen derived scaffold structures can form varying constructs with hydrogels and 
sponge scaffolds being prominent (Lee and Shin, 2007). Mammalian collagens are 
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compatible with sponge structures and also gel between room temperature and 37°C, 
during the process of fibrillogenesis (zhu and Kaufman, 2014). JCol fabrication 
techniques produce a sponge scaffold typical of marine collagen (Hoyer et al., 2014) 
however  no gelation occurred between 4 and 37C. Fibril formation is informed by 
the amino acid composition, with Cheng et al. showing a lower hydroxyproline 
content compared to mammalian counterparts, leading to a lower crosslinking 
density and a lower denaturation temperature (Cheng et al., 2017a). 
 
EDC cross-linking stabilised this sponge structure, providing mechanical, structural 
and thermal integrity (Davidenko et al., 2015). The low hydroxyproline content in 
JCol results in a low denaturation temperature (29°C), making it unsuitable for 
implantation into the human body (Subhan et al., 2015). Thermal stability increased 
after crosslinking. This trend was also witnessed in scaffold degradation properties 
with 1% crosslinked jellyfish scaffolds taking more time to undergo full digestion 
with collagenase however the scaffold did not show resistance.  
 
The mechanical properties of scaffolds have been closely linked with functional 
cellular differentiation (Plant et al., 2009). AFM analysis of scaffold during this 
project was unable to obtain mechanical data as hydrated constructs proved too soft 
in their nature. This is an issue often seen in hydrogels whereby water retention 
causes gels to be inherently weak (Brown et al., 2005). Increasing the concentration 
of EDC may further enhance the mechanical properties of scaffolds however it has 
been reported cell viability decreases with increasing EDC concentration. Also, as 
EDC capitalises on glutamic acid, found in the GFOGER cell binding motif, 
increasing concentration may lead to lower cell attachment (Thoreson et al., 2015).  
 
Previous reports have shown that plastic compression can remove excess water and 
increase fibril density, producing a stronger product (Cheema and Brown, 2013). 
Applied to jellyfish collagen scaffolds, plastic compression was unsuccessful as 
reswelling occurred, which is not seen in mammalian collagen constructs. It should 
be noted that literature based around plastic compression appears to have been 
conducted on hydrogels and not on collagen sponges and therefore it may be the 
form of scaffold that caused reswelling. To tailor scaffolds for specific applications it 
would be interesting to look at parameters involved in compression such as initial 
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fibril density and further develop the technique (Brown et al., 2005). In the absence 
of plastic compression, fabrication of size and shape scaffolds may affect cell-cell 
and cell-matrix interactions as well as the all important matrix cell density ratio, 
which drives functional differentiation in many tissues (Mao et al., 2016). During the 
project, scaffold fabrication was limited to a 3ml cylinder due to company interaction 
and restrictions around IP development.  
 
Scaffolds for tissue engineering are not seen as permanent implants but rather as 
temporary structures to provide guidance for the regeneration of tissues and therefore 
must be able to be remodelled by cells (Peters and Mooney, 1997). Sponge scaffold 
pore sizes fell within the critical range for applications in cartilage tissue engineering 
with the range obtained (20-150μm) previously reported to facilitate chondrocyte 
differentiation (Matsiko et al., 2015). Chondroprogenitor cell invasion, over 21 days, 
supports the suitability of a wider porosity as well as the presentation of appropriate 
mammalian cell binding motifs throughout the structure (Davidenko et al., 2016). 
Peptide alignment indicated areas of high sequence similarity with human COL1A1 
and COL3A1 and further functional analysis indicating these regions belong to 
pfam01391, the triple helical motif belonging to collagen. Collagen composition and 
structure plays a role in binding of cells through integrin binding (Emsley et al., 
2000). CP cell invasion and proximity to collagen ribbons, observed through 
histological staining, indicate that specific binding motifs such as GFOGER are 
present allowing cell-matrix interactions (Rentsch et al., 2014).  
 
Our results indicate show that JCol can be isolated from native tissue and shows 
presence of triple helix composition through functional peptide analysis and FTIR in 
a similar fashion to mammalian collagens. JCol scaffolds manipulated into sponges 
facilitate cell invasion and growth of cells within a 3D environment due to the 
similarity of the niche with native ECM of tissue when compared to cell only 
alternatives. The natural ECM environment guides cellular functions and the loss of 
this can cause alterations in cell phenotype and behaviour (Bonnans et al., 2014). A 
number of cell types have proved difficult to culture in 2D whilst maintaining their 
native biological including cancer cells and hepatocytes, whilst differentiation of 
stem cells into functional mature tissue cells show varying characteristics (Duval et 
al., 2017). Initial results regarding CPs and JCol scaffolds indicate that these 
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structures may present themselves as a suitable source for the in vitro culture of cells 
whilst maintaining their native biological phenotype and function.  
 
6.3 CPs, scaffold assisted enhanced chondrogenesis  
 
Biomimetic structures have been developed in order to produce a more functionally 
relevant engineered tissue for repair purposes (Zhang, 2012). The aim of biomimetic 
constructs is to provide a familiar niche for stem and progenitor cells to enable 
interaction and to enhance their differentiation capacity (Vinatier et al., 2009). 
Biomimicry can take multiple forms from matrix informed scaffold design, 
decoration of structure with ligands and mechanical tuning (Ravichandran et al., 
2012). Scaffolds in this project fulfil the requirements of biomimicry as they are 
produced from collagen, a natural matrix component and facilitate cell invasion.  
 
The MACI technique aims to produce a biomimetic environment by providing a 
scaffold to guide the growth of cells and enhance the production of cartilage specific 
matrix. Previous publications have shown that cartilage tissue engineering continues 
to aim for biomimicry of the native tissue through the alteration of pore size, use of 
different cell sources and biomaterials during in vitro examination (Taraballi et al., 
2017) . Although preclinical testing is basic as it removed from the entire tissue 
system, behaviour exhibited by the cells is seen as indicative of physiological 
function due to the mimicry of the construct involved. 
 
Pellet culture is the standard practice used for studying in vitro chondrogenesis, 
replicating the high cellular density needed to assess chondrocyte production of 
distinct cartilage matrix properties and protein components including distinct 
collagen architecture, as well as COL2A1 and GAG production (Bernstein et al., 
2009). Missing the fundamental complexity of the tissue due to the absence of ECM 
support, this model is inadequate to predict the in vivo potential of next generation 
MACI approaches (Achilli et al., 2012). Clinical studies have already shown that 
MACI surgery gives better cartilage repair in patients compared to those who were 
treated using microfracture or ACI indicating that matrix models have an enhanced 
chondrogenic capacity (Jeuken et al., 2016). This may indeed be due to the enhanced 
Chapter 6                                                                                                   General Discussion 
 
 262 
progenitor or stem cell migration to a familiar niche, relying on mechanical 
properties, concentration gradients of growth factors or simply the presentation of 
cell collagen peptides such as those detected in JCol.  
 
Bovine chondroprogenitors migrated throughout the JCol scaffold and showed 
enhanced differentiation in the presence of TGFβ1 (10ng/ml-1), previously shown to 
induce mesencymal cell condensation and initiate chondrogenesis in MSCs (Wang et 
al., 2014). Although pellet cultures exhibited a higher expression of SOX9, ACAN 
and COL2A1 when compared to scaffolds, interestingly they also exhibited the 
highest expression of hypertrophic markers RUNX2 and COL10A1. These results 
indicate that the presence of a matrix structure enables the guidance of CP cells 
towards chondrogenic lineage without inducing high amount of hypertrophic 
markers (Watts et al., 2013). 
 
Native Immature cartilage is seen to be softer and weaker than mature cartilage 
(Julkunen et al., 2009). Implantation of a scaffold in early chondrogenic stages 
would still require maturation and risks damage whereas in vitro maturation may 
produce tissue closer to native cartilage, increasing the likelihood that the cartilage 
implant could withstand the forces applied through the injured joint post operation 
(Jin et al., 2011). Initial models should show the process of chondrogenesis and 
cartilage formation and limited immunogeniticy occurs in vivo using heterotropic and 
orthotropic models where the construct is placed in at a non cartilage and non-weight 
bearing cartilage site (Reinholz et al., 2004). The presence of chondrogenesis in 
these constructs would allow for further in vivo testing for immunogenicity and 
finally in a weight-bearing model. While a non-weight bearing approach is one 
method of progressing a pre clinical study, in vitro maturation is an alternative option 
(Khan et al., 2013). Maturation is the process whereby cartilage undergoes resorption 
to form organised zonal structure and collagen fibre orientation resulting in increased 
mechanical integrity (Hunziker et al., 2007). Previous work has shown that a 
combination of growth factors can induce maturation including FGF2 and TGFβ1 
(Khan et al., 2013) and members of the BMP family causing growth and resorption 
as well as hypertrophy (Kraan et al., 2010). Enhanced chondrogenesis and 
maturation within the 3D JCol sponge could provide a tissue engineered construct, 
requiring a shorter rehabilitation process benefiting patient rehabilitation and 
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potentially reducing the economic burden of OA patients recovering from repair 
surgery (Schrock et al., 2017).  
 
The zonal variation throughout the depth of articular cartilage allows for its 
compressive resistance and therefore the advancement of chondromimetic scaffolds 
may potentially take native structure into account (Fox et al., 2009). Matrix based 
approaches have been researched in an attempt to emulate the structure (Klein et al., 
2009). These techniques have primarily involved the formation of biomaterial 
density throughout the construct leading to a more natural distribution found within 
the tissue to encourage hapotaxis before differentiation (Mimura et al., 2008). The 
development of JCol scaffolds through the modelling of concentration gradient may 
not only better mimic native cartilage but would potentially allow for better cell 
distribution and matrix deposition.   
 
6.4 Biocompatibility  
 
Whilst preclinical demonstration provides a robust defence of specific applications, 
ultimately these constructs need to be implanted. The initial implantation of a 
biomaterial is accompanied by injury that triggers the immune system (Franz et al., 
2011). This is characterised by adsorption of blood proteins to the biomaterial and 
acute inflammation caused by the activation of leukocytes (Brown and Badylak, 
2014). The persistence of leukocyte activation eventually results in chronic 
inflammation and fibrotic capsule formation with the risk of rejection and necrosis of 
implant and native tissue (Wiles et al., 2016).  
 
Using a bovine model, no information could be garnered regarding the compatibility 
of our cartilage construct. In the absence of ethical permissions and financial scope, 
an in vitro model was used during this project to identify any JCol characteristics 
indicative of abnormal immunogencicity, using human donor blood samples. 
Fulfilling the requirements set out by the International Organisation of 
Standardisation (Radley et al., 2017), immune cells from innate and adaptive phase 
were screened via FACS for activation markers (CD62L, CD11b and fMLPr) in the 
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presence and absence of JCol scaffolds, comparing favourably to research and 
clinical grade collagen.  
 
Cytokines are released by immune cells as a response to foreign material and have 
different functions (Turner et al., 2014). A cytokine release profile was also collated 
from in vitro testing with IL-6, a pro-inflammatory cytokine, and IL-10, an anti-
inflammatory cytokine chosen for investigation and shown to be comparable across 
all scaffold materials.  Carbodiimide crosslinking has been shown to increase M1 
response leading to an upregulation of proinflammatory cytokines (Boehler et al., 
2011) however our results showed that a there was minimal differences seen between 
crosslinking concentrations. The immune response is a cascade of reactions that are 
dependent on one another with neutrophil and monocytes activation leading to the 
increase in pro-inflammatory cytokine release and the subsequent activation of the 
adaptive arm of the response and anti-inflammatory cytokine release (Chaplin, 
2010). JCol scaffolds show that the levels of leukocyte activation lead to the relative 
cytokine release, exhibiting a favourable response compared to rejection of tissue. 
 
The preliminary data shown was gathered from a cohort of three donors, with donor 
variability clearly observed. Despite this variability, a similar trend was observed in 
mammalian research and clinical grade collagen, sources that are already used in 
vivo (Song et al., 2006). Similarly our in vitro testing incubated scaffolds with blood 
for 2 hours before analysing leukocyte activation and allowed 24 hours before 
cytokine analysis. This would suggest that the response to jellyfish scaffold is 
representative of the innate immune response and that in vivo analysis through an 
animal model over a longer time period would account for the adaptive immune 
response. In order to enhance the reliability of this data and account for variability a 
larger cohort would need to be screened prior to a full in vivo analysis.  
 
In vitro testing does not mimic the complex in vivo environment and response to 
biomaterials (Chu et al., 2010). The development of in vitro models allows for 
preliminary results to guide research towards the use of animal models that can 
assess immunogenicity in response to biomaterial implantation as well as 
regeneration through analysis of gene and protein expression (Al-Maawi et al., 
2017).  
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Heterotropic models take into account the performance of the construct under in vivo 
conditions by assessing tissue formation and immune response. However the 
response may be altered compared to when placed at the defect and therefore 
heterotropic models will inform in vitro and in vivo studies (Reinholz et al., 2004). In 
vivo cartilage studies are typically conducted using small animals however the small 
joint size leads to thin cartilage that does not benefit clinical translation (Chu et al., 
2010). Large animal, caprine, ovine and equine, models by-pass the limitation of 
rodent and lapine models, with larger joints that mimic load bearing patterns more 
similar to that seen in humans (Cook et al., 2014). 
 
Previous publications have reported different ways in which scaffolds can be 
immune tuned in order to avoid the elicitation of an immune response and potential 
rejection of the construct. Scaffold material choice and topography play a role in 
immune response modulation can be acquired by surface treatment and coating 
(Boehler et al., 2011). Increasing hydrophobicity of scaffolds has been shown to 
limit dendritic cell maturation (Kou and Babensee, 2011) whilst osteopontin coating 
displayed a reduction in the thickness of fibrotic capsule formed around the implant 
(Liu et al., 2008) and serum coated biomaterials induced anti-inflammatory cytokine, 
IL-10 (Boehler et al., 2011). 
 
ACI circumvents graft rejection by utilising cells from the patients however the 
limited number of cells and donor site morbidity make the technique less appealing 
(McCarthy et al., 2016). The use of allogenic cells, either alone or in combination 
with a scaffold for MACI can evade the further damage of healthy tissue via 
harvesting but may elicit an immune response (Dunkin and Lattermann, 2013). 
Research has been conducted in the immunomodulation of scaffold for cartilage 
tissue engineering with biomaterials coated in anti-inflammatory proteins shown to 
modulate inflammation in subcutaneous implantation (Fahy et al., 2015). 
 
6.5 Concluding remarks 
 
Currently, mammalian collagen is used in 2D and 3D culture to varying success 
and growing concerns over economic and ethical issues have resulted in the 
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interest of alternative sources. This thesis has shown that R. pulmo jellyfish 
collagen can be extracted at industrial scale whilst maintaining structural 
integrity and can be used to fabricate sponge scaffold structures. This thesis has 
demonstrated jellyfish collagen is biocompatible with multiple cell types 
displaying viability and phenotypic stability in comparison to traditional tissue 
culture plastic and other collagen sources. Furthermore, the in vitro 
immunogenic profile was found to be comparable to rat-tail and bovine 
collagen, both of which are used for research and clinical applications. In 
addition, chondrogenesis of bovine CPs within JCol scaffolds exhibited an 
enhanced chondrogenesis observed through chondrogenic gene expression and 
matrix deposition, with minimal expression of hypertrophic markers. Results 
from this thesis indicate that R. pulmo derived jellyfish collagen is a suitable 
alternative source of collagen that fulfils minimal requirements for tissue 
engineering purposes, specifically cartilage engineering. The knowledge from 
this body of work can now inform industrial partner, Jellagen, movements 
towards the development of R. pulmo collagen solutions and biomaterials for 2D 
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